Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
AAAS		ENSG00000094914	"Aladin WD repeat nucleoporin"	Q9NRG9	12	53307456-53324864	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040086	Approved		Approved	"Nuclear membrane,Centrosome,Cytosol"				"Nuclear membrane"	"Centrosome, Cytosol"	"HPA040086: AB_10805602"	"unprognostic (1.53e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.64e-2)"	"prognostic unfavourable (2.93e-4)"	"unprognostic (1.95e-1)"	"unprognostic (9.82e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.44e-2)"	15.0	35.1	13.4	22.0	16.6	19.9	16.5	19.2	18.4	17.6	16.4	22.6	20.9	15.4	19.3	26.1	18.2	25.3	19.4	20.7	13.2	11.8	20.4	26.0	13.4	23.4	19.3	10.1	19.7	27.3	33.1	27.3	23.6	15.8	17.3	19.3	21.5	22.8	18.5	19.7	22.2	17.5	21.2	16.4	22.0	19.1	26.6	19.5	39.1	19.5	24.6	24.4	17.2	16.9	15.3	17.2	8.2	14.7	10.0	16.7	10.1	10.1	30.9	24.2	14.8	11.5	14.0	15.5	11.6	12.6	29.2	16.9	21.0	21.6	24.4	20.0	14.7	14.8	42.1	31.0	17.3	15.4	27.2	19.8	13.7	21.1	11.7	17.5	15.0	13.3	15.6	19.4	18.9	23.0	26.2	28.3	14.1	32.9	27.4	18.1	16.6	21.6	27.0	16.1	27.3	20.7	8.4	13.0	16.5	8.5	19.4	9.0	24.8	15.3	10.4	13.9	21.1	11.0	12.2	12.7	16.0	22.1	11.2	15.2	16.0	1.2	12.1	8.2	13.7	14.0	16.5	15.2	12.3	12.6	13.7	15.3	16.7	16.2	1.1	10.0	14.7	17.2	12.6	10.1	13.4	16.6	19.2	18.4	13.2	11.8	19.3	10.1	15.8	19.5
ABCA13	"FLJ33876, FLJ33951"	ENSG00000179869	"ATP binding cassette subfamily A member 13"		7	48171458-48647496	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"bone marrow: 35.4;lung: 15.7;lymphoid tissue: 14.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 8.5;LHCN-M2: 3.6;U-2 OS: 10.2;U-266/84: 4.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"basophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA063601			Approved	Vesicles,Centrosome,Cytosol				Vesicles	"Centrosome, Cytosol"	"HPA063601: "	"unprognostic (8.97e-2)"	"unprognostic (5.82e-2)"	"unprognostic (3.18e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.86e-3)"	"unprognostic (6.03e-3)"	"unprognostic (3.26e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.62e-2)"	0.3	0.2	0.1	0.3	1.0	35.4	0.7	0.0	1.1	1.2	0.3	0.4	0.0	0.3	0.3	1.1	10.3	1.8	0.5	3.5	1.8	0.2	1.1	0.7	15.7	0.2	0.1	0.0	0.4	1.2	0.1	8.7	1.2	0.4	0.2	0.4	0.0	1.7	0.4	0.8	1.3	0.3	0.2	0.9	1.3	0.2	4.2	0.0	4.6	7.1	5.4	14.4	0.5	0.3	0.6	0.6	3.2	0.7	1.0	0.4	0.2	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.3	1.0	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.5	1.2	2.1	0.0	8.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.9	0.0	0.0	0.1	3.6	0.0	0.0	0.1	0.1	2.1	0.3	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.6	10.2	0.4	1.5	3.0	4.1	0.0	1.3	0.4	0.4	3.2	0.7	0.6	0.3	0.4	0.3	0.4	0.2	0.2	0.1	0.6	0.4	0.4	1.6	1.0	0.3	0.6	0.1	0.2	0.1	1.0	0.0	1.1	1.8	0.2	0.1	0.0	0.4	0.0
AK6	CINAP	ENSG00000085231	"Adenylate kinase 6"	Q9Y3D8	5	69350984-69370013	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005361, HPA070217"	Supported		Supported	"Nuclear speckles,Centrosome,Cytosol"				"Nuclear speckles"	"Centrosome, Cytosol"	"CAB005361: AB_2302969, HPA070217: "	"unprognostic (5.47e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.58e-2)"	"unprognostic (8.73e-2)"	"unprognostic (4.09e-2)"	"prognostic unfavourable (9.54e-4)"	"unprognostic (1.79e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.55e-2)"	27.6	27.7	25.1	16.9	25.4	14.8	23.3	21.5	23.6	17.6	22.7	11.3	16.4	18.3	18.3	30.4	26.7	15.4	15.1	17.9	23.2	22.2	30.2	42.3	17.0	18.7	20.9	16.2	18.8	17.2	15.8	26.3	21.5	23.3	18.2	20.6	12.3	14.5	14.6	41.4	11.9	24.0	16.7	19.6	21.8	17.0	46.1	17.5	25.2	24.3	24.2	18.8	19.7	13.7	22.2	22.0	14.3	15.9	16.6	21.2	10.0	17.2	9.6	12.6	16.8	20.7	13.8	23.7	26.0	9.8	12.8	15.9	26.8	14.9	37.0	24.6	11.8	5.8	19.7	12.4	19.6	15.1	9.5	18.2	20.5	20.4	16.9	21.6	7.9	8.0	16.4	12.7	18.3	8.3	17.0	12.2	16.4	20.0	19.9	14.6	10.5	6.4	23.4	15.7	20.5	20.1	14.1	6.5	6.4	13.4	10.8	18.6	11.5	24.4	10.9	9.6	15.4	17.9	21.5	14.7	30.6	32.8	12.4	31.8	12.4	13.7	13.0	14.3	15.5	15.9	16.1	22.2	18.4	19.3	18.0	18.1	20.1	21.2	2.1	16.6	14.2	22.0	18.1	10.0	25.1	25.4	21.5	23.6	23.2	22.2	20.9	16.2	23.3	17.5
AKAP9	"AKAP350, AKAP450, CG-NAP, HYPERION, KIAA0803, LQT11, MU-RMS-40.16A, PPP1R45, PRKA9, YOTIAO"	ENSG00000127914	"A-kinase anchoring protein 9"	Q99996	7	91940867-92110673	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease mutation, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008548, CAB012909, HPA026109"	Supported		Enhanced	"Golgi apparatus,Vesicles,Centrosome"				"Golgi apparatus"	"Vesicles, Centrosome"	"CAB012909: AB_2533235, HPA008548: AB_1078121, HPA026109: AB_1844688"	"unprognostic (9.57e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.59e-2)"	"unprognostic (7.59e-2)"	"unprognostic (6.32e-2)"	"prognostic favourable (2.10e-6)"	"unprognostic (8.89e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.96e-2)"	13.7	15.9	18.0	22.6	17.1	14.9	15.6	35.8	17.5	14.4	24.5	4.7	17.2	25.5	13.0	17.1	15.3	12.4	15.0	14.8	13.3	7.0	19.5	25.1	19.9	13.2	12.4	12.3	22.3	21.3	22.1	40.5	12.9	14.0	11.9	25.3	11.1	20.1	25.9	29.6	16.1	29.1	12.0	11.1	10.4	15.0	6.9	14.4	10.3	14.9	15.7	8.6	14.0	14.2	34.4	39.5	31.9	16.6	10.6	20.3	3.4	11.2	7.0	10.4	6.6	14.9	11.0	7.4	8.4	5.7	4.3	5.5	11.9	9.8	10.2	12.2	7.4	10.4	10.0	5.5	8.1	9.2	8.5	11.2	12.2	7.8	6.1	18.5	11.9	6.9	8.8	8.9	10.2	9.3	16.6	16.7	7.3	16.3	12.6	7.3	8.0	8.7	7.7	17.4	8.2	5.9	12.4	17.0	11.9	17.8	20.0	8.6	5.2	9.0	17.1	8.7	11.2	15.2	11.4	12.0	13.2	13.7	7.7	9.4	9.8	31.9	16.6	21.4	18.4	9.3	15.4	31.4	18.7	16.7	7.2	34.4	20.3	19.3	23.2	10.6	16.3	39.5	14.9	3.4	18.0	17.1	35.8	17.5	13.3	7.0	12.4	12.3	14.0	14.4
ALMS1	KIAA0328	ENSG00000116127	"ALMS1, centrosome and basal body associated protein"		2	73385758-73610793	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"testis: 23.2"	"Cell line enhanced"	"Detected in all"		"RH-30: 23.8"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA035276, HPA035277, HPA043200"	Enhanced		Enhanced	Nucleoplasm,Centrosome,Cytosol				"Centrosome, Cytosol"	Nucleoplasm	"HPA035276: , HPA035277: , HPA043200: AB_10796689"	"unprognostic (2.86e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.91e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.58e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.85e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	3.4	1.7	3.0	6.5	5.5	6.3	3.9	5.5	4.5	6.0	4.0	5.4	4.3	2.0	7.4	3.9	2.2	7.9	4.3	1.6	3.4		3.5	2.1	2.7	2.5	2.0	5.0	11.0	4.0	6.1	6.6	3.2	3.6	3.6	3.3	4.7	2.3	5.8	2.3	1.8	2.4	4.2	3.2	2.1	2.8	23.2	3.4	6.7	5.1	1.9	3.2	2.9	4.1	0.8	1.3	1.3	0.4	0.5	1.2	0.0	8.4	3.3	6.2	4.5	2.4	4.0	3.9	2.9	3.2	4.8	3.6	3.7	1.1	7.9	1.8	4.8	3.7	10.4	3.2	7.2	4.7	2.9	5.3	3.7	2.9	2.1	7.3	2.6	3.1	1.9	6.6	3.3	4.2	5.9	4.2	4.0	2.5	6.9	3.3	8.0	3.1	7.7	23.8	3.3	1.2	3.0	5.1	6.0	6.6	1.1	2.7	1.4	1.8	2.6	6.7	7.0	5.3	6.9	4.9	2.5	8.5	2.5	4.2	3.0	0.0	0.1	1.3	1.2	0.2	0.3	0.2	0.6	0.1	0.1	0.8	0.4	0.6	0.0	0.5	0.4	1.3	0.1	0.0										
ANKRD45	"CT117, FLJ45235"	ENSG00000183831	"Ankyrin repeat domain 45"	Q5TZF3	1	173609561-173669862	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 14.6;fallopian tube: 24.8;parathyroid gland: 16.8;pituitary gland: 7.9;testis: 20.8"	"Cell line enhanced"	"Detected in some"		"AF22: 11.8;BJ hTERT+: 4.2;BJ hTERT+ SV40 Large T+: 3.8;BJ hTERT+ SV40 Large T+ RasG12V: 6.4;HBF TERT88: 4.2;SH-SY5Y: 10.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031655, HPA031656, HPA031657"	Enhanced		Approved	"Plasma membrane,Centrosome,Cytosol"				Cytosol	"Plasma membrane, Centrosome"	"HPA031655: AB_10610975, HPA031656: AB_10600331, HPA031657: AB_10602196"	"unprognostic (1.93e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.02e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.15e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.49e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.91e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.61e-1)"	0.5	1.3	5.9	0.4	14.6	0.5	0.6	1.1	7.0	2.8	0.7	9.0	1.3	0.4	3.3	2.5	0.5	24.8	1.0	0.9	7.7	4.7	2.7	0.5	2.8	0.4	2.4	5.3	2.4	1.0	16.8	7.9	0.4	9.2	1.9	0.5	1.8	0.4	1.2	0.4	0.4	0.5	2.4	2.7	1.3	0.5	20.8	4.2	0.0	1.3	0.0	0.4	0.6	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.4	11.8	0.0	0.0	0.9	2.0	0.1	4.2	3.8	6.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.5	0.0	2.3	0.0	0.1	0.2	0.2	0.5	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.3	0.4	0.0	1.6	10.7	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.1	0.9	0.0	2.2	0.1	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.9	14.6	1.1	7.0	7.7	4.7	2.4	5.3	9.2	4.2
ANP32A	"C15orf1, I1PP2A, LANP, MAPM, mapmodulin, PHAPI, PP32"	ENSG00000140350	"Acidic nuclear phosphoprotein 32 family member A"	P39687	15	68778535-68820897	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB005231, HPA063133, HPA067561"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol			740000	"Nucleoplasm, Centrosome"	Cytosol	"CAB005231: AB_2289588, HPA063133: , HPA067561: "	"unprognostic (1.41e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.03e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.44e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.17e-1)"	25.8	20.4	32.7	32.0	40.1	46.0	28.2	50.7	33.7	24.5	30.7	40.5	16.0	27.0	26.8	21.7	28.8	30.0	23.4	47.8	32.3	23.6	30.0	29.6	27.2	55.0	33.9	30.0	26.7	25.6	24.2	18.3	38.6	26.6	30.4	35.4	27.2	23.6	27.8	41.7	18.9	28.9	30.5	42.7	40.1	29.8	9.4	36.7	75.0	29.0	18.5	52.4	35.7	27.6	12.7	19.8	27.7	19.9	18.1	12.3	9.6	26.0	32.0	42.1	36.3	14.8	13.0	28.0	13.7	18.5	27.0	22.8	26.4	49.1	84.6	25.8	15.5	38.3	97.4	28.1	32.5	38.1	33.1	64.0	27.1	33.0	9.2	50.3	34.6	10.4	19.9	14.8	29.6	39.2	46.5	33.1	23.1	18.2	50.5	41.3	37.4	16.2	70.9	39.1	50.2	23.8	41.2	55.9	34.7	20.9	23.6	38.7	31.4	66.0	17.5	28.0	44.6	19.3	36.7	20.1	55.7	98.0	18.6	84.7	25.6	8.1	17.6	27.7	11.9	19.9	10.0	12.7	9.8	12.3	19.8	12.7	12.1	10.6	18.1	18.1	16.8	17.6	11.2	9.6	32.7	40.1	50.7	33.7	32.3	23.6	33.9	30.0	26.6	36.7
ANP32B	"APRIL, PHAPI2, SSP29"	ENSG00000136938	"Acidic nuclear phosphoprotein 32 family member B"	Q92688	9	97983361-98015943	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA063133, HPA067561, HPA069657"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol			290000	Nucleoplasm	"Centrosome, Cytosol"	"HPA063133: , HPA067561: , HPA069657: "	"unprognostic (2.82e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.52e-2)"	"prognostic unfavourable (1.98e-7)"	"unprognostic (6.76e-3)"	"unprognostic (5.70e-2)"	"unprognostic (7.16e-2)"	"unprognostic (3.50e-1)"	"unprognostic (6.39e-2)"	"unprognostic (9.22e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.78e-2)"	43.0	24.6	37.9	46.5	55.5	105.7	37.7	15.6	30.1	43.2	38.9	81.0	24.6	32.7	46.3	38.4	40.4	28.4	39.2	27.0	41.8	32.0	26.0	35.9	35.0	70.4	55.7	21.7	51.1	46.0	29.3	20.7	37.5	41.8	38.9	42.3	26.2	32.5	29.7	29.4	38.6	34.9	45.3	88.3	38.6	36.7	19.0	47.6	85.9	37.0	31.9	81.8	64.5	58.6	34.8	32.6	36.8	44.6	22.7	51.3	25.1	70.9	38.4	42.8	35.7	24.1	42.7	39.0	36.9	32.7	39.7	33.5	48.1	34.9	87.1	22.1	24.7	47.0	57.7	41.6	45.6	56.5	32.5	75.3	33.0	51.9	31.0	129.1	43.9	32.3	30.5	31.8	65.8	34.4	144.9	61.7	30.5	94.8	97.4	114.8	16.7	38.2	58.2	66.8	41.4	25.9	29.8	34.6	30.2	43.3	42.3	37.8	23.9	48.3	41.7	25.9	42.0	32.5	38.7	56.0	63.2	52.6	24.0	51.8	48.2	23.1	27.2	36.8	22.7	30.9	31.3	34.8	42.7	31.9	32.6	29.6	51.3	38.7	11.3	22.7	44.6	31.8	50.8	25.1	37.9	55.5	15.6	30.1	41.8	32.0	55.7	21.7	41.8	47.6
ANP32D	PP32R2	ENSG00000139223	"Acidic nuclear phosphoprotein 32 family member D"	O95626	12	48472665-48473624	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.3;REH: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA063133, HPA067561"	Uncertain		Enhanced	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Centrosome"	Cytosol	"HPA063133: , HPA067561: "		"unprognostic (2.20e-1)"	"unprognostic (3.75e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.11e-2)"		"unprognostic (1.72e-3)"		"unprognostic (2.30e-2)"		"unprognostic (3.62e-3)"		"unprognostic (2.76e-2)"		"unprognostic (3.48e-1)"		0.1	0.9	0.3	0.0	0.2	0.1	0.2	0.2	0.6	0.0	0.5			0.0	0.6	0.8	0.2	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.7	0.0	0.2		1.1	0.1	0.0	0.2	0.5		0.3	0.2		0.4	0.3	0.2	0.0	0.1	0.2	0.2	0.5	0.2	0.9			0.8		0.0	0.4	0.1	0.1	0.1	0.6	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.4	0.4	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.6	0.2	0.0	0.0	0.3	0.0										
ANP32E	"LANP-L, LANPL, MGC5350"	ENSG00000143401	"Acidic nuclear phosphoprotein 32 family member E"	Q9BTT0	1	150218417-150236156	"Predicted intracellular proteins"		"Chaperone, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB021114, HPA063133, HPA067561"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol			18000	"Nucleoplasm, Centrosome"	Cytosol	"CAB021114: AB_10057407, HPA063133: , HPA067561: "	"unprognostic (1.04e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.51e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.47e-3)"	"prognostic unfavourable (4.50e-5)"	"unprognostic (1.64e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.73e-3)"	"unprognostic (2.47e-1)"	"prognostic unfavourable (3.82e-8)"	"unprognostic (1.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.52e-1)"	11.5	18.3	31.2	21.0	30.9	38.4	10.6	50.3	20.6	14.3	11.3	18.3	13.5	12.9	16.5	21.0	12.8	12.8	11.9	19.8	22.9	25.9	18.6	16.8	13.3	38.4	26.5	19.5	19.1	6.9	20.1	14.7	12.3	21.2	14.2	10.9	20.1	9.2	20.9	25.5	12.5	14.5	25.2	32.7	20.3	9.9	6.0	17.8	52.2	18.1	13.6	34.7	20.6	12.1	24.5	8.2	20.7	10.5	14.6	27.0	15.7	33.7	21.9	45.7	22.7	3.6	5.3	17.4	18.2	10.3	17.6	16.9	16.1	24.0	61.6	16.2	10.4	11.8	25.7	11.3	25.3	70.5	15.6	42.7	27.2	23.2	3.4	85.6	21.7	4.3	1.8	16.4	15.2	13.0	40.8	36.5	16.1	35.1	34.9	22.3	46.1	10.0	37.2	25.4	32.4	12.5	13.6	15.0	25.8	38.0	6.1	10.7	16.5	43.8	13.4	9.0	25.5	9.3	36.4	47.2	47.3	60.4	10.3	61.9	16.4	20.7	10.5	16.3	18.0	7.3	27.0	24.5	24.2	19.7	8.2	17.0	17.4	21.6	7.2	14.6	8.8	5.7	25.7	15.7	31.2	30.9	50.3	20.6	22.9	25.9	26.5	19.5	21.2	17.8
ASAP1	"CENTB4, DDEF1, KIAA1249, PAP, ZG14P"	ENSG00000153317	"ArfGAP with SH3 domain, ankyrin repeat and PH domain 1"	Q9ULH1	8	130052104-130443660	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 61.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 4.1;granulocytes: 13.0;monocytes: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011136, CAB037292, HPA048565"	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"			25000	"Plasma membrane, Centrosome, Cytosol"		"CAB037292: AB_476723, HPA011136: , HPA048565: "	"unprognostic (1.20e-2)"	"unprognostic (1.15e-2)"	"unprognostic (7.68e-2)"	"prognostic unfavourable (5.81e-5)"	"unprognostic (1.77e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavourable (5.63e-8)"	"prognostic unfavourable (3.56e-5)"	"unprognostic (3.34e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (1.50e-7)"	"unprognostic (3.79e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.22e-3)"	34.1	17.2	10.5	9.5	12.5	29.7	19.8	6.4	21.8	19.3	8.9	9.1	6.6	4.4	15.6	18.9	10.5	11.8	14.5	17.5	10.0	11.0	7.9	7.6	26.2	12.9	11.3	8.0	15.2	6.8	21.7	8.2	27.3	15.2	9.9	7.2	13.9	6.2	13.9	13.0	12.1	8.4	16.6	11.9	26.1	8.0	21.7	9.7	5.6	12.3	10.6	14.5	12.9	21.2	1.5	4.1	13.0	6.6	0.7	1.6	1.1	15.3	11.5	16.8	9.5	14.6	21.7	13.5	16.4	28.7	20.1	21.5	5.8	5.8	3.5	11.7	23.8	3.9	8.6	14.4	28.1	5.5	5.2	6.1	6.7	7.4	37.6	2.6	1.9	20.4	4.8	10.6	17.7	21.0	3.1	14.1	17.5	4.6	3.5	2.7	4.2	10.5	4.9	3.0	2.4	5.1	8.3	4.8	15.7	12.1	7.4	8.7	6.2	6.0	61.6	16.1	7.8	6.3	24.1	13.0	3.0	2.5	11.9	3.8	17.9	0.0	2.4	1.6	0.7	2.4	0.4	1.5	1.2	1.0	4.1	1.3	1.6	1.0	13.0	0.7	6.6	0.4	0.8	1.1	10.5	12.5	6.4	14.6	10.0	11.0	11.3	8.0	15.2	9.7
AURKA	"AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7"	ENSG00000087586	"Aurora kinase A"	O14965	20	56369389-56392337	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 32.3;testis: 41.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"CAB001454, HPA002636"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Centrosome, Cytosol"		"CAB001454: AB_563420, HPA002636: AB_1845217"	"unprognostic (7.73e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavourable (9.40e-5)"	"unprognostic (1.92e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavourable (1.49e-4)"	"unprognostic (4.69e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"prognostic unfavourable (6.13e-4)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (1.47e-8)"	"unprognostic (1.67e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (5.14e-2)"	3.7	2.3	1.5	12.7	1.3	8.3	3.0	1.3	1.8	1.4	6.7	1.3	0.8	7.3	1.8	1.2	7.7	1.1	3.7	4.1	1.1	1.1	2.4	5.1	2.9	12.3	1.6	0.9	8.3	1.4	0.3	0.7	6.1	1.5	1.0	8.3	1.5	2.7	0.5	6.9	2.1	7.2	2.7	1.3	7.4	4.3	41.1	1.1	32.3	1.2	5.9	13.3	2.4	2.4	3.9	5.2	6.0	8.7	2.0	6.6	2.6	32.5	24.0	16.1	11.3	0.9	2.1	20.4	26.7	12.5	64.7	27.3	67.2	22.8	10.7	18.4	10.9	26.3	28.5	17.9	69.0	9.6	10.9	19.0	24.6	41.8	0.5	25.4	26.8	1.0	1.9	22.4	20.1	15.1	21.5	8.5	27.5	33.2	15.2	19.7	14.7	24.8	11.6	31.1	11.8	10.3	8.6	13.9	7.5	37.3	43.0	17.9	25.5	15.9	8.6	28.1	27.9	15.5	37.6	11.9	13.8	18.5	15.2	14.8	23.2	0.2	5.3	6.0	1.9	8.7	2.9	3.9	3.3	1.9	5.2	1.4	1.5	1.5	3.7	2.0	4.8	1.2	6.6	2.6	1.5	1.3	1.3	1.8	1.1	1.1	1.6	0.9	1.5	1.1
AVEN	PDCD12	ENSG00000169857	"Apoptosis and caspase activation inhibitor"	Q9NQS1	15	33866227-34039176	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 6.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA020863	Approved		Approved	"Plasma membrane,Actin filaments,Centrosome"				"Plasma membrane, Actin filaments"	Centrosome	"HPA020863: AB_1845219"	"unprognostic (1.54e-3)"	"unprognostic (1.99e-1)"	"unprognostic (8.93e-2)"	"unprognostic (5.77e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (5.29e-10)"	"unprognostic (7.66e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.84e-3)"	11.0	11.1	7.1	8.7	7.7	5.2	16.1	14.4	8.8	9.6	12.4	6.8	8.6	9.0	13.4	9.5	11.5	8.9	10.6	35.0	6.9	8.7	5.8	16.7	8.0	6.0	8.6	6.8	10.3	41.0	3.6	9.0	15.0	8.3	10.6	12.2	5.4	9.8	11.8	25.7	9.3	9.9	15.3	8.1	7.3	10.9	14.1	6.1	9.9	5.4	11.6	9.4	11.6	15.0	1.2	6.1	0.2	1.7	1.2	2.3	0.3	8.3	13.6	14.1	4.6	11.5	13.1	8.4	21.3	19.1	17.1	11.0	3.7	5.9	7.8	13.2	17.9	5.7	6.4	13.9	14.1	7.6	4.2	13.5	8.9	10.4	17.2	13.5	9.9	10.9	27.5	10.0	24.4	18.3	13.3	11.5	23.7	8.9	5.3	23.3	6.6	4.7	8.1	7.9	16.7	13.9	11.0	7.5	9.1	11.8	6.2	5.8	6.7	15.0	12.9	15.1	5.2	6.4	17.6	11.3	8.9	16.5	7.2	15.9	8.0	0.0	0.8	0.0	1.6	1.7	2.0	1.2	1.7	0.6	0.6	0.6	0.8	1.1	0.2	1.2	0.7	6.1	2.3	0.3	7.1	7.7	14.4	8.8	6.9	8.7	8.6	6.8	8.3	6.1
BCAR3	"AND-34, NSP2, SH2D3B"	ENSG00000137936	"BCAR3, NSP family adaptor protein"	O75815	1	93561786-93847150	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 59.5"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.4;memory B-cell: 4.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014858	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	Centrosome	"HPA014858: AB_1845302"	"unprognostic (9.16e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.60e-3)"	"prognostic unfavourable (8.41e-4)"	"prognostic unfavourable (5.42e-4)"	"prognostic unfavourable (8.92e-7)"	"unprognostic (2.44e-1)"	"unprognostic (3.66e-1)"	"prognostic unfavourable (4.38e-4)"	"unprognostic (1.51e-2)"	"prognostic favourable (3.08e-7)"	"unprognostic (2.13e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.87e-1)"	26.0	10.4	10.1	11.6	14.2	0.9	23.1	8.6	8.1	10.2	14.1	10.0	6.2	12.4	5.7	5.9	8.9	9.4	15.5	10.6	10.6	8.0	15.5	11.0	12.8	11.8	11.7	5.6	11.2	4.1	4.5	4.6	59.5	10.6	11.2	15.7	10.1	20.5	14.5	19.5	13.3	14.8	10.6	9.7	5.4	15.2	7.3	8.0	2.6	10.0	6.6	11.7	12.7	17.7	4.5	1.7	4.4	1.1	0.0	0.3	0.1	15.1	6.5	12.2	0.9	5.3	4.2	10.5	15.6	27.3	12.9	8.0	1.1	11.3	2.4	5.4	24.1	9.4	0.3	20.2	11.3	1.0	0.3	0.0	4.7	2.8	9.5	0.1	0.0	4.9	22.4	13.3	45.4	14.2	0.4	0.0	34.9	2.3	0.2	0.0	3.8	22.5	1.0	17.6	0.3	33.8	19.2	0.4	1.0	7.6	8.1	9.7	9.1	0.6	16.7	19.2	5.0	8.2	20.6	1.3	0.5	0.3	2.8	0.0	7.0	4.4	0.0	0.1	0.0	1.1	0.0	4.5	0.1	0.0	0.8	2.5	0.0	0.3	0.0	0.0	0.0	1.7	0.3	0.1	10.1	14.2	8.6	8.1	10.6	8.0	11.7	5.6	10.6	8.0
BIRC7	"KIAP, ML-IAP, mliap, RNF50"	ENSG00000101197	"Baculoviral IAP repeat containing 7"	Q96CA5	20	63235883-63240507	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 14.4;placenta: 13.6;retina: 21.1"	"Cell line enriched"	"Detected in some"	4	"SK-MEL-30: 62.2"	"Cancer enriched"	"Detected in many"	10	"melanoma: 73.7"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	9	"T-cells: 2.0"	"Not detected"	"Not detected"							"HPA047850, HPA061283"			Enhanced	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA047850: , HPA061283: "	"unprognostic (3.60e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.24e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.82e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.84e-2)"	1.6	1.3	1.0	0.7	1.0	0.3	0.7	0.1	2.2	3.0	1.3	0.5	0.1	0.4	0.8	14.4	0.3	0.3	0.5	2.8	0.9	1.1	2.6	0.8	2.3	2.2	4.9	1.0	0.2	0.1	0.1	0.6	13.6	1.5	0.4	0.3	21.1	0.8	0.1	0.1	4.9	0.3	0.2	4.3	1.6	0.3	0.4	0.3	0.3	0.3	1.0	0.5	0.4	1.8	0.0	0.0	0.0	0.2	0.0	2.0	0.1	0.1	1.4	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	2.1	0.4	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.0	0.0	0.0	0.2	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	62.2	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	1.0	0.1	2.2	0.9	1.1	4.9	1.0	1.5	0.3
BUD31	"Cwc14, EDG-2, EDG2, fSAP17, G10, YCR063W"	ENSG00000106245	"BUD31 homolog"	P41223	7	99408641-99419616	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028943	Approved		Approved	Nucleoplasm,Microtubules,Centrosome				Nucleoplasm	"Microtubules, Centrosome"	"HPA028943: AB_10602396"	"unprognostic (1.68e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.63e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.16e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavourable (9.66e-4)"	"unprognostic (1.42e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.71e-1)"	26.4	31.9	43.6	26.1	44.8	66.6	29.5	28.3	36.4	25.6	31.3	25.6	31.6	27.0	25.1	32.2	35.2	35.7	28.1	30.8	39.2	36.3	37.9	33.2	26.2	34.5	39.5	27.4	28.8	31.4	21.0	35.2	33.7	32.3	27.3	22.7	22.0	31.5	28.9	20.7	23.5	31.2	25.4	34.5	29.1	26.7	51.2	27.0	24.1	40.1	29.0	31.6	35.3	26.5	39.1	32.2	91.2	42.7	34.1	37.6	56.6	25.0	29.6	16.6	37.1	16.6	18.7	16.1	24.1	23.1	27.7	30.4	34.5	25.0	19.2	29.5	23.2	15.0	18.2	22.0	23.2	23.2	24.7	14.0	21.1	22.6	34.7	23.8	18.5	18.3	27.3	25.2	47.6	21.5	34.3	44.1	25.4	65.8	31.2	64.6	36.4	37.1	16.4	16.7	33.2	24.1	20.0	29.1	35.0	23.8	27.5	50.0	17.3	30.1	17.5	26.4	33.6	52.2	37.6	27.7	46.5	51.3	23.3	35.6	47.7	59.1	39.3	91.2	34.1	40.5	31.9	39.1	32.8	33.0	32.2	36.6	27.9	29.2	83.0	34.1	42.7	31.1	37.6	56.6	43.6	44.8	28.3	36.4	39.2	36.3	39.5	27.4	32.3	27.0
C12orf73	"DKFZp547P055, FLJ13975"	ENSG00000204954	"Chromosome 12 open reading frame 73"	Q69YU5	12	103950202-103965708	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 43.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA038883	Uncertain		Approved	"Plasma membrane,Centrosome,Mitochondria"	"Secreted - unknown location"			"Centrosome, Mitochondria"	"Plasma membrane"	"HPA038883: AB_10794735"	"unprognostic (9.24e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.66e-3)"	"unprognostic (7.20e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (6.98e-4)"	"unprognostic (8.96e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.27e-2)"	"prognostic favourable (1.61e-4)"	6.7	11.4	14.3	8.3	14.5	4.4	9.7	15.5	17.5	7.2	7.4	11.4	7.2	7.7	9.5	13.2	7.0	8.9	5.5	11.1	13.0	14.6	9.4	8.3	5.8	10.0	13.3	13.3	11.5	9.7	9.4	21.0	7.3	13.6	10.7	9.5	8.3	8.3	11.1	43.8	9.0	7.7	7.9	14.1	7.0	9.9	10.1	13.8	11.4	11.5	12.9	10.2	6.6	6.9	11.7	11.3	8.6	5.1	12.0	14.5	3.9	5.9	11.2	16.9	10.4	4.9	6.5	11.0	6.5	3.9	7.2	5.9	11.9	5.2	7.1	8.6	3.9	9.6	10.1	8.2	5.5	10.1	20.4	10.7	16.3	14.9	7.2	15.7	9.8	5.7	9.5	3.6	6.4	6.6	13.7	4.9	6.6	6.8	17.4	23.7	8.2	19.1	10.1	6.3	7.0	9.5	8.1	27.8	9.5	6.5	11.4	15.0	19.4	8.5	3.4	8.9	5.0	6.6	6.6	13.2	20.2	14.8	10.1	8.9	7.7	7.3	5.1	8.6	10.5	4.2	10.4	11.7	9.8	10.0	7.2	10.7	14.5	13.5	1.4	12.0	3.8	11.3	13.8	3.9	14.3	14.5	15.5	17.5	13.0	14.6	13.3	13.3	13.6	13.8
C9orf40	FLJ10110	ENSG00000135045	"Chromosome 9 open reading frame 40"	Q8IXQ3	9	74946581-74952886	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 31.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 5.3"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA042167	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol			290000	"Nucleoplasm, Cytosol"	Centrosome	"HPA042167: AB_10797382"	"unprognostic (2.10e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.65e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.18e-1)"	"prognostic unfavourable (3.43e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.15e-3)"	"unprognostic (6.78e-3)"	"unprognostic (3.74e-2)"	"unprognostic (4.21e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.20e-2)"	6.2	4.0	8.3	9.7	8.0	9.0	18.8	8.1	12.4	5.1	9.9	5.6	2.8	14.3	5.2	3.0	5.2	3.6	5.0	3.6	7.4	8.4	4.1	5.1	2.8	8.4	8.4	5.6	4.2	3.5	6.6	4.4	6.5	6.7	3.9	9.2	2.2	3.0	4.8	4.7	3.5	18.7	4.9	11.2	5.4	3.6	31.1	5.1	10.5	3.0	3.4	8.0	5.0	16.0	1.8	0.9	5.3	0.5	0.0	2.1	0.3	16.7	3.7	9.6	3.9	3.9	5.0	17.9	13.4	4.2	9.3	10.1	1.0	5.2	15.1	4.0	3.3	5.0	7.5	0.7	15.0	20.4	11.6	8.0	6.7	6.4	3.1	9.6	12.8	2.4	5.1	5.2	3.7	2.8	11.3	10.3	12.1	4.7	16.9	11.3	11.3	11.3	15.9	7.6	3.6	3.9	4.1	10.5	4.6	5.8	5.0	4.0	6.0	7.4	3.7	8.5	9.5	11.5	11.6	19.8	14.8	9.6	6.4	10.8	9.0	1.8	0.2	5.3	1.0	0.4	0.4	1.8	1.1	1.0	0.2	1.3	2.1	1.3	0.5	0.0	0.5	0.9	1.2	0.3	8.3	8.0	8.1	12.4	7.4	8.4	8.4	5.6	6.7	5.1
CABCOCO1	"bA63A2.1, C10orf107, Em:AC022398.2, MGC44593"	ENSG00000183346	"Ciliary associated calcium binding coiled-coil 1"	Q8IVU9	10	61662961-61766766	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 33.1;testis: 18.6"	"Cell line enriched"	"Detected in some"	4	"MOLT-4: 23.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041398	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol				Centrosome	"Nucleoplasm, Cytosol"	"HPA041398: AB_10794374"	"unprognostic (1.89e-3)"	"unprognostic (7.37e-2)"	"unprognostic (2.23e-1)"	"prognostic favourable (1.79e-4)"	"prognostic unfavourable (4.88e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.52e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.33e-2)"	1.5	1.2	6.3	0.7	5.7	0.5	2.1	0.4	6.8	6.1	1.6	9.5	3.0	1.0	5.2	7.6	0.9	33.1	3.8	0.7	8.1	7.3	2.6	0.9	10.3	0.9	8.1	5.8	4.1	1.6	10.0	5.2	1.4	13.7	5.9	1.3	1.5	1.7	3.7	0.6	0.8	0.9	3.0	14.8	1.9	0.9	18.6	5.6	0.0	1.9	0.0	0.6	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	2.4	0.0	0.4	1.6	0.3	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.1	0.1	0.8	0.1	0.0	0.1	0.0	23.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	5.2	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	5.7	0.4	6.8	8.1	7.3	8.1	5.8	13.7	5.6
CAPRIN2	"C1QDC1, caprin-2, EEG1, FLJ11391, FLJ22569, RNG140"	ENSG00000110888	"Caprin family member 2"	Q6IMN6	12	30709552-30754951	"Predicted intracellular proteins"	"Differentiation, Growth regulation"	"Protein synthesis inhibitor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039746	Supported		Supported	Nucleoplasm,Centrosome,Cytosol				Cytosol	"Nucleoplasm, Centrosome"	"HPA039746: AB_10672902"	"unprognostic (7.45e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.91e-2)"	"unprognostic (9.90e-2)"	"unprognostic (3.09e-1)"	"unprognostic (3.30e-2)"	"prognostic unfavourable (3.50e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.82e-1)"	"prognostic favourable (8.36e-4)"	5.5	7.8	12.5	5.3	20.6	9.3	5.0	19.9	15.7	7.3	5.3	4.4	9.5	4.0	8.6	10.5	3.6	4.9	6.1	17.4	11.8	19.0	6.5	5.3	6.5	5.4	11.2	11.6	8.3	5.5	22.4	11.0	4.2	18.2	7.4	5.7	6.1	3.1	10.0	5.6	10.6	4.6	8.4	11.5	6.7	6.5	22.3	9.4	4.3	5.7	3.9	5.0	6.1	8.1	4.1	4.2	7.5	1.5	2.6	5.4	0.9	4.6	3.2	6.1	5.2	6.1	6.5	3.7	8.6	7.3	3.7	5.1	1.7	3.0	2.7	7.6	9.0	3.7	3.2	14.0	6.8	4.0	3.6	11.3	5.3	6.5	3.4	1.7	1.1	7.4	5.6	12.0	9.7	8.4	0.7	2.7	8.8	0.9	2.2	2.9	7.2	9.9	1.0	9.2	1.3	1.6	16.7	7.7	4.7	3.2	2.3	3.7	2.1	0.5	11.4	7.2	4.0	22.0	15.8	5.3	3.7	2.4	8.8	0.5	4.7	7.5	1.5	1.2	4.4	0.6	5.4	3.7	2.8	4.6	0.6	4.1	3.1	2.8	0.3	2.6	0.7	4.2	1.8	0.9	12.5	20.6	19.9	13.7	11.8	19.0	11.2	11.6	18.2	9.4
CAPS2		ENSG00000180881	"Calcyphosine 2"	Q9BXY5	12	75275979-75390928	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 21.7"	"Cell line enhanced"	"Detected in many"		"A549: 5.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 1.8"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040004	Uncertain		Approved	Nucleoplasm,Nucleoli,Centrosome				Centrosome	"Nucleoplasm, Nucleoli"	"HPA040004: AB_10794758"	"unprognostic (1.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.26e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.69e-1)"	2.6	4.2	8.0	1.2	5.8	1.6	3.7	15.5	11.2	3.7	2.5	5.5	2.1	1.8	5.0	8.8	3.6	21.7	3.4	5.4	6.3	6.6	6.6	4.2	5.8	1.3	5.4	5.6	4.5	2.6	7.3	15.8	0.9	7.8	5.1	2.0	4.4	5.5	3.6	3.8	2.6	1.9	2.0	8.7	2.6	3.2	8.0	9.5	1.4	9.3	2.2	1.4	2.6	2.0	0.1	0.6	0.0	0.7	1.1	1.8	0.1	1.8	5.0	1.4	0.4	2.5	1.9	0.2	1.0	0.2	2.7	2.9	0.0	2.3	0.5	4.4	0.7	1.1	0.0	2.2	1.9	1.7	0.8	2.1	0.8	0.0	0.0	0.3	0.0	0.8	1.3	2.3	0.5	0.3	0.4	0.8	3.5	0.1	2.4	2.0	0.7	0.7	0.0	0.0	0.2	3.5	0.0	2.9	1.4	0.2	0.1	1.6	1.7	0.7	1.1	2.5	1.1	0.6	0.4	0.2	0.0	0.0	2.2	0.0	2.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.7	0.0	0.0	0.1	0.6	0.9	0.0	1.1	0.7	0.6	1.8	0.1	8.0	5.8	15.5	11.2	6.3	6.6	5.4	5.6	7.8	9.5
CCDC51	FLJ12436	ENSG00000164051	"Coiled-coil domain containing 51"	Q96ER9	3	48432164-48440456	"Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010980, HPA011408"	Supported		Supported	Nucleoplasm,Centrosome,Mitochondria				"Nucleoplasm, Mitochondria"	Centrosome	"HPA010980: AB_1846155, HPA011408: AB_2072212"	"unprognostic (1.24e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.75e-3)"	"unprognostic (4.71e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.47e-3)"	"unprognostic (6.46e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-1)"	9.9	14.9	10.1	7.1	12.7	4.5	9.6	10.4	15.9	8.9	12.8	7.5	12.4	11.6	8.2	11.4	15.9	9.7	8.4	12.3	9.2	8.2	15.2	17.8	7.1	9.0	9.9	15.4	8.7	8.5	9.4	7.4	8.5	10.6	7.7	15.1	9.9	11.0	11.2	16.3	10.9	8.8	11.6	8.8	14.7	7.9	10.7	8.9	10.4	11.3	16.1	12.0	8.8	9.7	19.2	18.2	4.8	10.4	10.6	14.8	9.7	9.6	11.8	7.1	8.3	10.5	11.1	19.5	6.4	5.9	12.9	10.6	18.6	16.2	21.0	9.2	5.1	14.1	17.4	21.0	7.9	9.8	11.4	17.9	18.7	13.9	16.2	8.7	8.2	8.4	47.7	16.0	17.5	7.3	9.9	6.1	12.2	9.2	10.1	11.3	15.5	19.1	7.0	8.3	16.2	17.5	12.1	5.9	12.3	10.6	11.6	17.2	12.5	13.5	5.5	7.5	10.2	18.6	12.3	9.9	14.5	10.9	10.0	18.9	7.0	2.0	10.4	4.8	12.0	10.2	12.1	19.2	11.2	14.8	18.2	15.4	11.7	13.4	4.5	10.6	6.1	15.2	13.4	9.7	10.1	12.7	10.4	15.9	9.2	8.2	9.9	15.4	10.6	8.9
CCDC88B	"BRLZ, CCDC88, FLJ00354, FLJ37970, GIPIE, HkRP3"	ENSG00000168071	"Coiled-coil domain containing 88B"	A6NC98	11	64340223-64357534	"Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.5;brain: 23.7;lymphoid tissue: 29.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 39.8;Karpas-707: 10.4;THP-1: 15.8;U-937: 11.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"							HPA026652	Approved		Approved	Nucleoplasm,Centrosome,Cytosol	"Intracellular and membrane"			Centrosome	"Nucleoplasm, Cytosol"	"HPA026652: AB_1846168"	"unprognostic (1.18e-2)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.36e-1)"	"prognostic favourable (1.48e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.55e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.94e-1)"	"unprognostic (7.32e-2)"	"prognostic unfavourable (7.65e-5)"	"unprognostic (3.77e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.83e-2)"	3.5	2.5	5.2	29.5	5.4	32.5	2.7	23.7	2.8	2.6	6.1	4.5	6.9	3.2	2.0	1.3	4.2	2.5	8.5	2.3	4.1	2.6	2.0	1.6	11.4	18.6	8.6	2.2	1.3	2.1	0.7	1.6	1.4	6.5	2.9	2.9	1.7	7.5	8.9	0.8	1.9	11.1	1.3	7.2	26.6	3.3	7.3	6.5	16.8	1.9	2.7	20.8	4.1	2.8	3.0	3.5	11.3	6.5	7.1	4.6	1.6	0.1	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	1.5	9.0	1.4	0.5	0.7	0.0	0.2	0.0	9.8	0.0	6.8	1.8	0.5	0.4	4.2	39.8	0.0	0.0	0.1	0.0	0.2	0.2	10.4	0.3	0.4	5.7	3.5	0.3	0.2	5.4	0.1	8.4	0.1	0.1	2.2	0.0	0.0	0.2	0.4	1.2	15.8	0.0	0.0	0.3	0.0	0.1	2.2	0.7	7.3	0.5	11.5	0.2	3.6	6.5	7.6	4.6	4.7	1.4	2.2	2.7	3.8	2.1	3.0	2.6	3.2	11.3	7.1	3.1	3.5	0.8	1.6	5.2	5.4	23.7	2.8	4.1	2.6	8.6	2.2	6.5	6.5
CD163L1	"CD163B, M160, SCARI2, WC1"	ENSG00000177675	"CD163 molecule like 1"	Q9NR16	12	7346685-7479897	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 18.4;lymphoid tissue: 31.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 8.2;HUVEC TERT2: 8.8;TIME: 8.3;U-87 MG: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA015663	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol	"Intracellular and membrane"		170000	"Centrosome, Cytosol"	Nucleoplasm	"HPA015663: AB_2072575"	"unprognostic (1.25e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.46e-3)"	"unprognostic (2.29e-2)"	"unprognostic (7.79e-2)"	"unprognostic (9.39e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.26e-6)"	"unprognostic (8.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.69e-1)"	5.0	1.7	1.2	19.1	1.2	0.0	2.5	0.8	1.6	1.4	9.2	0.3	1.0	5.5	1.2	8.5	1.8	1.3	2.6	3.2	1.2	1.0	1.7	1.5	2.8	14.6	1.1	0.7	1.0	1.0	0.1	1.4	6.8	3.3	1.4	15.1	2.7	2.5	1.4	1.1	1.4	18.4	1.8	1.0	31.2	2.6	4.6	0.2	9.5	1.7	6.4	12.9	4.3	1.2	0.2	0.7	0.7	0.8	0.0	0.0	0.2	0.2	0.4	0.2	0.0	1.0	0.3	0.0	0.8	1.8	0.2	0.8	0.0	1.4	0.0	0.3	0.8	0.0	0.0	1.1	1.4	8.2	0.0	0.0	0.4	1.2	0.0	0.5	0.0	0.3	0.0	0.2	3.3	8.8	0.1	4.7	5.2	0.0	0.0	6.5	0.2	0.0	1.5	1.5	1.8	0.0	0.0	1.2	5.5	4.3	6.8	0.0	0.0	5.4	8.3	3.0	2.7	0.3	0.0	0.1	0.1	0.0	19.4	0.4	5.7	0.0	0.8	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	1.2	0.8	1.6	1.2	1.0	1.1	0.7	3.3	0.2
CDC45	"CDC45L, CDC45L2"	ENSG00000093009	"Cell division cycle 45"	O75419	22	19479459-19520612	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"		"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.7;lymphoid tissue: 25.4;testis: 43.5"	"Cell line enhanced"	"Detected in many"		"K-562: 86.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000614, CAB009459"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"CAB009459: AB_2078507, HPA000614: AB_1078487"	"unprognostic (5.56e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.17e-3)"	"unprognostic (3.42e-3)"	"unprognostic (3.57e-1)"	"unprognostic (7.42e-2)"	"prognostic unfavourable (6.95e-6)"	"unprognostic (6.01e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (8.94e-4)"	"unprognostic (7.28e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.62e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.10e-1)"	0.9	0.9	0.3	8.4	0.5	15.7	0.9	0.3	0.6	1.3	3.4	0.3	0.2	2.2	0.6	1.4	6.2	0.4	0.8	1.6	0.7	0.3	0.8	1.4	1.3	7.5	0.4	0.2	0.7	0.5	0.1	0.4	3.5	0.4	0.7	4.3	0.2	1.3	0.2	0.4	2.1	3.1	1.1	0.4	4.2	1.8	43.5	0.2	25.4	0.5	7.2	10.2	1.3	1.9	0.7	0.9	1.6	0.5	1.8	3.2	1.9	13.1	11.0	13.7	10.7	0.6	1.3	5.8	16.2	7.6	18.7	18.6	8.4	7.3	14.6	5.7	4.8	12.6	14.6	10.7	16.8	17.8	24.7	19.5	12.4	9.2	0.7	28.3	10.7	0.4	0.5	14.3	6.4	9.4	86.6	18.4	10.9	17.5	22.9	13.4	4.1	8.3	19.1	22.8	6.4	4.3	12.6	17.7	9.3	8.8	9.7	2.8	6.3	12.6	3.6	14.6	23.4	11.0	14.7	6.3	11.6	17.0	7.7	14.2	19.5	0.0	0.2	0.0	2.2	0.0	0.0	0.7	1.4	2.3	0.6	0.0	1.0	0.7	1.6	1.8	0.5	0.9	3.2	1.9	0.3	0.5	0.3	0.6	0.7	0.3	0.4	0.2	0.4	0.2
CDK2		ENSG00000123374	"Cyclin dependent kinase 2"	P24941	12	55966769-55972784	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 105.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 88.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013115, HPA066915"	Enhanced		Enhanced	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"CAB013115: AB_2536375, HPA066915: "	"unprognostic (2.36e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (9.94e-4)"	"prognostic unfavourable (8.61e-5)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.38e-3)"	"unprognostic (4.69e-3)"	"prognostic unfavourable (1.46e-10)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.16e-2)"	"unprognostic (6.75e-2)"	10.7	7.6	4.5	20.8	6.5	18.7	11.5	4.2	4.3	12.6	11.6	3.5	6.0	6.1	10.7	6.4	13.6	10.8	12.6	10.1	5.4	2.2	8.3	16.7	19.5	12.2	6.0	2.0	14.2	8.3	5.2	4.2	49.0	7.3	10.8	9.1	51.2	9.3	9.9	10.8	14.6	9.3	11.8	5.0	12.5	10.1	7.8	5.1	39.3	9.5	10.7	14.7	16.7	10.1	9.3	10.8	5.2	3.9	4.5	7.6	4.3	16.5	8.9	19.6	10.9	4.0	5.2	36.2	20.6	10.8	25.6	24.0	18.7	15.9	15.7	15.5	7.6	10.6	14.9	9.0	26.1	18.5	14.6	18.1	14.8	7.1	1.3	14.3	13.1	2.7	2.3	17.3	6.0	12.9	17.2	14.3	17.8	12.7	29.6	12.1	7.8	13.3	29.0	18.9	11.8	7.4	16.2	8.1	10.5	23.5	8.6	105.5	18.6	10.5	7.2	17.7	17.2	13.6	15.0	8.2	9.4	19.6	10.0	10.5	15.2	5.2	3.6	3.1	7.0	3.9	7.0	9.3	3.2	5.0	2.7	6.1	3.0	5.3	1.7	4.5	1.6	10.8	7.6	4.3	4.5	6.5	4.2	4.3	5.4	2.2	6.0	2.0	7.3	5.1
CDR1	"CDR, CDR34, CDR62A"	ENSG00000184258	"Cerebellar degeneration related protein 1"	P51861	X	140782405-140784871	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"brain: 56.2"	"Cell line enhanced"	"Detected in some"		"AF22: 3.3;BJ: 6.5;MOLT-4: 4.1;U-87 MG: 23.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA073147			Approved	"Nucleoplasm,Golgi apparatus,Centrosome"				"Nucleoplasm, Golgi apparatus, Centrosome"		"HPA073147: "	"unprognostic (7.10e-2)"				"unprognostic (2.87e-2)"	"unprognostic (2.85e-1)"		"unprognostic (3.49e-2)"		"unprognostic (1.44e-1)"	"unprognostic (1.03e-2)"		"unprognostic (2.41e-3)"	"unprognostic (1.46e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.84e-1)"		3.2	1.3	9.1	0.5	26.3	0.0	0.0	56.2	28.7	0.0	0.1			0.2	0.4	0.0	0.6	0.2	1.5	1.5	9.2	2.8	0.1	0.0	0.6	0.1	3.7		0.1	3.9	0.0	7.1	0.4		0.1	0.0		0.6	0.0	0.2	9.4	0.1	0.0	3.6	0.9	0.5	0.1			0.7		0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.6	3.3	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.1	0.0	0.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.4	0.0	1.2	0.0	0.0	0.0	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CENPJ	"BM032, CPAP, LAP, LIP1, MCPH6, Sas-4, SASS4, SCKL4"	ENSG00000151849	"Centromere protein J"	Q9HC77	13	24882284-24922889	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Dwarfism, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA060426			Approved	"Nucleoplasm,Plasma membrane,Centrosome"				"Nucleoplasm, Plasma membrane, Centrosome"		"HPA060426: "	"unprognostic (2.69e-1)"	"unprognostic (3.17e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.15e-5)"	"unprognostic (7.41e-2)"	"unprognostic (1.50e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.48e-2)"	"prognostic unfavourable (1.75e-5)"	"unprognostic (7.36e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-1)"	5.0	3.5	6.6	6.7	11.9	10.2	6.2	18.4	6.4	10.3	7.6	5.0	7.2	7.5	8.8	4.8	6.6	6.0	3.3	4.2	5.4	4.4	3.9	2.9	4.9	8.5	9.7	3.8	8.1	3.2	2.1	4.6	7.6	7.2	6.3	8.8	2.4	4.6	12.0	3.6	7.6	9.0	9.1	11.6	7.4	4.6	24.3	10.1	14.6	20.8	5.7	7.8	7.9	7.8	4.3	2.4	3.8	1.3	2.2	2.1	0.7	5.2	5.1	17.6	16.3	2.5	3.6	9.9	12.4	5.6	7.7	7.2	6.7	9.4	9.7	3.7	4.5	12.9	13.2	7.0	11.9	8.8	6.6	34.9	12.2	5.6	1.2	16.0	11.5	2.1	2.0	6.8	3.8	5.8	9.8	18.0	8.0	5.1	10.9	21.8	9.9	3.9	12.2	12.2	4.9	3.0	6.0	8.9	8.3	6.3	6.8	5.0	3.4	10.9	5.5	9.1	6.2	12.6	8.1	5.0	9.1	10.4	4.2	11.7	14.1	1.9	0.8	3.8	2.1	1.3	0.9	4.3	1.4	1.6	0.9	4.1	1.8	0.9	0.4	2.2	0.9	2.4	1.5	0.7	6.6	11.9	18.4	6.4	5.4	4.4	9.7	3.8	7.2	10.1
CEP170	"FAM68A, KAB, KIAA0470"	ENSG00000143702	"Centrosomal protein 170"	Q5SW79	1	243124428-243255348	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.7"	"Cell line enhanced"	"Detected in many"		"WM-115: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042151, HPA045597, HPA045787"	Uncertain		Enhanced	"Mitotic spindle,Centrosome,Cytosol"				Centrosome	"Mitotic spindle, Cytosol"	"HPA042151: , HPA045597: , HPA045787: "	"unprognostic (2.97e-1)"	"unprognostic (2.49e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.83e-5)"	"unprognostic (8.05e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.09e-2)"	"unprognostic (3.52e-2)"	"unprognostic (6.65e-2)"	"prognostic unfavourable (1.30e-9)"	"unprognostic (2.21e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.49e-3)"	"unprognostic (9.62e-3)"	9.5	6.1	13.7	10.8	13.2	36.5	6.8	27.7	23.2	7.4	5.4	11.4	3.1	3.1	9.1	5.2	5.5	6.4	11.1	8.6	12.8	11.2	3.8	6.7	8.4	7.3	19.3	13.7	13.3	2.8	2.8	10.8	9.8	20.2	5.0	4.2	3.3	4.2	5.5	9.3	4.2	4.7	7.4	25.8	7.8	4.2	53.7	18.0	11.6	14.4	3.3	8.9	8.6	6.6	9.4	8.4	12.3	10.1	2.8	4.7	2.1	6.0	5.1	13.1	11.1	8.2	15.9	2.8	16.1	9.5	12.1	11.4	3.1	5.9	4.5	9.8	13.6	3.0	11.3	6.9	17.2	10.0	6.5	4.6	4.8	2.2	7.1	8.2	8.8	10.0	1.9	38.5	16.9	28.1	11.3	4.7	15.3	1.3	5.0	4.3	16.5	14.5	9.0	9.4	1.5	2.5	1.0	19.0	25.7	8.2	0.7	7.7	2.8	11.1	31.1	22.6	6.7	12.1	18.4	4.6	5.9	9.0	12.0	7.5	51.8	3.5	8.3	7.6	1.9	10.0	2.7	3.6	3.8	1.6	8.4	9.4	4.7	2.7	12.3	2.8	10.1	5.5	2.9	2.1	13.7	13.2	27.7	15.8	12.8	11.2	19.3	13.7	20.2	18.0
CEP70	"BITE, FLJ13036"	ENSG00000114107	"Centrosomal protein 70"	Q8NHQ1	3	138494344-138594538	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"gdT-cell: 4.2;MAIT T-cell: 5.0;memory B-cell: 2.9;memory CD4 T-cell: 3.4;memory CD8 T-cell: 3.7;naive B-cell: 2.0;naive CD4 T-cell: 5.9;naive CD8 T-cell: 6.4;NK-cell: 3.6;T-reg: 2.0"	"Group enriched"	"Detected in many"	8	"B-cells: 2.9;NK-cells: 3.6;T-cells: 6.4"	"Low region specificity"	"Detected in all"							"HPA036941, HPA036942"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Cytosol"	Centrosome	"HPA036941: AB_10670567, HPA036942: AB_10670957"	"unprognostic (1.61e-1)"	"prognostic favourable (2.93e-4)"	"unprognostic (2.27e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.95e-2)"	"unprognostic (9.92e-3)"	"unprognostic (9.04e-2)"	"unprognostic (4.25e-2)"	"unprognostic (5.01e-3)"	"prognostic unfavourable (9.60e-5)"	"unprognostic (8.90e-3)"	"unprognostic (8.07e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.71e-3)"	"unprognostic (6.43e-2)"	5.5	8.3	11.0	5.7	15.8	3.5	9.0	14.7	15.6	20.8	12.2	7.1	22.8	35.7	14.0	14.8	10.2	20.3	8.9	11.3	10.9	15.9	17.0	18.8	11.5	4.2	12.6	10.2	14.4	17.4	16.6	27.8	2.7	14.4	14.3	12.1	12.6	6.1	28.7	10.6	4.6	11.5	14.0	19.1	3.9	8.6	41.5	15.3	24.2	26.2	6.7	4.5	13.3	9.1	2.9	0.2	0.5	0.1	3.6	6.4	2.0	21.5	4.5	10.6	13.0	6.6	7.5	10.0	4.2	8.1	5.9	8.8	6.3	11.7	5.1	10.2	8.0	9.5	9.7	8.5	13.5	8.9	6.3	14.6	10.5	8.2	10.5	0.7	5.4	40.2	5.0	4.5	11.2	8.6	10.6	17.1	9.7	8.1	15.3	0.8	6.3	10.2	16.9	13.8	13.1	11.4	9.6	13.0	8.4	22.5	5.4	25.4	27.0	7.0	5.0	4.4	8.4	9.0	5.2	15.9	8.7	17.3	9.8	1.4	14.9	0.4	0.1	0.2	4.2	0.1	5.0	2.9	3.4	3.7	0.1	2.0	5.9	6.4	0.5	3.6	0.0	0.2	2.0	2.0	11.0	15.8	14.7	15.6	10.9	15.9	12.6	10.2	14.4	15.3
CHPF	"CHSY2, CSS2"	ENSG00000123989	"Chondroitin polymerizing factor"	Q8IZ52	2	219538947-219543787	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035123	Approved		Supported	Vesicles,Centrosome,Cytosol	"Intracellular and membrane"			Cytosol	"Vesicles, Centrosome"	"HPA035123: AB_10602799"	"unprognostic (1.13e-3)"	"prognostic unfavourable (1.57e-4)"	"unprognostic (3.65e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.86e-3)"	"prognostic unfavourable (1.68e-4)"	"unprognostic (1.37e-1)"	"unprognostic (6.59e-3)"	"unprognostic (7.74e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (2.96e-4)"	8.6	14.1	9.7	8.4	11.8	1.4	6.8	8.5	19.4	22.1	8.6	11.3	23.0	18.4	17.0	24.6	7.9	9.2	17.1	36.3	12.2	10.7	11.3	52.1	11.6	5.4	9.0	10.5	38.1	60.7	16.3	36.9	62.7	10.4	19.3	3.8	27.4	31.6	19.9	4.3	9.0	13.3	9.1	8.3	4.5	15.6	34.2	7.0	3.8	17.9	7.4	10.6	11.9	8.5	1.3	11.1	6.9	0.1	2.1	3.0	0.8	18.5	3.7	2.7	23.2	10.6	16.6	31.8	18.9	16.0	5.4	4.9	10.3	16.4	5.8	40.7	18.2	23.8	1.8	11.4	0.8	8.9	6.4	2.0	5.2	44.5	14.8	1.8	12.2	22.3	20.1	5.4	5.2	0.0	12.9	14.2	5.1	29.2	0.2	4.8	11.5	14.3	0.0	8.8	11.3	6.4	8.4	6.8	10.4	9.1	8.8	25.8	3.0	6.3	0.4	19.9	10.9	23.7	9.8	17.1	5.3	2.6	18.2	1.8	20.0	2.1	0.0	6.9	2.4	0.1	3.0	1.3	1.9	1.6	0.0	0.1	2.2	0.8	0.0	2.1	0.0	11.1	1.2	0.8	9.7	11.8	8.5	19.4	12.2	10.7	9.0	10.5	10.4	7.0
CKAP5	"ch-TOG, KIAA0097, TOG, TOGp"	ENSG00000175216	"Cytoskeleton associated protein 5"	Q14008	11	46743048-46846308	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039377, HPA040375"	Supported		Approved	"Nucleoli,Plasma membrane,Centrosome"			460000	"Plasma membrane, Centrosome"	Nucleoli	"HPA039377: AB_10805477, HPA040375: AB_10794739"	"unprognostic (8.00e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.08e-2)"	"prognostic unfavourable (1.03e-6)"	"unprognostic (6.09e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.30e-3)"	"unprognostic (3.77e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.48e-1)"	"unprognostic (4.69e-2)"	13.7	25.5	20.6	11.5	25.7	18.6	12.5	34.6	32.9	11.3	14.6	16.5	7.3	10.2	13.7	10.4	11.7	9.5	10.1	16.6	19.2	19.3	9.7	37.7	8.5	14.1	18.8	21.1	23.8	7.9	20.0	20.8	13.8	33.0	13.5	15.0	9.1	8.7	12.0	26.3	10.7	9.9	16.1	22.5	8.8	12.9	25.4	22.2	28.6	8.0	10.8	14.7	12.6	9.7	8.6	8.4	6.0	8.7	11.7	10.0	3.6	25.9	25.1	53.9	23.1	12.8	20.1	12.5	29.8	18.1	28.4	30.2	20.4	8.8	28.3	10.5	20.0	29.5	38.6	16.9	35.7	25.5	29.5	47.2	20.1	19.6	9.5	36.0	19.8	10.2	9.0	15.9	34.5	21.4	33.3	26.6	23.4	17.9	30.6	9.3	29.0	20.2	32.5	57.4	24.8	9.1	16.0	25.1	21.4	40.5	14.5	14.8	26.7	9.8	18.4	27.6	24.4	46.7	43.9	15.1	32.6	40.8	17.3	17.1	27.0	5.4	5.7	6.0	9.0	8.7	8.8	8.6	6.7	10.0	8.4	8.0	8.2	8.5	0.9	11.7	7.8	5.4	7.5	3.6	20.6	25.7	34.6	31.2	19.2	19.3	18.8	21.1	33.0	22.2
CNOT10	"FLJ12890, FLJ13165"	ENSG00000182973	"CCR4-NOT transcription complex subunit 10"	Q9H9A5	3	32685145-32773875	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 64.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035614, HPA041450"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Centrosome"	Cytosol	"HPA035614: AB_10669975, HPA041450: "	"unprognostic (3.75e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.45e-3)"	"unprognostic (6.01e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.60e-2)"	"prognostic unfavourable (1.03e-6)"	"unprognostic (1.88e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.43e-1)"	12.3	12.6	11.3	15.2	12.4	16.6	14.0	14.2	13.4	13.4	14.0	12.5	12.8	10.8	19.8	13.5	14.8	16.1	9.8	13.0	10.5	9.4	13.1	13.5	11.4	14.7	9.7	11.9	14.7	14.0	16.0	23.0	11.3	13.3	13.1	15.7	12.2	12.0	10.9	13.5	14.9	14.7	12.8	10.5	15.1	12.2	40.5	10.9	30.2	13.8	11.9	17.4	13.0	12.6	15.0	14.1	16.0	21.0	9.0	18.5	11.2	8.2	9.3	9.7	9.1	4.7	5.4	64.7	7.0	7.0	10.0	11.3	7.0	7.2	13.6	4.7	4.9	7.3	11.4	9.2	10.0	11.7	11.7	17.4	8.4	6.8	13.7	14.3	6.7	4.0	8.3	11.0	14.6	8.1	18.1	10.6	5.8	6.8	12.7	6.9	14.6	8.9	12.9	6.6	13.6	6.4	9.7	5.5	10.7	10.3	14.5	8.4	14.1	16.2	5.0	6.2	8.8	8.1	11.5	11.0	22.5	13.6	6.3	10.9	7.5	12.8	11.2	16.0	11.4	15.7	12.3	14.8	18.5	13.6	14.1	15.0	18.5	16.2	8.8	9.0	21.0	7.8	14.4	11.2	11.3	12.4	14.2	13.4	10.5	9.4	9.7	11.9	13.3	10.9
CNTLN	"bA340N12.1, C9orf101, C9orf39, FLJ20276"	ENSG00000044459	Centlein	Q9NXG0	9	17134982-17503923	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 25.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 6.9"	"Lineage enriched"	"Detected in many"	4	"monocytes: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007201, HPA036728, HPA036729"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol				Centrosome	"Nucleoplasm, Cytosol"	"HPA007201: , HPA036728: AB_10670847, HPA036729: AB_10670240"	"unprognostic (1.97e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.71e-3)"	"unprognostic (5.07e-3)"	"unprognostic (1.06e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.38e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.80e-2)"	13.2	5.6	4.3	5.2	5.1	12.5	7.4	15.5	4.5	16.6	8.6	4.2	6.7	2.2	22.6	6.0	6.0	8.0	7.4	4.9	4.2	3.8	5.0	20.0	5.4	4.8	4.9	2.6	15.2	3.6	10.0	13.2	6.1	6.3	9.8	4.0	7.0	3.8	6.3	5.9	3.5	4.4	11.9	8.1	8.6	4.4	8.2	6.8	4.4	5.5	5.8	2.8	11.7	13.5	0.3	1.5	0.8	6.9	1.2	0.2	0.5	5.8	4.0	8.9	5.0	4.4	10.3	0.3	6.9	4.6	5.1	7.0	0.3	2.0	4.3	1.1	4.7	0.3	10.2	2.8	8.1	0.2	3.6	25.0	8.6	1.4	4.8	3.4	5.5	6.5	1.5	4.3	4.2	7.3	0.9	1.0	8.2	0.5	2.8	5.5	6.9	7.5	4.1	8.2	2.1	3.0	1.4	5.6	5.8	8.4	0.2	2.1	1.7	8.7	5.3	7.1	2.8	7.7	5.9	3.5	4.2	0.1	3.3	4.3	3.2	0.6	2.7	0.1	0.1	3.3	0.0	0.3	0.2	0.1	1.5	0.3	0.1	0.1	0.8	1.2	6.9	1.5	0.2	0.5	4.3	5.1	15.5	4.5	4.2	3.8	4.9	2.6	6.3	6.8
CPA4	CPA3	ENSG00000128510	"Carboxypeptidase A4"	Q9UI42	7	130293134-130324180	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 18.0;skin 1: 41.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 30.8;LHCN-M2: 62.5;U-2 OS: 34.2;U-87 MG: 61.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 10.0;head and neck cancer: 9.8"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							HPA021030			Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted in other tissues"		480000	Nucleoplasm	"Centrosome, Cytosol"	"HPA021030: AB_1846010"	"unprognostic (7.60e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.36e-3)"	"unprognostic (3.23e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.37e-3)"	"unprognostic (6.49e-2)"	"unprognostic (6.21e-10)"	"unprognostic (2.39e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavourable (1.31e-4)"	2.7	2.3	0.1	0.4	0.4	0.2	2.8	0.1	0.4	8.1	1.1	0.3	0.1	0.1	1.1	1.2	18.0	0.2	0.2	4.4	0.1	1.2	1.2	0.2	0.8	0.3	0.1	0.1	1.8	6.9	0.1	1.1	8.8	0.9	0.3	0.1	0.6	4.4	0.1	0.3	41.0	0.5	0.7	0.7	1.7	0.2	2.2	0.1	0.8	0.1	12.3	2.3	1.7	6.7	0.4	0.4	1.6	0.4	1.5	0.4	0.1	20.2	1.1	0.0	0.0	0.1	0.3	0.0	16.2	30.8	16.6	4.1	0.1	1.7	0.0	3.2	6.9	1.2	0.0	8.9	17.2	0.1	0.0	0.0	6.5	0.4	0.4	0.0	0.0	0.2	14.5	1.5	2.1	0.0	0.0	0.0	62.5	0.0	0.0	0.0	0.1	2.4	0.0	16.7	0.0	7.8	0.8	0.0	0.0	10.7	5.1	0.1	0.1	0.0	12.4	4.0	34.2	1.3	1.6	0.0	0.0	0.0	61.4	0.0	0.1	1.0	0.4	0.4	0.4	0.1	0.2	0.3	0.2	0.3	0.0	0.4	0.3	0.3	1.6	1.5	0.2	0.4	0.3	0.1	0.1	0.4	0.1	0.3	0.1	1.2	0.1	0.1	0.9	0.1
CPE		ENSG00000109472	"Carboxypeptidase E"	P16870	4	165361194-165498320	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 203.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 49.9;SCLC-21H: 70.2;SiHa: 103.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.5"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003819, CAB024907"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome	"Intracellular and membrane"		470000	Centrosome	"Nucleoplasm, Vesicles"	"CAB024907: , HPA003819: "	"unprognostic (1.84e-1)"	"unprognostic (5.64e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.91e-3)"	"unprognostic (9.01e-2)"	"unprognostic (4.84e-3)"	"unprognostic (5.56e-3)"	"prognostic unfavourable (2.60e-4)"	"unprognostic (4.35e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	"prognostic unfavourable (2.12e-4)"	27.7	33.8	123.1	4.4	135.5	0.9	21.5	82.9	203.7	10.7	9.6	31.6	5.3	5.0	13.3	94.3	16.4	15.7	14.0	19.6	116.9	56.3	12.0	6.3	11.0	7.6	56.9	70.7	23.4	35.5	33.9	40.0	2.2	53.0	66.5	8.8	13.2	12.0	20.1	11.0	5.5	6.2	18.5	40.5	2.8	19.2	30.4	53.3	0.9	40.7	4.3	7.7	6.3	9.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.3	9.0	1.7	7.2	0.8	0.4	0.0	3.6	1.3	2.9	0.0	0.0	0.0	2.6	0.0	0.2	3.4	0.7	0.8	0.0	13.2	0.0	3.7	49.9	0.5	0.0	0.0	17.6	3.7	0.0	0.0	0.0	0.0	0.3	1.8	2.5	0.0	0.4	5.7	2.0	0.0	0.0	0.1	0.1	0.5	70.2	23.2	103.0	12.9	0.0	7.7	0.3	0.0	2.8	7.2	0.2	0.2	3.9	0.0	0.3	2.6	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	123.1	135.5	82.9	82.2	116.9	56.3	56.9	70.7	53.0	53.3
CTNNBL1	"C20orf33, FLJ21108, NAP, NYD-SP19, P14, P14L"	ENSG00000132792	"Catenin beta like 1"	Q8WYA6	20	37693955-37872129	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004742, HPA027906, HPA027907"	Approved		Enhanced	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA004742: AB_1847323, HPA027906: , HPA027907: AB_10601362"	"unprognostic (2.81e-1)"	"unprognostic (3.42e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.31e-2)"	21.0	14.7	19.6	25.8	21.4	27.3	18.9	20.9	21.3	20.3	23.5	18.4	31.7	16.1	25.4	25.2	18.9	21.0	17.7	25.6	17.5	15.8	19.3	35.3	19.3	26.9	17.9	14.7	21.7	14.6	14.5	22.6	22.4	17.5	19.4	18.1	16.1	15.5	34.3	27.3	20.1	19.7	23.8	16.6	49.5	25.9	35.5	20.6	31.0	15.9	15.5	29.7	22.2	29.3	24.9	31.4	60.3	29.1	21.7	18.2	18.4	15.3	14.2	13.6	10.6	9.8	8.1	21.5	9.8	10.3	23.6	20.9	52.9	12.4	17.1	14.4	9.9	16.5	18.2	23.2	25.5	8.2	9.1	56.1	7.8	25.8	10.2	17.7	74.6	8.6	13.8	13.3	13.3	14.1	15.1	7.0	12.6	12.7	28.7	23.6	12.2	20.6	20.2	26.3	12.9	10.3	12.9	10.9	13.0	17.0	24.5	17.2	12.0	14.3	10.4	23.7	14.1	15.5	15.9	8.2	10.4	19.9	16.6	11.1	12.5	60.3	22.3	27.9	15.8	29.1	15.0	24.9	15.4	16.2	31.4	23.4	15.5	16.6	4.9	21.7	28.7	24.7	18.2	18.4	19.6	21.4	20.9	21.3	17.5	15.8	17.9	14.7	17.5	20.6
CUEDC1		ENSG00000180891	"CUE domain containing 1"	Q9NWM3	17	57861243-57955323	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	10	"plasmacytoid DC: 17.6"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023050, HPA024836"	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	Centrosome	"HPA023050: AB_1847332, HPA024836: AB_1847333"	"unprognostic (4.46e-1)"	"unprognostic (3.76e-3)"	"unprognostic (4.77e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.04e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavourable (2.65e-5)"	"unprognostic (6.69e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.37e-1)"	"prognostic favourable (8.46e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.65e-2)"	9.8	10.6	11.7	8.6	19.3	5.2	9.3	8.5	16.6	22.3	18.5	39.1	11.8	5.0	13.4	13.9	21.2	21.6	12.9	24.2	12.6	12.1	12.0	3.7	13.7	4.4	30.0	8.0	6.4	11.6	7.1	11.5	7.8	18.5	13.0	7.2	19.3	19.1	18.4	48.9	5.5	7.3	19.2	18.7	6.6	12.2	2.9	28.3	2.5	11.2	15.8	4.7	15.4	10.4	0.0	17.6	1.8	1.3	0.1	0.0	0.1	8.2	25.4	26.6	4.7	4.3	8.0	0.9	5.8	11.8	12.2	8.9	4.6	31.6	0.1	23.7	11.2	6.6	2.9	12.5	4.4	16.0	4.9	0.2	16.5	3.8	10.5	0.1	2.0	8.1	7.6	7.1	6.0	5.9	0.3	0.1	11.2	4.6	0.4	0.2	0.9	7.0	0.8	6.9	1.2	8.3	5.4	11.0	6.0	2.4	2.6	10.0	36.8	0.9	7.4	32.7	20.7	8.9	12.9	0.0	0.1	0.1	14.2	1.1	26.1	0.6	0.4	1.8	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.1	1.3	17.6	0.0	0.1	11.7	19.3	8.5	15.4	12.6	12.1	30.0	8.0	18.5	28.3
CYB5D2	MGC32124	ENSG00000167740	"Cytochrome b5 domain containing 2"	Q8WUJ1	17	4143168-4187310	"Predicted intracellular proteins, Predicted secreted proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042299	Approved		Approved	"Nuclear membrane,Nucleoli,Centrosome"	"Secreted - unknown location"			"Nuclear membrane"	"Nucleoli, Centrosome"	"HPA042299: AB_10793879"	"unprognostic (2.57e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.16e-2)"	"prognostic favourable (6.19e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.75e-2)"	"prognostic favourable (4.98e-6)"	"unprognostic (1.57e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.71e-3)"	"prognostic favourable (7.76e-5)"	"unprognostic (2.04e-1)"	"prognostic favourable (2.03e-10)"	"unprognostic (2.01e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.97e-1)"	13.1	17.3	18.7	5.1	26.4	3.6	15.0	20.6	27.5	15.0	8.1	21.8	14.6	13.3	13.9	27.1	9.8	17.4	14.5	10.3	17.8	21.6	22.9	25.3	8.6	7.4	19.7	26.1	19.5	17.0	28.5	18.5	9.9	19.1	12.0	6.8	17.3	17.5	16.8	12.2	11.7	10.3	7.8	21.7	7.9	12.3	54.1	17.1	4.8	20.6	7.1	6.8	12.0	8.6	9.4	13.0	14.7	12.7	5.9	12.5	9.0	7.8	10.5	6.1	6.4	39.3	11.6	2.5	7.6	16.4	5.5	5.7	3.1	5.2	2.5	6.9	8.8	11.1	2.5	3.5	2.2	8.3	12.6	2.4	6.6	5.2	7.1	1.0	4.8	15.1	8.4	3.0	6.0	10.0	2.5	15.5	4.2	9.6	3.6	1.6	2.2	5.7	4.4	5.4	6.2	12.8	4.1	4.9	4.1	8.5	5.0	11.2	13.2	1.5	13.5	8.1	2.1	7.5	3.9	3.0	2.2	1.9	10.0	2.2	3.1	0.6	12.7	14.7	7.2	10.4	8.1	9.4	11.4	8.8	12.0	9.4	10.8	9.7	11.7	5.9	9.4	13.0	12.5	9.0	18.7	26.4	20.6	27.5	17.8	21.6	19.7	26.1	19.1	17.1
DDX11	"CHL1, CHLR1, KRG2, WABS"	ENSG00000013573	"DEAD/H-box helicase 11"	Q96FC9	12	31073845-31104791	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA065197	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Centrosome"				Nucleoplasm	"Nucleoli fibrillar center, Centrosome"	"HPA065197: "	"unprognostic (6.10e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.79e-3)"	"prognostic unfavourable (2.40e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.89e-3)"	"unprognostic (3.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (5.23e-8)"	"unprognostic (1.89e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.03e-3)"	6.3	5.3	6.4	8.0	8.7	21.0	5.9	18.1	10.5	7.6	6.1	6.0	8.8	7.1	11.0	3.7	7.6	7.5	5.1	4.0	7.0	2.7	6.5	7.0	4.9	14.9	8.4	4.6	9.6	19.0	7.7	9.3	5.6	7.1	8.0	8.6	5.0	11.3	7.1	8.8	14.2	12.1	8.0	6.7	10.9	8.0	8.2	9.4	33.2	7.2	6.4	11.1	5.8	7.8	5.8	4.9	1.3	7.3	4.3	5.5	1.9	12.4	12.2	14.1	12.6	2.2	4.7	20.8	7.7	3.9	9.1	9.7	14.4	21.2	16.3	10.8	4.1	12.3	11.1	10.6	7.3	14.9	22.8	19.4	20.2	8.9	0.8	13.6	12.6	4.5	4.7	11.5	9.0	4.4	9.5	36.5	6.5	10.3	23.3	20.4	29.7	6.5	18.8	22.1	22.7	4.8	14.2	10.2	7.5	7.9	12.2	3.9	10.3	8.7	3.6	7.9	15.6	15.3	14.0	14.8	11.4	39.0	9.4	10.9	7.2	0.0	2.3	1.3	4.2	2.5	3.3	5.2	4.0	3.1	3.1	5.8	4.1	5.5	1.1	4.3	7.3	4.9	3.4	1.9	6.4	8.7	18.1	10.5	7.0	2.7	8.4	4.6	7.1	9.4
DENND1C	"FAM31C, FLJ22757"	ENSG00000205744	"DENN domain containing 1C"	Q8IV53	19	6467207-6482557	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 26.7;lymphoid tissue: 32.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 12.9;HEL: 8.6;HMC-1: 26.9;MOLT-4: 8.3;THP-1: 7.9;U-937: 17.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA042758, HPA042839"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol				Cytosol	"Nucleoplasm, Centrosome"	"HPA042758: AB_10962357, HPA042839: AB_10959898"	"unprognostic (5.94e-2)"	"unprognostic (1.41e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.91e-2)"	"prognostic favourable (1.23e-4)"	"unprognostic (7.76e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavourable (8.95e-4)"	"prognostic favourable (7.51e-14)"	"unprognostic (1.37e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.53e-2)"	"prognostic favourable (5.62e-4)"	2.1	1.3	1.5	22.0	2.5	14.1	2.0	0.5	1.6	1.0	2.8	2.5	0.0	3.4	1.0	1.5	1.7	1.7	3.4	1.0	1.3	1.3	2.2	2.0	5.2	30.1	3.1	0.6	0.8	1.0	0.0	1.1	1.3	2.2	1.7	0.8	1.4	5.4	0.8	0.6	1.0	12.1	0.8	2.7	31.3	3.5	0.5	2.7	32.9	1.8	1.2	25.2	3.0	1.5	16.3	12.2	19.0	20.6	14.1	26.7	20.2	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	12.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	8.6	0.0	0.8	0.0	4.2	26.9	0.0	0.0	0.0	0.0	0.0	0.1	5.6	0.0	0.0	8.3	6.5	0.0	0.0	0.9	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.2	1.1	6.0	0.0	17.9	0.0	10.4	11.6	19.0	26.7	20.6	23.4	16.3	19.1	22.9	12.2	13.7	24.8	21.6	17.6	14.1	20.0	7.1	21.9	20.2	1.5	2.5	0.5	1.6	1.3	1.3	3.1	0.6	2.2	2.7
DHRS1	"FLJ25430, MGC20204, SDR19C1"	ENSG00000157379	"Dehydrogenase/reductase 1"	Q96LJ7	14	24290598-24299833	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 47.1"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 18.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000599	Approved		Approved	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA000599: AB_1078655"	"unprognostic (2.08e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.57e-1)"	"unprognostic (6.57e-2)"	"prognostic favourable (1.18e-5)"	"prognostic favourable (6.83e-4)"	"unprognostic (3.66e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (9.88e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-1)"	6.5	8.9	3.0	6.1	5.0	3.3	7.4	6.3	6.0	8.6	12.0	9.8	8.4	16.1	6.7	8.9	35.7	5.4	10.2	3.7	2.7	3.1	8.5	47.1	6.7	4.8	3.6	5.3	4.2	10.7	11.5	5.2	4.1	6.0	5.5	5.4	7.1	14.0	15.6	1.8	20.8	25.7	4.8	4.4	6.3	6.1	2.8	3.7	5.6	6.6	25.6	16.5	6.0	13.0	10.4	10.7	17.3	9.5	4.2	11.7	4.7	11.0	2.6	2.9	1.1	6.7	7.1	0.7	3.9	8.7	9.4	10.2	1.0	10.7	5.2	1.7	6.1	9.0	2.1	18.3	4.5	3.5	2.3	1.5	6.4	17.4	3.1	3.1	1.2	6.4	10.7	2.3	1.7	7.0	3.2	4.9	7.6	4.4	1.1	1.1	0.5	4.0	3.9	2.0	7.1	7.2	4.1	2.5	1.8	5.6	7.6	1.9	3.9	0.9	2.7	0.7	1.8	1.1	1.3	2.8	2.2	2.5	3.3	2.7	0.9	10.0	8.7	17.3	6.9	9.5	7.5	10.4	7.5	6.3	10.7	7.0	7.6	4.2	5.7	4.2	5.9	6.4	11.7	4.7	3.0	5.0	6.3	6.0	2.7	3.1	3.6	5.3	6.0	3.7
DHX35	"C20orf15, DDX35, FLJ22759, KAIA0875"	ENSG00000101452	"DEAH-box helicase 35"	Q9H5Z1	20	38962299-39039723	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054451, HPA062700"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Centrosome"				"Nuclear bodies"	"Nucleoplasm, Centrosome"	"HPA054451: , HPA062700: "	"unprognostic (8.31e-2)"	"unprognostic (2.34e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavourable (4.25e-5)"	"unprognostic (1.29e-2)"	"unprognostic (8.38e-2)"	"prognostic unfavourable (5.63e-6)"	"unprognostic (9.83e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.47e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.31e-1)"	10.4	7.3	9.7	6.9	14.6	13.9	9.8	9.7	14.3	12.2	23.2	14.8	10.7	9.9	19.7	13.9	13.9	12.5	9.2	16.9	9.0	5.8	10.4	7.5	8.7	12.6	8.2	6.7	13.9	6.5	12.1	13.5	8.4	10.9	13.3	14.3	12.4	10.4	12.6	12.5	11.1	12.4	14.7	9.9	8.4	13.4	12.5	9.4	12.1	8.5	7.6	11.2	15.9	11.8	4.6	6.7	2.0	4.9	5.8	8.2	4.4	7.3	4.4	11.9	4.9	4.6	6.0	8.4	4.4	7.8	10.1	7.8	21.0	7.2	8.4	7.8	8.4	11.7	8.2	12.9	10.1	2.1	4.0	11.2	10.0	11.9	5.5	13.0	5.9	7.0	8.3	8.9	8.4	4.5	11.3	4.8	5.4	6.0	21.3	10.0	6.8	9.9	10.4	17.4	6.8	3.7	8.4	10.5	8.2	12.1	7.3	11.1	9.9	10.8	4.4	14.6	8.0	5.7	9.1	4.8	6.4	8.8	8.6	5.9	7.6	0.0	4.9	2.0	5.3	4.5	5.2	4.6	4.5	5.6	6.7	4.3	8.2	4.3	1.0	5.8	3.8	2.4	2.8	4.4	9.7	14.6	9.7	14.3	9.0	5.8	8.2	6.7	10.9	9.4
DIS3L	"DIS3L1, FLJ38088, KIAA1955, MGC4562"	ENSG00000166938	"DIS3 like exosome 3'-5' exoribonuclease"	Q8TF46	15	66293217-66333898	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041805	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	Centrosome	"HPA041805: AB_10796783"	"unprognostic (2.57e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.99e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.42e-3)"	"unprognostic (2.66e-1)"	"unprognostic (6.18e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.40e-1)"	13.7	15.4	18.7	14.7	16.6	11.8	14.5	15.7	16.4	13.7	11.8	20.7	19.1	9.0	14.7	15.5	10.6	15.5	10.0	20.1	17.3	17.0	14.2	15.2	10.8	14.0	19.4	10.8	16.2	24.4	24.9	18.9	9.0	17.7	14.7	10.3	15.4	14.4	16.3	29.4	9.4	9.0	15.2	19.6	11.1	10.5	15.4	14.0	19.3	18.0	9.4	12.8	12.5	9.7	9.1	10.5	7.8	13.1	14.1	13.2	8.0	8.4	19.2	5.8	7.7	7.3	9.9	8.2	6.3	6.9	9.3	7.8	9.4	5.7	30.0	6.9	7.5	14.4	14.3	5.0	6.9	7.9	13.2	17.6	12.5	10.7	5.5	17.1	6.2	4.0	5.7	2.5	8.3	7.2	10.2	7.3	8.3	6.2	7.6	10.0	9.2	10.6	11.5	25.0	17.5	3.1	9.6	9.9	9.7	12.8	4.2	7.0	6.3	11.4	9.3	10.8	10.2	4.5	10.8	6.4	19.9	14.5	3.7	22.6	4.3	7.8	5.9	5.1	9.9	7.1	12.8	8.5	9.5	13.2	10.5	9.1	11.6	9.6	0.7	14.1	13.1	7.5	8.8	8.0	18.7	16.6	15.7	16.4	17.3	17.0	19.4	10.8	17.7	14.0
DVL3	KIAA0208	ENSG00000161202	"Dishevelled segment polarity protein 3"	Q92997	3	184155388-184173610	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046486, HPA058265"	Approved		Approved	"Intermediate filaments,Midbody ring,Centrosome"				"Midbody ring, Centrosome"	"Intermediate filaments"	"CAB046486: AB_10610845, HPA058265: "	"unprognostic (2.20e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (1.90e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (8.41e-4)"	"unprognostic (8.61e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavourable (4.77e-5)"	"prognostic unfavourable (1.53e-8)"	"unprognostic (1.87e-1)"	"unprognostic (4.10e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.95e-1)"	22.8	18.5	18.0	16.8	19.4	15.3	25.1	18.3	23.2	22.6	27.6	24.7	23.9	16.2	32.1	16.4	20.0	22.2	22.2	27.9	19.9	12.3	16.8	13.1	20.6	12.1	21.4	16.0	30.0	22.7	17.2	17.8	56.0	17.4	19.7	15.8	31.1	18.7	26.2	26.3	27.6	19.1	30.3	16.4	17.8	19.4	15.6	20.1	7.3	20.9	13.3	14.6	24.5	26.3	2.5	2.7	4.1	4.0	1.5	3.1	1.2	19.8	6.5	15.8	17.9	16.4	16.4	40.7	11.8	12.1	14.3	11.9	19.1	8.0	13.9	31.7	15.4	17.0	12.9	9.4	10.0	21.9	13.5	15.5	9.8	11.5	24.6	8.6	12.1	16.5	16.9	10.4	11.9	10.4	15.5	19.3	15.0	19.0	12.7	10.2	13.9	9.4	20.3	18.3	12.1	13.3	16.4	17.1	21.7	14.7	17.0	28.8	42.5	11.0	10.2	13.0	12.7	13.6	18.3	20.7	15.3	15.5	12.9	9.2	10.0	0.2	2.4	4.1	2.3	4.0	3.1	2.5	1.5	2.4	2.3	2.0	2.0	1.3	3.6	1.5	2.8	2.7	1.1	1.2	18.0	19.4	18.3	23.2	19.9	12.3	21.4	16.0	17.4	20.1
EDRF1	"C10orf137, DKFZp586F1019, FLJ21617"	ENSG00000107938	"Erythroid differentiation regulatory factor 1"	Q3B7T1	10	125719515-125764143	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031820			Approved	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA031820: AB_10600753"	"unprognostic (2.10e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.64e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.84e-4)"	"unprognostic (4.76e-3)"	"unprognostic (8.67e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.63e-3)"	"unprognostic (4.62e-2)"	"prognostic unfavourable (3.16e-5)"	"unprognostic (3.44e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.68e-3)"	9.2	6.7	6.3	16.6	9.7	27.9	9.0	20.3	10.0	10.5	8.1	7.7	6.8	7.1	12.2	8.3	7.5	9.8	6.4	7.5	7.4	5.4	5.9	5.0	7.2	12.5	8.8	7.3	13.4	14.0	6.3	18.1	8.2	8.0	10.0	7.3	5.2	19.7	12.7	12.7	8.3	9.0	9.5	7.8	9.3	8.4	21.2	9.0	20.2	7.7	4.5	10.7	10.1	8.7	9.6	9.9	9.1	7.0	6.9	9.7	3.5	8.9	8.7	10.9	11.9	5.1	8.5	5.7	11.2	11.0	13.0	14.8	11.0	7.6	12.0	5.6	7.1	11.3	17.2	2.7	14.8	7.9	13.7	8.4	7.4	6.4	8.6	12.6	8.7	5.2	4.3	12.4	5.6	6.1	7.9	9.2	7.3	3.6	12.5	8.7	16.1	7.9	10.0	10.5	7.8	4.5	4.1	5.9	11.6	8.3	4.2	7.6	7.7	4.8	3.9	6.9	7.1	9.0	12.7	12.0	8.0	18.9	7.4	6.2	3.8	9.1	7.0	6.5	7.8	5.8	9.7	9.6	6.9	7.1	6.8	8.1	7.3	7.5	8.4	6.9	4.2	9.9	7.4	3.5	6.3	9.7	20.3	10.0	7.4	5.4	8.8	7.3	8.0	9.0
ELP6	"C3orf75, FLJ20211, TMEM103"	ENSG00000163832	"Elongator acetyltransferase complex subunit 6"	Q0PNE2	3	47495640-47513761	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046358, HPA064545"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Cytosol"	Centrosome	"HPA046358: AB_10961011, HPA064545: "	"unprognostic (2.00e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.41e-3)"	"unprognostic (2.41e-2)"	"unprognostic (2.67e-1)"	"unprognostic (8.62e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.07e-2)"	"unprognostic (5.38e-2)"	"prognostic favourable (3.42e-6)"	"unprognostic (1.54e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.29e-2)"	10.8	25.9	15.6	16.3	18.5	8.8	15.3	23.2	24.6	12.8	13.3	22.7	19.0	13.3	17.5	22.1	14.2	16.0	13.3	17.0	16.3	15.7	16.4	18.7	11.6	17.5	16.7	21.8	20.8	18.8	16.6	18.8	12.9	19.9	18.1	13.0	18.5	14.8	17.5	23.6	14.7	11.7	16.4	18.6	14.9	13.9	24.9	13.6	23.7	17.8	13.7	17.8	15.5	11.9	20.4	19.5	10.4	12.0	18.4	21.3	14.2	16.7	15.9	21.3	21.5	17.1	15.8	12.1	20.3	14.1	26.0	23.6	15.5	17.8	31.6	12.7	17.5	10.4	20.6	29.6	15.9	17.6	16.0	28.6	24.6	17.2	18.8	21.6	17.8	17.1	16.0	29.6	18.9	22.3	29.9	9.9	25.8	18.5	25.8	24.5	25.5	27.3	12.9	10.3	19.3	18.2	14.9	19.0	18.5	17.3	14.0	10.5	19.1	17.5	14.5	26.6	19.0	13.8	25.3	20.9	27.4	29.0	13.8	26.4	27.1	10.4	12.0	8.4	19.5	11.0	15.1	18.7	18.3	19.5	15.0	20.4	17.3	17.4	1.7	18.4	7.6	19.5	21.3	14.2	15.6	18.5	23.2	24.6	16.3	15.7	16.7	21.8	19.9	13.6
ENKD1	"C16orf48, DKFZP434A1319"	ENSG00000124074	"Enkurin domain containing 1"	Q9H0I2	16	67662945-67667265	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 4.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041163, HPA041478"	Approved		Supported	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane"	"Centrosome, Cytosol"	"HPA041163: AB_10794986, HPA041478: AB_10794668"	"unprognostic (6.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.59e-3)"	"prognostic favourable (1.68e-4)"	"unprognostic (4.41e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.69e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.60e-2)"	8.5	7.7	4.9	5.9	7.0	3.8	6.6	5.0	6.9	10.4	11.7	6.1	18.6	4.7	11.2	14.2	8.2	14.5	11.0	6.1	5.4	5.2	10.9	4.7	8.9	2.9	4.5	4.4	10.9	38.8	23.7	12.0	4.8	8.3	12.7	3.6	7.9	11.7	12.6	6.0	7.2	5.1	12.9	4.3	6.1	7.3	19.6	6.4	7.1	20.4	5.2	4.9	12.9	6.4	0.6	4.2	3.0	1.3	0.7	1.5	0.5	6.9	4.8	11.3	5.2	3.8	3.9	5.6	5.5	3.3	4.3	5.4	3.4	10.7	2.6	9.4	3.4	8.1	2.9	6.5	5.4	4.0	6.6	2.5	14.4	8.1	6.0	4.6	3.6	3.4	4.7	6.0	5.4	3.5	4.2	1.6	2.2	3.5	5.0	19.2	5.3	1.9	17.8	1.2	19.1	4.6	0.7	11.4	12.4	11.6	1.1	5.9	10.2	6.5	9.2	5.4	7.5	10.0	0.0	12.5	5.6	2.7	8.1	6.8	1.6	0.0	1.3	0.0	0.3	0.5	1.5	0.6	1.2	0.7	0.5	0.0	0.8	1.1	3.0	0.7	0.7	4.2	0.0	0.5	4.9	7.0	5.0	6.9	5.4	5.2	4.5	4.4	8.3	6.4
ERCC6L	"FLJ20105, PICH, RAD26L"	ENSG00000186871	"ERCC excision repair 6 like, spindle assembly checkpoint helicase"	Q2NKX8	X	72204657-72239047	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 13.1"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"testis cancer: 11.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"NK-cell: 5.3"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050492	Approved		Supported	Nucleoplasm,Centrosome,Cytosol				Centrosome	"Nucleoplasm, Cytosol"	"HPA050492: "	"prognostic unfavourable (1.80e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.76e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.23e-6)"	"unprognostic (8.63e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.68e-5)"	"unprognostic (4.61e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.97e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.41e-2)"	0.4	0.5	0.2	3.1	0.2	6.0	3.0	0.9	0.8	1.5	2.2	0.2	0.2	1.5	0.9	0.8	4.6	0.6	1.0	0.2	0.2	0.3	0.5	0.5	0.8	4.7	0.7	0.2	1.2	0.5	0.0	0.6	0.9	0.9	0.7	2.5	0.2	1.1	0.2	2.6	1.3	2.1	0.5	1.3	4.0	1.5	2.0	0.2	13.1	0.5	2.8	5.6	0.7	1.6	0.5	0.3	0.5	0.2	5.3	1.1	0.4	10.9	9.6	8.9	5.6	0.6	1.1	4.9	11.8	5.4	10.4	10.9	7.8	6.9	17.8	4.5	4.2	9.1	16.6	8.8	18.5	10.1	12.1	6.1	3.3	4.6	0.0	11.9	8.6	0.1	0.5	14.4	2.7	5.7	8.0	4.4	10.5	8.6	11.3	7.0	16.1	14.9	9.5	15.9	3.1	2.6	6.8	7.3	5.2	8.7	5.9	2.2	4.5	2.6	3.5	7.0	11.3	13.2	7.7	3.4	5.3	15.3	4.9	8.3	7.0	0.0	0.2	0.5	0.1	0.1	0.6	0.2	0.5	0.1	0.1	0.5	0.4	1.1	0.3	5.3	0.2	0.3	1.1	0.4	0.2	0.2	0.9	0.8	0.2	0.3	0.7	0.2	0.9	0.2
FAM155A		ENSG00000204442	"Family with sequence similarity 155 member A"	B1AL88	13	107163510-107866735	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.0;pituitary gland: 10.3"	"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 11.6;SCLC-21H: 7.1;SH-SY5Y: 16.1;U-138 MG: 5.0;U-87 MG: 10.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA039453, HPA058768"	Enhanced		Approved	Nucleoplasm,Vesicles,Centrosome				"Nucleoplasm, Vesicles"	Centrosome	"HPA039453: AB_10795290, HPA058768: "	"unprognostic (8.40e-2)"	"unprognostic (9.98e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.38e-3)"	"unprognostic (2.69e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.26e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.02e-5)"	"unprognostic (5.56e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.45e-2)"	"unprognostic (3.69e-3)"	0.9	2.7	10.7	0.6	4.3	0.4	0.6	6.9	19.0	1.5	0.7	0.6	0.0	0.5	1.7	4.0	0.7	0.7	1.3	0.7	8.8	10.8	0.7	0.4	1.2	0.5	6.4	4.9	0.7	0.5	0.4	10.3	1.2	2.0	2.7	0.7	0.7	0.3	3.8	0.4	0.5	0.7	1.2	2.7	0.6	0.7	2.3	0.5	0.0	1.3	0.0	0.9	1.4	0.2	0.2	0.0	0.4	0.1	0.8	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.6	0.0	2.4	0.1	2.3	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.2	0.0	11.6	1.9	7.1	16.1	0.0	0.0	0.0	4.1	0.0	0.2	5.0	2.0	1.7	0.2	0.0	0.0	0.0	10.2	0.0	3.4	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.4	0.8	0.0	0.0	0.0	0.0	10.7	4.3	6.9	12.3	8.8	10.8	6.4	4.9	2.0	0.5
FAM241B	C10orf35	ENSG00000171224	"Family with sequence similarity 241 member B"	Q96D05	10	69630251-69633599	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.5"	"Cell line enhanced"	"Detected in many"		"EFO-21: 20.5;PC-3: 26.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 14.2"	"Lineage enriched"	"Detected in single"	25	"T-cells: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034591	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Centrosome"	Cytosol	"HPA034591: AB_10670572"	"unprognostic (1.12e-1)"	"unprognostic (6.37e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.17e-3)"	"prognostic unfavourable (8.64e-4)"	"prognostic unfavourable (1.03e-4)"	"unprognostic (3.56e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.37e-2)"	"unprognostic (3.12e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.52e-1)"	"prognostic favourable (9.72e-4)"	1.4	3.3	13.1	2.0	13.5	1.1	5.3	34.5	23.9	1.3	3.0	3.2	0.6	3.0	2.7	13.0	4.0	4.8	2.1	6.9	15.0	17.8	4.7	2.3	4.1	2.7	10.8	14.4	2.0	7.9	5.6	5.3	1.3	8.3	7.8	2.6	5.1	5.6	5.6	1.6	2.4	2.2	4.5	4.6	0.8	4.2	11.4	2.4	0.7	6.0	0.1	2.4	2.6	1.6	0.3	0.0	0.5	0.0	0.2	14.2	2.8	13.3	14.6	1.8	15.0	0.0	0.0	6.5	1.3	0.3	2.4	2.6	10.5	11.1	0.0	20.5	0.3	5.5	7.8	4.5	3.4	13.3	10.7	0.0	3.2	4.0	4.0	0.0	4.8	0.0	4.4	0.1	2.3	0.0	4.9	0.0	0.2	17.9	0.1	0.0	9.0	26.9	0.0	0.0	0.1	5.1	7.6	7.6	10.4	5.5	14.0	8.5	9.6	2.4	0.6	0.4	9.3	0.0	3.9	2.4	6.6	0.0	0.2	0.0	0.3	0.0	0.0	0.0	3.4	0.0	8.9	0.1	8.5	5.6	0.0	0.3	14.2	4.9	0.5	0.2	0.0	0.0	5.3	2.8	13.1	13.5	34.5	23.9	15.0	17.8	10.8	14.4	8.3	2.4
FAM45A		ENSG00000119979	"Family with sequence similarity 45 member A"	Q8TCE6	10	119104086-119137984	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041159			Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Centrosome, Cytosol"		"HPA041159: AB_10793871"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.64e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.20e-2)"	12.2	13.2	16.2	8.5	20.0	17.0	9.5	10.2	17.6	11.6	12.5	10.2	6.5	7.6	9.4	10.7	16.0	9.0	8.5	10.8	13.5	10.4	16.6	18.9	8.6	6.8	10.6	17.6	17.3	8.8	11.6	5.4	10.8	18.4	8.9	11.0	7.7	10.7	8.3	14.0	12.0	9.7	9.8	13.5	8.4	9.7	7.1	11.5	10.1	14.8	10.8	9.9	13.1	14.7	2.3	9.9	30.2	19.2	3.8	10.0	6.0	8.3	9.8	12.5	14.4	21.4	21.4	5.5	11.9	29.8	10.7	10.3	9.5	11.2	5.9	4.5	14.6	12.6	10.6	10.4	9.3	10.0	6.0	1.3	3.4	8.3	24.4	3.5	2.8	22.2	8.9	7.8	11.0	14.4	2.8	6.7	13.4	6.7	4.4	6.0	7.5	4.0	4.8	15.7	4.3	10.3	8.9	2.1	8.3	8.5	8.9	17.4	8.6	12.3	14.6	7.6	3.9	7.8	6.0	7.3	2.7	6.5	12.3	15.3	3.4	23.0	15.1	30.2	4.2	18.3	3.4	2.3	6.3	5.5	9.9	1.9	3.1	4.1	20.1	3.8	19.2	2.5	10.0	6.0	16.2	20.0	10.2	17.6	13.5	10.4	10.6	17.6	18.4	11.5
FCHO2		ENSG00000157107	"FCH domain only 2"	Q0JRZ9	5	72955981-73090522	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.9"	"Group enriched"	"Detected in many"	8	"granulocytes: 15.9;monocytes: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037685, HPA037686, HPA077850"	Enhanced		Approved	Vesicles,Centrosome,Cytosol				Centrosome	"Vesicles, Cytosol"	"HPA037685: AB_2675610, HPA037686: AB_10673636, HPA077850: "	"unprognostic (1.14e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.68e-3)"	"unprognostic (4.99e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.67e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.21e-1)"	"prognostic favourable (7.00e-5)"	"unprognostic (1.43e-1)"	"unprognostic (3.27e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.76e-1)"	32.2	9.6	10.7	10.0	12.2	8.3	18.0	23.1	18.3	16.2	18.3	8.9	15.3	15.5	23.7	13.0	30.2	14.6	15.7	12.5	11.2	7.0	18.6	16.0	22.8	18.5	10.8	9.5	16.1	11.1	17.5	11.4	19.2	10.9	12.6	16.1	9.9	17.1	12.6	17.7	15.2	20.8	16.6	11.9	18.9	12.2	10.5	12.4	3.2	22.4	11.7	11.8	14.6	22.5	0.7	1.1	15.9	4.5	0.7	1.3	0.5	9.0	7.4	7.1	6.2	10.0	13.3	20.9	8.0	11.9	6.1	9.6	3.7	15.9	2.2	11.3	11.1	6.9	6.0	14.1	8.3	2.3	7.0	4.4	6.1	4.6	5.0	0.9	4.6	8.9	7.3	8.2	13.1	13.8	5.0	3.9	12.5	4.2	0.0	4.4	2.2	3.7	2.0	6.9	2.6	14.8	12.9	2.8	4.5	11.0	7.8	5.0	9.5	6.3	14.3	8.0	3.8	8.8	5.6	1.4	2.5	0.4	5.2	0.6	9.8	11.5	2.6	6.4	1.3	3.5	0.8	0.3	0.4	0.5	1.1	0.7	0.2	0.4	15.9	0.7	4.5	0.4	0.3	0.5	10.7	12.2	23.1	18.3	11.2	7.0	10.8	9.5	10.9	12.4
GNAI1		ENSG00000127955	"G protein subunit alpha i1"	P63096	7	80133955-80219402	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"	Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"NK-cell: 20.0"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022449, HPA042141"	Approved		Supported	Nucleoplasm,Nucleoli,Centrosome			9000000	Centrosome	"Nucleoplasm, Nucleoli"	"CAB022449: , HPA042141: "	"unprognostic (2.29e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavourable (5.09e-4)"	"unprognostic (9.78e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.48e-1)"	"unprognostic (9.41e-3)"	"prognostic unfavourable (6.47e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.53e-1)"	33.2	23.4	17.2	5.4	26.2	1.5	14.4	14.4	33.7	9.4	10.5	36.9	3.0	6.9	10.0	3.0	16.6	9.0	8.6	5.7	23.8	18.3	25.9	13.1	10.3	3.4	40.3	21.9	14.3	5.4	2.5	7.3	30.4	26.2	10.1	9.0	2.8	4.9	9.5	4.2	32.4	5.3	12.2	49.7	5.7	8.3	11.1	32.0	0.9	11.1	3.2	4.6	15.5	9.0	0.1	3.7	2.1	1.5	20.0	2.3	0.7	2.9	20.5	18.8	0.1	23.4	15.0	8.6	12.5	15.1	11.1	13.7	0.0	3.2	0.1	4.0	13.4	3.0	10.4	12.8	14.7	0.1	9.6	17.6	18.1	1.2	23.7	2.2	3.8	16.1	32.4	5.9	17.1	7.4	1.4	0.0	20.7	0.5	0.1	0.1	5.4	7.4	8.2	7.2	8.8	33.1	9.9	13.8	9.5	13.4	0.2	10.6	2.5	0.4	13.1	24.8	17.5	5.7	4.7	0.1	0.0	0.1	6.5	1.3	11.0	2.1	0.7	0.7	0.1	0.7	0.0	0.0	0.3	0.2	3.7	0.1	2.3	0.9	0.3	20.0	1.5	0.3	0.2	0.7	17.2	26.2	14.4	25.5	23.8	18.3	40.3	21.9	26.2	32.0
GNAI3	87U6	ENSG00000065135	"G protein subunit alpha i3"	P08754	1	109548611-109618321	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	Transducer	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022099, HPA042141"	Approved		Approved	Nucleoplasm,Nucleoli,Centrosome			8400000	Centrosome	"Nucleoplasm, Nucleoli"	"CAB022099: , HPA042141: "	"unprognostic (2.19e-1)"	"unprognostic (1.64e-1)"	"prognostic favourable (1.62e-4)"	"unprognostic (1.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.45e-3)"	"prognostic unfavourable (5.30e-6)"	"unprognostic (2.56e-3)"	"unprognostic (2.18e-2)"	"prognostic favourable (4.59e-4)"	"unprognostic (1.83e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavourable (4.34e-4)"	"unprognostic (7.27e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.66e-2)"	25.2	13.0	12.3	15.5	11.3	26.4	15.8	12.8	10.7	19.0	14.7	10.3	14.3	12.1	19.7	15.7	34.8	12.5	13.2	9.3	12.3	9.4	18.1	25.8	13.2	23.8	13.1	8.3	18.4	13.7	10.7	11.0	22.4	11.5	17.2	13.8	8.0	16.2	14.4	8.6	27.9	17.0	15.9	12.9	21.6	12.1	14.0	12.0	22.2	12.9	25.2	20.6	20.0	20.4	6.1	9.6	16.8	13.1	5.8	7.2	9.3	13.9	4.9	9.5	5.6	9.1	10.9	7.8	10.6	8.5	10.8	10.8	7.5	4.9	7.5	7.1	11.3	7.4	8.9	10.8	15.1	8.4	5.5	6.5	8.5	6.4	7.8	10.2	6.0	8.1	9.2	12.4	8.6	12.9	8.5	7.4	10.7	9.5	7.8	8.3	9.5	5.8	5.6	22.4	4.8	12.0	10.7	6.1	10.7	7.4	8.4	11.6	6.5	9.0	11.7	9.1	12.5	13.6	12.0	7.9	8.9	8.7	15.1	10.1	14.1	8.5	9.1	16.6	6.8	13.1	7.2	6.1	6.7	6.5	9.6	5.0	5.6	6.4	16.8	5.8	12.3	4.3	6.9	9.3	12.3	11.3	12.8	10.7	12.3	9.4	13.1	8.3	11.5	12.0
GNB5	GB5	ENSG00000069966	"G protein subunit beta 5"	O14775	15	52115105-52191369	"Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		Transducer	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032353, HPA041942, HPA044198"	Uncertain		Approved	"Nuclear speckles,Centrosome,Rods & Rings"			11000	"Nuclear speckles"	"Centrosome, Rods & Rings"	"CAB032353: AB_2263274, HPA041942: AB_10794309, HPA044198: "	"unprognostic (2.38e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.97e-3)"	"prognostic favourable (1.47e-6)"	"unprognostic (6.15e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.10e-1)"	"prognostic favourable (3.32e-11)"	"unprognostic (1.40e-3)"	"unprognostic (8.12e-3)"	"unprognostic (3.55e-3)"	"unprognostic (1.52e-1)"	6.2	11.2	17.7	8.2	25.6	3.7	8.9	42.5	30.7	15.2	9.2	4.0	9.6	4.6	21.2	13.4	9.0	20.4	15.4	17.3	13.0	18.6	26.9	10.3	5.8	14.7	13.6	21.9	38.1	13.7	35.5	14.7	4.4	21.3	12.9	4.5	20.4	6.5	20.3	1.7	4.8	7.0	13.3	5.9	8.3	7.5	11.7	9.2	7.0	16.2	1.9	14.1	14.6	14.0	21.6	9.9	3.6	1.9	10.8	19.7	9.3	8.0	20.8	5.8	10.2	9.9	12.4	5.6	15.8	15.4	14.1	15.4	5.8	6.1	14.1	5.0	12.9	11.9	10.2	15.0	10.7	10.9	7.7	9.4	28.1	6.7	11.8	4.7	34.1	11.4	12.7	11.3	4.2	8.8	0.7	13.3	15.4	14.4	7.4	13.4	5.3	9.2	10.0	20.1	17.1	10.0	24.7	9.3	8.1	15.1	1.4	12.3	4.9	14.7	21.6	12.7	13.9	14.4	15.9	8.5	16.3	15.4	26.7	11.5	20.4	3.6	1.9	0.2	10.7	1.7	8.9	21.0	14.0	12.8	4.8	21.6	13.2	11.3	1.0	10.8	1.4	9.9	19.7	9.3	17.7	25.6	42.5	30.7	13.0	18.6	13.6	21.9	21.3	9.2
GVQW3		ENSG00000179240	"GVQW motif containing 3"	Q3ZCU0	11	76381313-76414619	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"		"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA057405	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Centrosome"				"Nucleoplasm, Centrosome"	"Endoplasmic reticulum"	"HPA057405: "	"unprognostic (8.90e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.04e-3)"	"unprognostic (8.56e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.28e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.05e-4)"	"unprognostic (7.45e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.28e-2)"	"unprognostic (2.13e-1)"	3.3	5.8	7.0	4.7	11.8	3.5	5.8	13.9	14.3	5.0	3.2	5.0	2.2	4.5	6.7	4.0	1.8	7.1	2.5	3.2	6.2	5.2	5.1	2.5	2.9	6.0	4.0	7.2	8.4	16.0	3.2	15.9	3.0	8.7	3.5	4.9	7.6	9.1	3.3	2.9	4.5	3.6	3.5	4.2	5.0	4.2	9.6	4.6	5.5	5.5	0.4	5.7	2.8	4.0	3.1	1.7	5.1	1.2	3.8	4.1	1.2	1.7	2.2	9.4	5.0	2.3	4.7	2.5	1.2	1.0	2.2	2.1	6.5	4.0	7.4	3.3	1.2	5.3	5.1	1.3	3.0	5.2	3.0	3.8	8.4	2.1	1.2	3.4	2.0	1.1	1.5	3.4	1.3	1.4	2.4	4.5	0.7	2.1	4.7	5.6	1.5	3.4	7.0	5.5	4.7	0.7	1.8	12.3	4.3	2.9	1.3	0.8	3.8	1.0	0.8	3.9	3.9	6.1	1.4	4.8	2.3	6.9	1.2	3.0	2.2	3.5	1.2	1.2	3.7	0.7	2.5	3.1	3.8	1.7	1.7	3.1	4.1	4.1	5.1	3.8	0.8	1.2	3.3	1.2	7.0	11.8	13.9	14.3	6.2	5.2	4.0	7.2	8.7	4.6
HAUS2	"C15orf25, CEP27, FLJ10460, HsT17025"	ENSG00000137814	"HAUS augmin like complex subunit 2"	Q9NVX0	15	42548810-42569994	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039965	Approved		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Cytosol"	Centrosome	"HPA039965: AB_10673025"	"unprognostic (5.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.69e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.62e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.33e-1)"	"unprognostic (6.81e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.62e-3)"	18.7	11.3	13.1	12.1	11.5	49.9	18.6	13.3	15.4	9.9	11.9	11.1	5.6	8.9	14.0	10.4	12.8	9.7	9.3	10.8	14.1	13.6	10.3	11.0	16.8	16.6	14.6	13.9	12.1	12.1	8.4	9.9	11.6	13.1	8.8	10.8	8.5	10.5	8.5	13.5	11.8	9.5	12.3	18.7	11.2	9.7	13.7	11.7	18.4	10.1	11.8	13.0	10.8	14.0	10.3	7.2	7.5	13.5	4.4	8.7	4.3	11.3	6.0	11.0	7.0	5.6	6.3	10.7	11.5	6.9	10.9	9.1	12.2	7.2	7.3	5.7	6.3	19.0	11.7	7.4	10.9	9.4	6.8	10.0	10.6	9.5	8.0	17.5	9.1	5.5	5.6	8.6	8.9	10.9	17.3	9.0	10.5	7.1	12.8	14.1	9.6	7.9	14.4	13.4	9.4	6.9	8.1	9.0	7.4	11.5	11.1	6.8	11.1	13.0	8.6	16.7	12.2	25.8	21.3	13.7	38.3	21.9	10.4	19.2	12.7	7.3	7.7	7.5	8.4	9.0	8.3	10.3	8.3	6.0	6.5	8.9	6.1	8.3	3.8	4.4	13.5	7.2	8.7	4.3	13.1	11.5	13.3	15.4	14.1	13.6	14.6	13.9	13.1	11.7
HIPK1	"KIAA0630, MGC26642, MGC33446, MGC33548, Myak, Nbak2"	ENSG00000163349	"Homeodomain interacting protein kinase 1"	Q86Z02	1	113929192-113977869	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 90.1"	"Cell line enhanced"	"Detected in all"		"MCF7: 61.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016664	Approved		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Centrosome, Cytosol"		"HPA016664: AB_1850725"	"unprognostic (2.98e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.89e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.47e-2)"	"unprognostic (9.84e-3)"	"unprognostic (4.64e-3)"	"unprognostic (7.22e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.99e-2)"	15.1	16.8	21.2	14.7	23.0	90.1	13.6	38.1	20.4	20.4	14.4	20.7	14.5	10.2	15.5	14.2	18.7	27.3	17.5	27.9	22.9	17.2	14.8	13.8	19.3	14.7	15.0	16.4	18.7	16.8	20.7	23.8	13.8	21.3	14.4	15.2	20.7	13.0	14.9	19.7	18.5	13.4	15.1	18.3	15.9	14.8	33.5	21.3	47.2	23.3	13.1	15.5	17.3	26.7	2.3	6.2	9.8	4.2	4.3	6.0	2.3	8.1	6.6	9.2	7.0	10.8	5.7	6.2	5.6	6.8	8.0	7.7	7.6	3.1	10.9	7.7	8.9	5.5	11.8	6.6	11.6	7.9	6.0	15.9	8.3	8.0	9.0	12.7	19.7	6.1	9.6	10.2	10.5	11.8	10.8	11.8	11.5	61.5	16.6	7.2	9.4	5.9	10.1	27.0	3.8	7.2	7.0	4.1	5.4	10.2	11.0	7.2	6.4	18.3	11.5	7.9	10.7	12.8	8.5	7.4	5.8	9.5	8.8	10.3	17.9	3.4	4.2	8.2	5.5	3.7	5.2	1.7	4.9	4.9	3.1	2.3	5.0	6.0	9.8	4.3	2.6	6.2	3.6	2.3	21.2	23.0	38.1	20.4	22.9	17.2	15.0	16.4	21.3	21.3
HMMR	"CD168, RHAMM"	ENSG00000072571	"Hyaluronan mediated motility receptor"	O75330	5	163460203-163491945	"CD markers, FDA approved drug targets, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 54.5;testis: 16.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002433, HPA040025, HPA043926, HPA061524"	Enhanced		Enhanced	Microtubules,Centrosome,Cytosol				Microtubules	"Centrosome, Cytosol"	"CAB002433: AB_564080, HPA040025: , HPA043926: , HPA061524: "	"unprognostic (3.53e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.38e-3)"	"unprognostic (8.88e-3)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (5.52e-4)"	"prognostic unfavourable (1.93e-7)"	"prognostic unfavourable (1.09e-4)"	"unprognostic (5.68e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavourable (3.71e-5)"	"unprognostic (1.02e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.65e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.77e-2)"	1.6	1.4	0.6	13.4	0.6	11.4	2.4	0.4	0.9	1.7	5.0	0.6	0.6	4.5	0.6	2.3	6.4	0.5	0.9	1.6	0.8	0.7	1.4	1.8	2.5	10.9	1.0	0.4	0.6	1.1	0.6	0.5	6.9	1.1	0.7	5.6	0.4	1.6	0.2	1.4	2.3	4.8	1.4	1.9	8.6	2.6	16.7	0.3	54.5	0.7	5.6	10.8	1.8	2.1	1.2	1.8	0.6	0.7	1.5	4.8	0.8	21.1	13.3	27.1	14.5	1.4	2.6	20.2	20.1	9.8	25.2	22.9	27.0	40.8	35.1	19.2	6.2	24.4	31.3	19.0	43.0	31.8	9.7	21.0	9.5	13.1	0.4	18.6	19.4	0.7	1.1	23.6	18.5	14.3	19.8	28.8	26.2	7.7	19.6	10.6	23.4	14.5	21.4	36.3	17.6	9.8	5.7	22.7	12.6	29.9	9.4	11.4	27.6	14.9	9.3	18.1	15.3	14.4	26.9	15.5	25.9	28.3	11.9	28.8	17.3	0.5	0.7	0.0	0.5	0.3	0.9	1.2	1.0	0.6	0.9	0.9	0.4	0.7	0.6	1.5	0.0	1.8	4.8	0.8	0.6	0.6	0.4	0.9	0.8	0.7	1.0	0.4	1.1	0.3
HNMT		ENSG00000150540	"Histamine N-methyltransferase"	P50135	2	137964020-138016364	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 61.3;HSkMC: 25.1;RT4: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	19	"classical monocyte: 34.6;intermediate monocyte: 26.7;myeloid DC: 20.9;non-classical monocyte: 14.6"	"Group enriched"	"Detected in many"	22	"dendritic cells: 20.9;monocytes: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035480, HPA035481, HPA073754"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol			64000	"Nucleoplasm, Cytosol"	Centrosome	"HPA035480: , HPA035481: AB_10672094, HPA073754: "	"unprognostic (1.32e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.02e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (3.41e-4)"	"unprognostic (5.24e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.21e-1)"	"prognostic favourable (4.68e-4)"	41.4	5.8	12.2	12.3	11.1	3.3	28.8	10.7	11.3	27.6	16.3	8.6	13.9	8.7	22.2	21.4	11.6	14.6	21.6	14.7	12.7	7.8	33.4	74.2	21.9	17.0	13.7	9.2	33.1	14.1	24.5	5.5	14.3	11.2	22.3	17.7	8.7	14.1	20.1	4.9	8.1	11.1	13.2	14.8	18.5	11.5	11.7	14.6	1.0	7.3	8.5	6.5	21.3	12.0	0.5	20.9	1.2	34.6	0.1	0.2	9.2	0.2	0.3	1.5	4.1	17.6	18.9	0.1	1.1	1.7	0.1	0.7	7.8	4.4	0.2	13.9	4.6	0.4	3.2	0.0	0.0	0.2	1.6	0.1	13.1	61.3	7.9	0.0	0.2	25.1	0.0	6.2	0.0	4.4	0.2	0.3	13.2	1.0	0.0	0.2	7.8	1.6	0.1	0.5	0.0	18.9	31.8	0.1	0.4	6.0	7.7	0.0	0.2	14.4	1.3	1.3	3.4	1.8	4.4	0.1	0.0	0.2	6.0	7.5	0.9	0.8	34.6	0.2	0.2	26.7	0.1	0.5	0.1	0.1	20.9	0.3	0.1	0.2	1.2	0.1	14.6	0.6	0.2	9.2	12.2	11.1	10.7	11.3	12.7	7.8	13.7	9.2	11.2	14.6
HSPBP1	"FES1, HspBP1"	ENSG00000133265	"HSPA (Hsp70) binding protein 1"	Q9NZL4	19	55262231-55280381	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 68.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005865, HPA070398, HPA071444"	Supported		Approved	Vesicles,Centrosome,Cytosol				Cytosol	"Vesicles, Centrosome"	"CAB005865: AB_304116, HPA070398: , HPA071444: "	"unprognostic (3.07e-2)"	"unprognostic (6.36e-2)"	"unprognostic (5.41e-2)"	"unprognostic (8.05e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.12e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.20e-3)"	"unprognostic (7.23e-2)"	"unprognostic (4.28e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.14e-2)"	14.1	13.9	24.5	15.8	42.9	16.4	13.8	13.3	32.5	11.3	17.3	9.1	13.0	18.8	14.8	12.4	14.5	30.3	13.3	19.1	25.3	20.1	15.4	18.0	18.2	17.6	16.2	20.0	17.4	21.1	13.0	10.2	9.8	15.2	12.0	8.3	7.6	19.3	13.6	35.4	15.4	17.2	16.8	15.0	11.6	15.3	21.1	9.3	11.7	12.0	24.4	8.9	10.5	10.5	24.0	23.0	3.0	19.0	18.4	20.5	11.5	22.0	39.7	7.0	10.3	4.2	3.5	21.6	11.6	4.7	11.6	9.9	22.4	15.4	14.6	11.3	6.2	15.4	8.3	11.2	3.1	12.4	68.3	19.5	12.6	20.6	9.1	18.2	10.3	4.9	10.1	11.6	5.5	5.8	15.5	8.3	4.0	20.9	16.4	16.9	25.2	33.4	16.0	11.1	31.5	7.8	14.5	19.4	29.0	14.3	14.8	11.1	11.3	14.2	8.0	14.0	15.2	7.9	21.1	13.3	30.6	15.2	15.6	15.8	14.8	0.8	11.5	3.0	18.0	19.0	18.7	21.0	19.8	20.5	23.0	24.0	19.9	19.3	0.8	18.4	16.0	13.1	17.8	11.5	24.5	42.9	13.3	32.5	25.3	20.1	16.2	20.0	15.2	9.3
ID2	"bHLHb26, GIG8"	ENSG00000115738	"Inhibitor of DNA binding 2"	Q02363	2	8678845-8684453	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 274.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 107.5;HEK 293: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 110.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027612			Approved	"Nucleoplasm,Nuclear bodies,Centrosome"				"Nucleoplasm, Nuclear bodies"	Centrosome	"HPA027612: AB_10599729"	"unprognostic (2.53e-1)"	"unprognostic (8.16e-3)"	"unprognostic (8.51e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.24e-1)"	"prognostic favourable (9.95e-4)"	"unprognostic (4.39e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.92e-3)"	34.2	37.4	24.9	19.1	20.6	69.8	31.5	11.3	57.3	21.9	34.0	22.9	13.2	20.7	18.6	11.6	12.1	28.1	33.5	46.1	20.0	14.6	31.2	117.5	25.4	22.4	19.0	35.3	59.7	15.0	274.1	17.2	14.8	20.0	27.2	26.4	13.3	24.5	72.7	8.8	16.6	20.4	19.2	15.8	21.3	16.2	7.1	14.2	19.0	46.8	15.1	10.2	31.8	38.0	0.3	25.0	110.4	26.0	90.9	42.4	18.0	0.2	19.9	8.2	10.1	13.2	2.1	31.4	22.7	2.7	10.2	4.3	39.8	1.0	0.5	27.0	38.8	17.1	5.3	0.1	3.0	107.5	69.6	14.3	12.2	48.6	3.9	10.6	40.3	3.6	0.4	4.6	0.2	0.2	0.8	17.0	15.7	6.7	1.1	1.2	14.9	15.7	1.4	5.7	10.7	10.2	8.9	15.5	22.0	1.2	17.3	1.7	2.8	6.3	4.1	12.6	2.2	18.6	1.3	1.3	1.0	12.4	15.9	32.8	6.8	9.0	8.2	110.4	42.4	24.2	25.3	0.3	13.1	29.5	25.0	0.2	16.4	31.4	11.2	90.9	26.0	1.1	1.0	18.0	24.9	20.6	11.3	57.3	20.0	14.6	19.0	35.3	20.0	14.2
IL1RN	"ICIL-1RA, IL-1RN, IL1F3, IL1RA, IRAP, MGC10430"	ENSG00000136689	"Interleukin 1 receptor antagonist"	P18510	2	113107214-113134016	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 217.8;lymphoid tissue: 194.7;tongue: 123.7"	"Cell line enhanced"	"Detected in some"		"A-431: 20.6;HaCaT: 40.8;RT4: 39.8;THP-1: 11.5"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 92.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"classical monocyte: 17.1;myeloid DC: 17.1;neutrophil: 65.2"	"Group enriched"	"Detected in many"	332	"dendritic cells: 17.1;granulocytes: 65.2;monocytes: 17.1"	"Not detected"	"Not detected"							"HPA001482, CAB009633"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted to blood"	421933		Nucleoplasm	"Centrosome, Cytosol"	"CAB009633: AB_2125576, HPA001482: AB_1078437"	"unprognostic (3.85e-3)"	"unprognostic (3.96e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (3.00e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.46e-2)"	"unprognostic (9.54e-2)"	"prognostic unfavourable (6.85e-4)"	"unprognostic (5.59e-3)"	"prognostic unfavourable (2.66e-6)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (8.23e-4)"	"unprognostic (4.25e-2)"	"unprognostic (1.03e-1)"	17.3	0.2	0.2	7.2	0.3	32.9	1.1	0.2	0.5	27.2	3.8	0.6	1.4	1.1	1.5	0.7	217.8	0.2	4.1	0.5	0.2	0.0	0.5	23.5	2.9	1.9	0.3	0.2	0.4	0.4	0.1	0.3	3.1	0.6	1.6	0.3	0.4	30.9	1.3	0.5	14.4	3.7	0.7	0.2	3.6	5.7	1.4	0.2	1.0	0.7	123.7	194.7	3.3	42.2	0.0	17.1	65.2	17.1	0.0	0.0	4.9	20.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.2	0.1	0.1	0.0	40.8	0.0	1.1	0.0	0.0	0.0	0.1	0.0	6.9	0.0	0.1	7.7	0.0	5.3	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	39.8	0.0	0.0	0.0	0.3	0.0	0.0	11.5	0.1	0.5	0.0	0.3	0.0	0.3	0.0	0.0	3.9	4.6	0.1	0.0	17.1	0.3	0.0	7.6	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	65.2	0.0	3.4	0.1	0.0	4.9	0.2	0.3	0.2	0.5	0.2	0.0	0.3	0.2	0.6	0.2
INTS6L	"DDX26B, FLJ41215"	ENSG00000165359	"Integrator complex subunit 6 like"	Q5JSJ4	X	135520643-135582510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 16.1;U-937: 15.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA001552, HPA013200, HPA013335, HPA030747"	Uncertain		Approved	"Nuclear bodies,Centrosome,Mitochondria"				Centrosome	"Nuclear bodies, Mitochondria"	"HPA001552: AB_1078659, HPA013200: , HPA013335: AB_1847553, HPA030747: "	"unprognostic (2.03e-1)"	"prognostic favourable (5.39e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.33e-3)"	"prognostic favourable (5.54e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavourable (4.28e-8)"	"unprognostic (2.87e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.37e-2)"	"prognostic favourable (2.94e-4)"	4.2	9.8	5.5	10.6	6.7	15.4	5.4	22.6	6.1	8.4	7.8	7.4	3.8	3.6	7.8	4.6	6.4	8.6	6.6	5.9	4.8	3.2	4.4	1.7	5.6	15.6	6.8	6.2	11.5	2.9	3.7	11.5	4.5	6.5	6.5	10.0	5.3	18.2	7.9	1.5	8.3	9.3	5.4	4.9	13.3	4.5	9.7	10.4	17.8	4.6	2.8	15.0	8.6	7.5	5.5	3.6	2.2	2.7	2.7	9.0	4.0	0.1	0.0	6.1	7.1	1.8	2.1	0.0	1.5	3.2	1.8	5.5	0.5	2.6	6.1	5.2	1.3	4.5	6.8	2.0	1.3	4.5	2.5	5.0	0.5	0.0	1.6	5.2	0.4	2.7	2.0	2.1	2.0	2.3	3.2	9.6	1.3	4.4	5.1	16.1	2.8	2.5	4.2	2.1	4.9	1.4	2.5	1.0	2.2	2.0	2.1	0.2	2.2	9.8	1.2	4.7	2.7	0.0	1.7	11.1	8.7	9.0	1.5	15.0	0.9	0.0	2.5	2.2	5.1	2.2	6.1	5.5	5.8	5.9	3.6	4.9	9.0	5.8	1.6	2.7	2.7	3.5	3.1	4.0	5.5	6.7	22.6	6.1	4.8	3.2	6.8	6.2	6.5	10.4
ITGB6		ENSG00000115221	"Integrin subunit beta 6"	P18564	2	160099666-160200313	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Amelogenesis imperfecta, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 62.1"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 36.6;RPTEC TERT1: 73.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA023626, CAB073536"	Approved		Approved	"Nucleoplasm,Cell Junctions,Centrosome"				"Nucleoplasm, Cell Junctions"	Centrosome	"CAB073536: , HPA023626: "	"unprognostic (1.27e-1)"	"unprognostic (1.57e-2)"	"unprognostic (6.90e-2)"	"unprognostic (8.22e-3)"	"unprognostic (3.61e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.06e-2)"	"prognostic unfavourable (5.03e-6)"	"unprognostic (1.04e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.00e-1)"	0.3	0.3	0.3	3.1	0.3	0.0	8.7	0.3	0.3	4.1	8.3	0.1	4.5	3.5	2.1	2.5	18.7	1.2	12.0	0.7	0.3	0.3	62.1	0.3	28.8	0.1	0.3	0.1	1.5	3.8	7.0	2.2	18.7	0.2	7.5	3.0	0.1	3.8	4.8	31.5	1.9	11.7	2.0	0.3	0.3	7.9	0.6	0.1	0.1	4.9	6.8	5.9	12.8	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	36.6	0.0	0.2	0.0	7.5	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	8.4	0.0	0.0	0.0	0.0	0.0	1.0	1.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	73.2	12.1	0.0	0.0	0.0	11.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.2	0.1
IVL		ENSG00000163207	Involucrin	P07476	1	152908545-152911886	"Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 97.1;tongue: 152.1"	"Group enriched"	"Detected in some"	25	"HaCaT: 77.0;RT4: 20.2;SK-BR-3: 23.2"	"Group enriched"	"Detected in many"	5	"cervical cancer: 44.0;head and neck cancer: 145.4;melanoma: 50.9;urothelial cancer: 47.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB002243, HPA055211"	Enhanced		Supported	"Nuclear bodies,Centrosome,Cytosol"			8000000	Cytosol	"Nuclear bodies, Centrosome"	"CAB002243: AB_563785, HPA055211: "	"unprognostic (3.29e-4)"	"unprognostic (1.91e-1)"		"unprognostic (2.92e-2)"		"unprognostic (2.31e-2)"		"unprognostic (7.60e-2)"	"unprognostic (2.22e-1)"		"unprognostic (4.82e-2)"	"unprognostic (3.11e-1)"		"unprognostic (3.66e-1)"		"unprognostic (1.22e-2)"	"unprognostic (1.32e-1)"	0.1	0.1	0.0	0.1	0.0	0.1	2.0	0.0	0.1	39.0	0.1	0.0	0.4	0.1	4.2	11.5	97.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	1.8	0.1	0.0	18.7	0.1	0.2	34.2	0.1	1.0	0.0	0.1	0.1	0.1	0.0	1.9	0.1	152.1	49.1	4.9	43.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	77.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	23.2	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNH5	"eag2, H-EAG2, Kv10.2"	ENSG00000140015	"Potassium voltage-gated channel subfamily H member 5"	Q8NCM2	14	62699454-63102037	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 4.6;brain: 9.2;retina: 5.7"	"Group enriched"	"Detected in some"	5	"HeLa: 9.9;RT4: 13.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030487, HPA072351"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol				Centrosome	"Nucleoplasm, Cytosol"	"HPA030487: AB_10609995, HPA072351: "		"unprognostic (1.16e-1)"		"unprognostic (7.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.23e-2)"		"unprognostic (2.70e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.76e-2)"	"unprognostic (8.45e-2)"		"unprognostic (2.66e-1)"	"unprognostic (1.70e-3)"		"unprognostic (3.11e-1)"	0.9	4.6	1.7	0.5	3.6	0.3	0.4	0.2	9.2	0.3	0.4	0.4	0.0	0.3	0.4	0.5	0.3	0.3	0.3	0.3	1.3	3.0	0.4	0.3	0.3	0.3	1.2	4.2	0.3	0.3	0.3	1.5	1.2	6.5	0.7	0.3	5.7	0.3	0.3	0.3	0.3	0.3	0.3	1.6	0.3	0.3	1.7	0.0	0.0	0.3	0.0	0.3	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	13.1	0.1	0.0	1.7	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.6	0.2	9.2	1.3	3.0	1.2	4.2	6.5	0.0
KIAA1211L	"C2orf55, MGC42367"	ENSG00000196872	"KIAA1211 like"	Q6NV74	2	98793846-98936259	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.4;epididymis: 27.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 21.9;HDLM-2: 31.3;Karpas-707: 9.2;SiHa: 8.9;SK-BR-3: 11.9"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"amygdala: 19.0;basal ganglia: 23.7;cerebral cortex: 27.4;hippocampal formation: 12.9;olfactory region: 18.3"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"							"Group enriched"	"Detected in many"	15	"amygdala: 29.7;basal ganglia: 59.8;cerebral cortex: 52.5;hippocampal formation: 81.9;olfactory region: 36.3"	"HPA051082, HPA061678"	Enhanced		Approved	"Microtubules,Cytokinetic bridge,Centrosome"				"Microtubules, Centrosome"	"Cytokinetic bridge"	"HPA051082: , HPA061678: "	"unprognostic (3.56e-3)"	"unprognostic (1.23e-3)"	"unprognostic (5.88e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.67e-3)"	"unprognostic (2.12e-1)"	"unprognostic (5.10e-2)"	"unprognostic (7.65e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.61e-2)"	"prognostic favourable (1.13e-5)"	"unprognostic (1.22e-1)"	"unprognostic (3.34e-1)"	"prognostic favourable (1.33e-5)"	"unprognostic (2.22e-2)"	2.7	0.8	19.0	1.3	23.7	0.5	3.5	2.4	27.4	4.6	5.0	0.8	3.5	6.7	1.5	27.7	9.1	19.3	2.5	1.4	12.9	1.9	2.5	0.4	3.9	0.6	2.7	18.3	1.4	3.7	9.6	4.3	4.0	0.1	1.6	4.0	0.0	9.0	4.3	1.3	4.3	6.1	2.1	1.2	1.0	6.8	3.6	3.6	0.0	4.3	3.3	2.5	2.4	3.2	0.0	0.7	1.4	0.3	0.2	0.9	0.0	4.2	0.2	0.1	1.7	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.2	2.5	0.0	5.5	0.0	3.8	0.1	0.2	0.0	31.3	0.6	0.0	0.2	0.2	0.0	0.0	0.0	0.1	1.2	0.0	0.6	1.3	0.0	9.2	0.0	8.4	0.1	0.6	0.0	0.4	0.0	0.0	0.4	1.7	3.4	3.1	0.5	8.9	11.9	0.0	4.6	0.7	5.4	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.1	0.0	1.4	0.2	0.0	0.7	0.0	0.0	19.0	23.7	2.4	27.4	12.9	1.9	2.7	18.3	0.1	3.6
KIF19	"FLJ37300, KIF19A"	ENSG00000196169	"Kinesin family member 19"	Q2TAC6	17	74326210-74355820	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.9;fallopian tube: 25.2"	"Cell line enriched"	"Detected in single"	11	"SCLC-21H: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 5.5"	"Lineage enriched"	"Detected in single"	55	"T-cells: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043638, HPA073303"	Enhanced		Approved	"Plasma membrane,Actin filaments,Centrosome"				"Plasma membrane"	"Actin filaments, Centrosome"	"HPA043638: AB_10962579, HPA073303: "	"unprognostic (1.59e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.37e-3)"	"unprognostic (9.64e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.83e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.59e-9)"	"unprognostic (5.16e-5)"	"unprognostic (2.72e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.53e-1)"	1.6	0.9	9.3	1.6	29.5	1.1	1.1	25.8	14.1	2.1	3.1	17.4	0.0	6.6	1.1	1.1	1.1	25.2	1.6	1.1	11.9	6.6	0.9	1.6	3.1	1.0	25.0	4.2	1.1	3.0	0.9	0.3	0.8	6.5	0.9	2.1	0.8	2.5	1.3	1.0	0.8	5.2	1.6	6.2	11.6	2.2	1.2	29.9	0.0	2.3	0.0	1.0	1.3	1.3	0.0	0.0	0.0	0.0	0.0	5.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	9.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.6	0.0	0.9	1.6	0.0	0.0	0.7	2.4	0.0	0.0	0.0	0.0	0.0	0.7	9.3	29.5	25.8	14.1	11.9	6.6	25.0	4.2	6.5	29.9
KIF2A	"HK2, KIF2"	ENSG00000068796	"Kinesin family member 2A"	O00139	5	62306162-62537249	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis"	"Developmental protein, Motor protein"	"Cancer-related genes, Disease mutation, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004715, HPA004716"	Approved		Enhanced	Nucleoplasm,Nucleoli,Centrosome			2100000	"Nucleoplasm, Nucleoli, Centrosome"		"HPA004715: , HPA004716: AB_1079211"	"unprognostic (2.40e-2)"	"unprognostic (3.43e-1)"	"prognostic favourable (1.70e-4)"	"unprognostic (2.74e-2)"	"unprognostic (1.43e-1)"	"prognostic favourable (5.45e-4)"	"prognostic unfavourable (3.17e-6)"	"unprognostic (8.77e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (3.81e-5)"	"unprognostic (3.53e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.58e-1)"	11.3	9.3	25.4	21.9	26.4	12.4	15.5	15.4	40.1	19.7	13.5	19.4	8.0	10.3	12.9	7.6	14.3	17.5	13.7	7.2	26.2	24.1	8.2	5.8	10.6	29.4	24.9	24.6	13.0	12.3	15.2	14.3	27.8	37.0	10.2	14.5	6.8	10.7	11.9	7.4	7.9	15.8	13.5	34.3	17.4	9.6	39.2	26.4	28.7	13.0	5.6	26.7	17.4	14.8	9.0	8.4	7.1	3.0	15.8	25.4	9.7	17.2	17.3	28.9	25.6	10.9	15.4	23.6	18.5	15.3	20.2	25.6	18.6	18.9	42.8	20.4	16.3	11.0	21.9	14.9	27.0	42.9	15.3	43.0	16.2	10.1	12.9	23.4	16.4	12.7	9.8	19.6	17.8	18.4	30.4	26.1	16.8	13.0	39.1	11.6	16.8	10.9	28.9	22.9	23.6	9.0	21.0	25.9	21.5	25.1	10.6	13.0	13.8	13.2	15.9	12.0	19.9	13.9	18.4	24.7	35.6	45.2	13.9	28.2	14.7	7.1	3.0	3.4	20.2	2.6	22.8	9.0	20.3	20.6	4.0	7.8	17.9	18.4	5.3	15.8	1.8	8.4	25.4	9.7	25.4	26.4	15.4	31.2	26.2	24.1	24.9	24.6	37.0	26.4
KIF2C	"CT139, KNSL6, MCAK"	ENSG00000142945	"Kinesin family member 2C"	Q99661	1	44739818-44767767	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 39.9;testis: 61.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 5.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA006219			Supported	Nucleoplasm,Midbody,Centrosome				"Nucleoplasm, Centrosome"	Midbody	"HPA006219: "	"unprognostic (3.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavourable (3.07e-7)"	"unprognostic (7.49e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.66e-1)"	"prognostic unfavourable (6.86e-4)"	"unprognostic (4.27e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.41e-1)"	1.1	0.7	0.4	8.7	0.4	12.7	0.8	0.5	0.5	1.2	2.4	0.4	0.2	2.1	1.3	1.4	4.6	0.6	0.7	0.9	0.6	0.5	0.7	0.6	1.6	6.7	0.4	0.2	0.7	0.4	0.3	0.6	2.2	0.6	0.6	3.2	0.4	1.1	0.2	0.4	2.3	2.2	1.1	0.4	3.3	1.4	61.4	0.2	39.9	0.8	4.7	12.0	0.9	1.7	1.3	1.5	0.0	0.2	3.9	5.8	1.0	28.7	11.2	25.0	20.0	1.3	2.9	16.8	21.6	15.4	44.2	38.6	18.9	20.8	33.1	10.4	10.6	13.7	25.4	14.5	40.5	21.4	10.9	39.2	19.8	15.7	0.1	28.9	18.2	0.7	1.4	31.5	15.4	14.2	30.9	28.4	27.9	11.2	30.4	17.5	24.4	14.1	24.4	37.8	20.8	7.4	10.4	17.2	12.3	28.7	20.5	18.1	11.8	22.0	8.4	16.1	31.9	17.4	37.8	15.1	15.3	47.8	10.3	28.2	30.9	0.0	0.0	0.0	1.9	0.0	0.1	1.3	3.4	2.6	0.3	0.2	0.7	0.5	0.0	3.9	0.2	1.5	5.8	1.0	0.4	0.4	0.5	0.5	0.6	0.5	0.4	0.2	0.6	0.2
KLHL35	FLJ33790	ENSG00000149243	"Kelch like family member 35"	Q6PF15	11	75422394-75430629	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 14.1;testis: 11.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 13.9;HMC-1: 9.3;PC-3: 8.0;SiHa: 16.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 5.4;T-cells: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039864, HPA070736"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Centrosome"				"Nucleoplasm, Centrosome"	"Nucleoli fibrillar center"	"HPA039864: AB_10794204, HPA070736: "	"unprognostic (3.53e-2)"	"prognostic favourable (4.63e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.88e-2)"	"unprognostic (4.15e-3)"	"unprognostic (4.98e-2)"	"unprognostic (3.92e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.39e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.28e-1)"	1.1	3.4	4.5	0.7	14.1	0.7	3.5	1.8	8.2	3.2	1.0	3.0	0.2	0.7	0.5	1.0	1.0	2.0	1.1	1.1	3.7	6.2	0.6	0.6	2.7	0.7	3.1	3.3	0.5	4.5	0.5	0.8	0.8	6.2	0.7	0.6	0.7	1.3	1.0	0.9	1.2	0.5	1.1	4.3	1.0	2.3	11.2	2.4	0.0	1.4	0.0	0.7	0.7	0.2	0.2	0.8	5.4	0.3	0.0	2.1	1.2	0.0	0.3	0.1	0.0	0.2	1.2	0.0	0.8	0.0	0.8	0.1	13.9	1.2	0.0	3.9	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.7	3.5	9.3	0.2	0.2	0.0	0.0	0.3	0.0	0.0	1.0	0.6	0.3	0.1	0.1	8.0	0.0	0.0	0.8	0.6	0.1	1.0	0.9	16.4	3.1	0.0	3.1	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	2.1	0.0	0.5	0.0	1.2	0.7	0.8	0.2	0.3	0.5	0.1	0.0	0.3	0.0	0.0	1.2	4.5	14.1	1.8	7.1	3.7	6.2	3.1	3.3	6.2	2.4
KXD1	"BORCS4, C19orf50, FLJ25480, KXDL, MGC2749"	ENSG00000105700	"KxDL motif containing 1"	Q9BQD3	19	18557762-18569387	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041507, HPA041599"	Approved		Approved	"Nucleoli fibrillar center,Centrosome,Cytosol"				"Nucleoli fibrillar center, Centrosome, Cytosol"		"HPA041507: AB_10795698, HPA041599: AB_10795502"	"unprognostic (8.48e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.35e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavourable (8.46e-4)"	"unprognostic (7.36e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavourable (7.71e-10)"	"unprognostic (7.55e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.63e-1)"	52.9	42.2	47.2	48.7	44.9	49.1	42.8	28.4	60.9	37.2	44.5	56.7	34.3	43.7	48.9	43.2	45.9	45.6	44.1	43.2	43.3	41.8	39.6	73.3	42.2	56.1	46.7	34.2	52.3	58.9	33.6	48.2	53.7	43.7	46.6	43.2	40.0	60.4	45.4	58.3	46.8	39.9	49.3	56.2	48.3	44.5	75.4	38.9	42.1	47.0	45.5	53.2	57.2	54.0	26.9	37.1	41.3	46.4	29.7	37.6	30.6	32.8	33.2	27.3	31.0	28.3	32.8	44.7	36.5	29.3	27.3	31.7	27.2	39.4	22.7	42.9	32.4	25.1	41.9	44.6	24.6	27.5	59.2	24.9	26.0	24.5	32.7	38.8	27.4	34.8	31.8	40.9	49.0	38.6	38.6	35.9	28.4	38.2	34.9	28.6	34.4	50.9	33.6	21.4	33.0	27.8	30.1	25.4	32.7	23.8	21.4	30.6	18.2	26.8	31.3	24.6	21.7	78.6	47.2	42.8	31.9	33.9	42.5	45.6	35.5	15.0	41.0	35.0	29.8	46.4	27.7	26.9	27.6	29.5	37.1	26.4	22.2	24.2	41.3	29.7	43.4	22.1	37.6	30.6	47.2	44.9	28.4	60.9	43.3	41.8	46.7	34.2	43.7	38.9
LEO1		ENSG00000166477	"LEO1 homolog, Paf1/RNA polymerase II complex component"	Q8WVC0	15	51938025-51971806	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040741, HPA040941"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Centrosome"				"Nucleoplasm, Nucleoli fibrillar center"	Centrosome	"HPA040741: AB_10794859, HPA040941: AB_10805832"	"unprognostic (2.76e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.08e-1)"	10.7	15.2	15.0	15.3	27.9	8.3	17.0	42.6	24.4	13.4	17.8	14.1	9.7	13.9	12.6	11.2	24.4	9.7	14.2	10.6	14.0	14.0	21.4	27.8	10.2	17.2	14.8	14.9	10.6	10.3	25.2	22.4	12.7	22.7	13.8	21.0	9.1	21.2	12.5	13.5	21.8	19.8	12.6	15.3	14.3	13.9	9.8	18.5	23.4	12.0	9.4	18.2	16.9	15.7	12.3	15.3	9.6	15.3	18.9	19.7	10.0	9.5	22.3	14.4	11.6	14.9	12.9	10.3	15.6	12.9	13.4	12.3	15.4	6.3	19.4	9.1	15.9	18.7	19.1	13.9	13.0	12.8	8.6	30.5	18.2	27.0	11.8	27.4	42.6	13.9	10.9	10.4	13.6	13.0	18.4	10.7	15.9	40.6	14.5	20.9	6.2	9.6	16.3	25.0	20.3	11.8	26.8	10.2	15.6	11.9	18.3	12.1	15.2	25.0	15.5	13.3	9.2	12.2	18.5	8.4	26.1	17.8	11.7	39.3	14.1	5.4	9.4	9.6	18.7	14.6	17.5	12.3	18.7	15.2	15.3	10.1	19.5	17.5	2.3	18.9	15.3	11.5	19.7	10.0	15.0	27.9	42.6	24.4	14.0	14.0	14.8	14.9	22.7	18.5
LONRF1	"FLJ23749, RNF191"	ENSG00000154359	"LON peptidase N-terminal domain and ring finger 1"	Q17RB8	8	12721894-12756073	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023584, HPA024814"	Uncertain		Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	Centrosome	"HPA023584: AB_1853233, HPA024814: AB_1853235"	"unprognostic (2.59e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.35e-2)"	"unprognostic (3.56e-1)"	"unprognostic (9.09e-2)"	"unprognostic (3.96e-3)"	"unprognostic (3.13e-1)"	"unprognostic (5.78e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.39e-1)"	"unprognostic (5.46e-3)"	"unprognostic (8.97e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.08e-3)"	"unprognostic (1.15e-1)"	16.5	7.6	7.6	4.9	9.9	4.9	10.4	9.9	8.4	14.0	8.1	6.3	8.8	2.2	11.1	13.0	12.9	11.2	9.4	6.5	8.9	5.3	6.3	9.3	8.1	8.7	6.9	6.9	20.4	10.3	12.6	4.9	9.6	5.5	12.8	4.2	13.9	7.9	10.9	18.4	29.7	5.3	10.0	6.1	9.2	6.9	16.1	4.5	6.2	8.6	7.3	7.3	10.6	19.0	1.1	0.9	2.4	2.1	0.1	1.6	0.2	0.6	1.6	8.4	2.6	8.9	4.3	5.6	2.1	3.5	2.3	3.2	0.5	2.1	12.9	0.5	3.6	1.0	6.6	2.5	2.6	2.0	3.7	4.2	0.3	3.4	8.3	1.1	1.6	4.0	4.6	1.4	5.1	3.6	0.6	31.8	1.5	2.3	5.5	3.7	8.6	0.5	3.1	5.7	2.3	2.0	5.6	17.7	2.1	1.2	2.8	16.4	0.6	5.7	1.6	1.2	2.1	5.0	1.6	2.4	10.7	6.8	6.8	3.9	3.8	0.0	0.5	2.4	0.5	1.8	1.6	1.0	1.0	0.6	0.4	1.1	0.0	0.0	1.9	0.1	2.1	0.9	0.0	0.2	7.6	9.9	9.9	8.4	8.9	5.3	6.9	6.9	5.5	4.5
LZTR1	"BTBD29, LZTR-1"	ENSG00000099949	"Leucine zipper like transcription regulator 1"	Q8N653	22	20982013-20999038	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067852, HPA068772, HPA071248"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA067852: , HPA068772: , HPA071248: "	"unprognostic (1.88e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.44e-2)"	"prognostic unfavourable (5.15e-4)"	"unprognostic (9.81e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.25e-2)"	21.2	16.9	17.3	15.6	17.4	10.3	17.9	20.7	24.7	18.5	18.3	25.3	20.6	18.9	24.9	14.0	16.5	18.3	21.2	15.8	15.4	10.9	17.2	13.1	16.2	12.8	19.6	16.5	21.7	16.2	24.9	26.0	18.8	19.0	16.9	12.9	18.9	17.5	18.0	17.2	15.0	15.7	21.9	14.0	19.3	14.5	10.8	19.2	10.8	19.6	12.6	12.5	18.5	16.4	1.6	2.2	0.2	3.4	1.8	3.0	1.5	6.2	5.1	7.6	9.2	17.6	12.2	6.2	12.8	9.0	7.3	10.0	3.0	2.6	6.6	4.8	14.2	8.4	5.7	10.5	2.9	12.3	13.3	7.1	6.7	4.4	9.4	3.8	9.4	11.2	5.3	9.2	6.7	14.1	29.4	11.5	8.2	3.8	6.8	3.6	2.4	5.6	8.0	11.1	2.6	5.7	8.4	7.5	11.2	6.9	12.1	7.5	5.6	7.1	12.6	17.0	8.7	7.7	6.9	5.0	4.4	2.0	7.7	3.7	8.2	0.0	2.5	0.2	3.0	3.1	1.6	1.6	1.5	2.8	2.2	1.0	2.1	1.5	0.1	1.8	3.4	1.2	0.5	1.5	17.3	17.4	20.7	24.7	15.4	10.9	19.6	16.5	19.0	19.2
NAE1	"APP-BP1, APPBP1, ula-1"	ENSG00000159593	"NEDD8 activating enzyme E1 subunit 1"	Q13564	16	66802875-66873256	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041178, HPA042041"	Enhanced		Approved	Nucleoplasm,Microtubules,Centrosome			53000	Nucleoplasm	"Microtubules, Centrosome"	"HPA041178: AB_10964773, HPA042041: AB_10964772"	"unprognostic (3.22e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavourable (3.92e-8)"	"unprognostic (2.31e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.12e-3)"	"unprognostic (5.34e-2)"	"unprognostic (3.85e-2)"	"unprognostic (7.09e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.84e-1)"	"prognostic favourable (9.44e-5)"	"unprognostic (1.97e-1)"	23.6	27.4	25.3	20.2	31.8	27.2	27.3	36.7	41.7	26.0	25.8	24.4	23.7	26.2	27.9	31.0	27.5	23.9	20.2	23.6	25.4	29.0	24.3	25.9	18.3	27.0	27.7	31.9	31.0	26.6	38.8	42.2	26.4	34.9	24.9	30.0	22.1	24.3	23.5	33.2	26.9	27.6	25.4	25.3	18.4	22.2	36.9	25.9	28.9	27.9	28.0	24.9	24.7	22.4	9.4	6.4	6.7	3.2	8.6	19.4	9.4	22.6	17.5	31.2	30.7	12.5	17.8	25.9	17.3	17.6	25.7	31.2	21.2	17.6	25.1	19.9	13.0	23.0	23.4	20.8	36.5	9.2	26.7	17.8	12.1	32.9	14.4	33.1	22.4	14.4	15.5	20.4	18.0	17.9	42.1	8.9	19.7	7.9	34.6	37.9	43.2	31.6	37.2	37.2	33.5	19.8	20.0	33.6	24.7	51.8	11.1	19.9	11.9	22.4	13.9	18.0	18.0	18.7	20.0	16.8	25.9	90.5	16.2	22.0	21.7	1.3	3.1	6.7	15.4	3.0	19.4	9.4	16.4	16.6	4.2	7.9	17.8	17.7	1.4	8.6	3.2	6.4	14.0	9.4	25.3	31.8	36.7	41.7	25.4	29.0	27.7	31.9	34.9	25.9
NEDD1	"GCP-WD, TUBGCP7"	ENSG00000139350	"Neural precursor cell expressed, developmentally down-regulated 1"	Q8NHV4	12	96907223-96953777	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038591	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome"				"Nucleoplasm, Centrosome"	"Plasma membrane"	"HPA038591: AB_10674688"	"unprognostic (7.93e-2)"	"unprognostic (3.18e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.92e-2)"	"prognostic unfavourable (1.94e-4)"	"prognostic unfavourable (3.70e-4)"	"unprognostic (1.81e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.46e-3)"	"unprognostic (7.29e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.59e-2)"	10.7	6.2	5.7	10.0	6.6	9.8	9.8	2.5	7.1	10.8	9.3	7.1	1.7	4.9	13.5	8.3	11.6	10.0	5.5	8.3	6.0	4.4	12.6	5.4	9.4	10.3	7.0	3.7	13.3	7.7	14.9	13.5	7.9	6.5	11.9	7.2	6.3	8.5	6.3	25.5	7.8	10.3	15.4	8.4	14.5	7.2	17.8	8.3	30.6	11.9	24.3	10.7	15.1	9.6	9.4	5.9	19.9	11.1	15.6	14.0	7.3	13.4	8.9	15.4	9.4	7.7	6.9	10.9	46.8	16.6	21.6	18.7	5.8	5.0	8.3	4.5	37.4	12.1	10.4	10.8	29.2	15.9	8.9	10.4	5.9	5.1	6.4	14.1	9.4	5.1	8.9	13.1	10.2	10.5	6.0	6.1	15.4	5.5	25.7	6.4	8.5	28.5	13.6	15.7	8.2	8.8	8.8	4.8	8.5	13.1	7.4	8.1	10.0	5.0	7.5	13.6	10.5	9.7	11.0	6.0	7.3	11.1	4.2	7.2	16.4	10.0	6.9	19.9	12.1	11.1	13.7	9.4	13.4	12.9	5.9	8.1	14.0	10.9	5.4	15.6	7.8	4.6	14.0	7.3	5.7	6.6	2.5	7.1	6.0	4.4	7.0	3.7	6.5	8.3
NFKBIB	"IKBB, TRIP9"	ENSG00000104825	"NFKB inhibitor beta"	Q15653	19	38899700-38908893	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 80.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063734			Approved	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA063734: "	"unprognostic (2.73e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.82e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.50e-3)"	7.9	7.1	7.0	12.5	9.8	22.0	6.8	2.9	7.3	3.9	7.6	8.1	7.6	10.8	5.8	5.7	8.6	5.1	7.6	7.1	7.3	5.8	7.9	14.6	6.7	8.7	11.2	5.2	4.3	9.7	4.0	3.9	7.2	7.2	5.0	3.6	5.1	8.6	6.6	13.9	8.0	11.7	5.1	9.9	9.2	12.4	80.2	9.3	6.0	6.6	8.7	8.7	6.6	5.1	3.8	5.4	12.4	5.8	8.7	7.2	2.9	8.0	10.0	1.4	3.6	1.5	0.9	4.8	5.4	2.2	2.9	3.3	7.1	4.4	8.9	6.1	1.2	4.4	3.8	2.6	0.9	27.2	4.8	5.9	1.9	4.0	5.2	6.8	12.6	1.2	3.0	3.2	4.1	1.6	6.9	8.2	1.1	5.2	8.4	6.7	5.1	4.1	11.8	6.2	8.1	1.4	3.2	8.7	5.2	3.4	5.0	3.8	3.0	5.8	3.8	5.0	6.4	8.6	8.3	17.0	15.1	19.0	3.2	7.1	6.1	1.5	4.3	12.4	5.3	5.8	4.1	3.6	3.1	4.5	3.8	3.8	2.3	3.4	9.0	8.7	4.7	5.4	7.2	2.9	7.0	9.8	2.9	7.3	7.3	5.8	11.2	5.2	7.2	9.3
NIN		ENSG00000100503	Ninein	Q8N4C6	14	50719763-50831121	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA005939, HPA070691"	Approved		Enhanced	Nucleoplasm,Nucleoli,Centrosome				Centrosome	"Nucleoplasm, Nucleoli"	"HPA005939: , HPA070691: "	"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.58e-2)"	"unprognostic (7.66e-3)"	13.0	6.1	15.1	24.9	10.3	34.8	9.7	12.6	14.0	8.0	9.2	7.6	4.5	5.0	11.8	6.1	11.8	8.2	7.6	16.4	11.7	4.9	6.7	5.2	10.7	30.2	7.6	10.0	11.0	5.4	9.1	12.3	20.2	7.1	6.5	7.7	6.2	8.2	5.1	16.9	10.9	8.3	12.0	7.1	18.2	9.3	4.6	9.0	16.4	7.8	5.1	25.8	11.7	10.3	6.8	6.3	18.4	2.3	1.5	6.0	1.3	12.2	8.7	18.1	15.4	7.0	11.2	7.6	10.5	9.1	8.9	7.5	5.6	6.5	28.8	7.2	14.1	12.9	14.5	6.6	18.7	13.9	4.5	10.6	5.3	5.3	4.1	18.4	30.6	7.7	5.3	15.5	6.4	14.1	2.6	11.8	13.4	13.4	13.9	7.4	2.5	9.6	15.8	33.5	2.0	8.0	13.9	8.4	9.5	13.2	4.0	11.3	7.5	16.4	20.5	22.6	31.4	8.6	11.6	9.5	4.8	19.9	5.9	15.0	12.2	12.6	2.3	18.4	3.3	1.7	3.5	6.8	2.2	6.0	1.5	5.5	4.4	3.8	8.3	1.5	1.5	6.3	1.9	1.3	15.1	10.3	12.6	14.0	11.7	4.9	7.6	10.0	7.1	9.0
NPTX2		ENSG00000106236	"Neuronal pentraxin 2"	P47972	7	98617297-98629868	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 24.0;brain: 45.6;pancreas: 19.5;pituitary gland: 71.6;testis: 20.7"	"Cell line enriched"	"Detected in some"	12	"LHCN-M2: 125.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	16	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB020801, HPA049799, HPA058320"	Enhanced		Approved	"Golgi apparatus,Actin filaments,Centrosome"	"Secreted to blood"	2488000	320000	"Golgi apparatus, Actin filaments"	Centrosome	"CAB020801: , HPA049799: , HPA058320: "	"unprognostic (1.18e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.56e-2)"	"prognostic unfavourable (5.46e-5)"	"unprognostic (1.91e-3)"	"unprognostic (9.20e-2)"	"unprognostic (2.42e-2)"	"unprognostic (6.04e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.64e-2)"	"unprognostic (2.35e-1)"	"prognostic unfavourable (5.46e-9)"	"unprognostic (1.06e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.69e-2)"	4.3	24.0	7.1	2.3	8.4	1.0	1.4	0.2	45.6	8.2	3.8	3.2	0.1	1.1	1.8	3.9	2.2	1.5	1.6	3.2	9.2	11.0	0.9	0.9	0.8	0.7	9.4	2.2	1.5	19.5	0.8	71.6	0.8	7.0	2.1	1.4	1.3	1.5	2.2	2.9	4.0	1.3	2.9	2.9	6.1	1.9	20.7	5.0	0.0	1.6	0.1	0.9	1.4	2.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.4	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	125.7	0.0	0.9	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	10.8	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	7.1	8.4	0.2	24.6	9.2	11.0	9.4	2.2	7.0	5.0
NR6A1	"CT150, GCNF, GCNF1, RTR"	ENSG00000148200	"Nuclear receptor subfamily 6 group A member 1"	Q15406	9	124517275-124771310	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 28.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 47.0;CACO-2: 10.8;Hep G2: 10.5;K-562: 13.8;NTERA-2: 16.7;U-266/84: 10.1"	"Cancer enriched"	"Detected in many"	16	"testis cancer: 27.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 8.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 8.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031461, HPA045145"			Supported	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA031461: , HPA045145: "	"unprognostic (1.73e-1)"	"unprognostic (6.66e-2)"	"unprognostic (4.53e-1)"	"unprognostic (1.34e-6)"	"unprognostic (4.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.52e-5)"	"unprognostic (6.31e-2)"	"unprognostic (8.01e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.26e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.09e-1)"	0.6	1.0	2.9	1.4	3.4	5.5	1.8	5.8	3.5	0.8	7.9	1.2	1.3	2.5	0.9	1.4	2.2	1.0	0.9	1.0	3.3	1.3	1.9	2.8	1.8	0.7	2.1	2.4	0.6	3.3	1.5	2.2	4.2	2.2	1.7	2.3	1.7	1.5	1.4	1.9	2.6	5.3	0.8	2.3	1.1	0.7	28.2	2.8	0.0	7.3	0.8	1.1	1.3	1.4	0.3	1.0	8.6	1.2	0.1	0.0	0.1	0.5	1.2	6.2	0.8	0.1	0.1	47.0	0.0	0.4	0.3	0.5	10.8	1.2	2.1	0.4	0.0	1.1	0.6	0.5	0.7	0.5	2.0	1.6	1.7	10.5	0.0	0.9	3.1	0.0	0.6	0.5	0.6	0.1	13.8	0.3	0.2	0.2	0.0	1.3	16.7	0.5	0.5	0.6	0.9	0.2	0.8	0.9	0.3	0.0	0.3	0.4	1.1	0.5	0.0	0.6	1.3	0.4	0.3	1.4	10.1	1.9	0.3	0.9	0.3	0.1	1.2	2.0	0.0	0.9	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.0	8.6	0.1	0.6	0.2	0.0	0.1	2.9	3.4	5.8	3.5	3.3	1.3	2.1	2.4	2.2	2.8
NUDT5	"hYSAH1, YSA1H"	ENSG00000165609	"Nudix hydrolase 5"	Q9UKK9	10	12165325-12196144	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019827	Approved		Approved	Nucleoplasm,Vesicles,Centrosome			660000	Vesicles	"Nucleoplasm, Centrosome"	"HPA019827: AB_1854704"	"unprognostic (2.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.77e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.39e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.97e-2)"	"prognostic unfavourable (7.14e-12)"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.12e-2)"	"unprognostic (3.68e-2)"	19.6	22.0	17.4	18.6	21.2	13.5	20.2	15.4	21.4	16.7	20.4	16.1	15.2	17.3	10.0	16.5	25.8	16.3	12.1	10.0	16.2	14.3	26.0	57.1	16.8	22.7	21.7	12.8	12.5	16.9	19.1	35.7	19.9	18.5	13.4	24.2	13.2	16.7	19.7	5.1	20.6	15.9	11.6	17.9	22.4	14.1	8.0	21.5	28.2	19.1	16.5	29.5	16.2	18.6	22.4	45.9	50.1	19.5	16.2	37.0	20.4	37.3	27.6	33.0	30.7	32.0	31.6	29.3	27.7	17.7	32.7	35.1	39.6	35.7	37.4	24.1	22.4	37.6	46.0	42.9	30.0	30.6	45.0	31.1	33.9	58.1	33.4	20.6	21.9	33.2	25.6	35.6	18.2	41.6	41.6	25.6	29.7	34.3	38.6	24.2	28.7	17.2	35.3	12.0	43.4	30.5	12.9	15.9	23.9	33.6	25.9	38.5	44.4	21.3	26.0	13.9	26.7	38.8	33.8	21.6	37.9	50.3	29.3	26.9	10.3	8.1	19.1	33.5	22.8	19.5	26.2	22.4	24.6	26.8	27.0	18.3	17.0	23.0	50.1	16.2	14.8	45.9	37.0	20.4	17.4	21.2	15.4	21.4	16.2	14.3	21.7	12.8	18.5	21.5
NUP107	NUP84	ENSG00000111581	"Nucleoporin 107"	P57740	12	68686734-68745809	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031679			Uncertain	"Nucleoplasm,Nuclear membrane,Centrosome"				Nucleoplasm	"Nuclear membrane, Centrosome"	"HPA031679: "	"unprognostic (2.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.10e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.32e-2)"	"prognostic unfavourable (3.12e-9)"	"unprognostic (4.03e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavourable (1.28e-6)"	"unprognostic (3.43e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.96e-1)"	18.3	12.6	10.2	16.5	13.2	18.7	17.4	20.7	15.2	19.0	12.2	12.1	12.2	9.2	18.6	18.0	14.0	16.6	8.5	12.1	12.2	6.6	12.1	11.1	12.5	21.4	13.2	10.2	19.8	12.5	14.2	16.2	23.5	12.2	12.6	15.3	11.3	13.0	11.8	13.9	14.8	15.8	13.7	12.5	19.7	12.0	20.5	15.9	40.6	12.5	13.1	22.5	17.8	13.1	13.6	7.0	9.5	14.2	20.6	17.0	8.0	17.0	22.0	26.3	19.0	7.8	10.0	28.5	18.7	10.8	28.2	23.6	22.1	14.5	31.3	18.3	8.9	19.7	29.5	13.8	37.6	29.3	21.9	35.7	15.8	18.5	4.9	31.4	12.1	5.2	6.6	22.5	14.8	16.8	42.5	22.6	17.6	20.7	25.8	27.5	28.9	21.6	26.5	31.6	18.8	12.2	18.2	15.5	15.9	20.7	15.6	11.2	23.4	15.2	10.2	15.4	15.7	17.8	22.7	9.9	19.7	37.9	11.8	23.0	18.1	6.3	6.5	9.5	13.1	8.5	17.0	13.5	13.0	14.0	7.0	13.6	16.2	14.5	1.7	20.6	14.2	5.5	13.4	8.0	10.2	13.2	20.7	15.2	12.2	6.6	13.2	10.2	12.2	15.9
PCM1	PTC4	ENSG00000078674	"Pericentriolar material 1"	Q15154	8	17922840-18029944	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023370, HPA023374, CAB058695"	Enhanced		Enhanced	"Nuclear membrane,Centrosome,Cytosol"				Centrosome	"Nuclear membrane, Cytosol"	"CAB058695: , HPA023370: AB_1855072, HPA023374: AB_1855073"	"unprognostic (1.52e-2)"	"unprognostic (1.77e-2)"	"unprognostic (6.54e-3)"	"unprognostic (3.35e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.45e-1)"	19.6	19.0	26.2	26.7	40.4	25.1	25.1	29.2	29.0	25.0	21.1	21.6	22.8	12.4	23.3	27.3	16.4	26.4	17.8	23.0	22.9	18.4	18.8	22.0	19.1	21.1	24.5	24.9	29.1	27.0	42.0	35.8	19.8	26.4	20.2	16.3	16.2	19.4	25.3	63.1	17.6	18.3	26.7	27.2	20.8	17.9	80.0	28.0	40.2	28.2	19.1	20.4	27.0	22.6	11.5	14.9	19.9	7.5	11.2	13.0	4.3	20.3	21.7	33.4	44.2	18.9	19.7	17.3	17.2	21.2	18.4	20.8	14.7	12.2	26.7	11.9	17.1	14.8	21.3	15.8	31.4	8.8	8.2	45.8	15.4	29.8	21.1	20.0	11.8	17.1	16.9	21.3	23.7	21.1	30.9	20.8	22.4	10.2	42.9	33.2	27.5	6.3	25.9	29.9	9.5	15.2	28.3	25.6	19.3	18.4	10.1	26.4	15.9	29.3	18.8	16.8	13.7	20.5	14.5	8.9	19.6	23.9	14.2	22.1	17.1	19.9	6.0	14.4	11.5	3.8	12.0	11.1	10.4	13.0	5.9	11.5	11.6	11.6	6.4	11.2	7.5	14.9	10.3	4.3	26.2	40.4	29.2	29.0	22.9	18.4	24.5	24.9	26.4	28.0
PEAR1	"FLJ00193, JEDI, MEGF12"	ENSG00000187800	"Platelet endothelial aggregation receptor 1"	Q5VY43	1	156893698-156916434	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.9;HBEC3-KT: 13.5;HHSteC: 10.2;HUVEC TERT2: 23.8;TIME: 38.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035217	Approved		Approved	"Nucleoplasm,Cell Junctions,Centrosome"			35000000	"Nucleoplasm, Cell Junctions"	Centrosome	"HPA035217: AB_10669902"	"unprognostic (1.02e-1)"	"unprognostic (1.84e-5)"	"unprognostic (4.77e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.62e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.04e-1)"	"prognostic unfavourable (4.31e-4)"	"unprognostic (1.20e-2)"	"unprognostic (3.37e-3)"	"unprognostic (8.51e-2)"	"unprognostic (2.64e-2)"	18.5	7.1	1.8	3.0	5.1	2.8	29.2	1.2	2.9	16.5	5.8	2.7	6.3	2.3	15.9	10.5	6.6	8.9	10.3	11.1	2.7	1.8	6.8	3.8	12.0	10.1	3.2	2.1	10.6	3.2	1.7	3.9	15.5	3.7	9.6	1.4	15.5	4.1	5.5	11.4	4.4	4.1	9.6	3.1	12.2	4.1	8.1	1.5	0.6	10.5	5.8	2.1	6.7	11.5	0.0	0.0	0.4	0.0	0.0	0.0	2.4	0.2	1.3	0.3	0.0	0.0	1.7	0.0	5.2	8.9	2.2	1.3	0.1	0.2	0.0	0.2	3.9	0.1	0.0	13.5	0.6	0.0	0.0	6.5	0.2	0.3	10.2	0.0	0.0	5.3	0.0	3.0	0.7	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	38.4	0.0	3.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.4	1.8	5.1	1.2	2.9	2.7	1.8	3.2	2.1	3.7	1.5
PLVAP	"FELS, gp68, PV-1, PV1"	ENSG00000130300	"Plasmalemma vesicle associated protein"	Q9BX97	19	17351448-17377350	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 128.3"	"Cell line enriched"	"Detected in some"	28	"EFO-21: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 22.1"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 22.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA002279	Supported		Approved	"Plasma membrane,Centrosome,Cytosol"			53000	Cytosol	"Plasma membrane, Centrosome"	"HPA002279: AB_1079636"	"unprognostic (3.19e-1)"	"unprognostic (8.22e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.49e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.96e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.17e-2)"	128.3	9.8	0.8	16.4	0.9	0.0	56.3	0.4	1.5	28.7	29.8	3.2	12.8	20.2	32.0	19.8	27.4	16.6	43.1	18.9	1.1	0.4	33.7	4.6	13.1	34.6	0.9	0.5	14.3	22.9	13.8	16.1	12.6	2.7	26.1	5.2	26.3	16.0	10.4	20.7	11.5	23.7	13.5	1.2	77.8	22.1	9.5	0.7	3.8	88.3	13.9	15.2	30.1	87.7	0.0	22.1	0.0	3.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	109.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.9	0.0	0.4	0.0	0.0	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	22.1	0.0	0.3	0.8	0.9	0.4	1.5	1.1	0.4	0.9	0.5	2.7	0.7
POLR3H	"KIAA1665, RPC8"	ENSG00000100413	"RNA polymerase III subunit H"	Q9Y535	22	41525804-41544606	"Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046787	Approved		Supported	Nucleoplasm,Vesicles,Centrosome				Nucleoplasm	"Vesicles, Centrosome"	"HPA046787: AB_2679806"	"unprognostic (1.55e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (2.04e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.43e-2)"	"prognostic favourable (5.41e-4)"	"unprognostic (6.40e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.70e-1)"	16.8	14.0	30.0	9.1	28.8	5.5	13.5	21.0	27.4	12.1	7.5	15.8	12.6	6.1	10.5	11.7	17.0	19.0	10.3	14.8	24.0	20.5	10.0	18.9	14.7	10.9	22.2	17.6	22.4	13.7	13.1	11.5	7.9	17.2	11.0	6.8	12.1	12.2	14.2	7.7	14.6	6.2	14.4	14.2	7.2	7.9	14.2	16.5	7.0	15.4	8.2	9.3	8.1	9.1	11.6	11.2	0.6	13.8	3.9	10.2	7.5	16.1	10.9	10.1	14.7	11.1	10.1	6.7	13.6	12.7	23.2	18.7	22.0	5.3	13.8	10.7	22.8	7.4	18.5	22.2	14.6	12.5	22.8	8.2	17.3	10.5	11.5	34.1	14.1	12.6	14.5	30.5	8.2	11.3	17.3	8.9	12.9	15.4	8.7	9.3	7.1	14.2	13.4	7.9	14.3	10.8	9.5	9.8	5.8	17.7	18.0	8.6	7.2	9.7	10.1	13.9	15.0	24.0	18.0	6.7	12.5	20.8	24.2	12.2	13.1	0.0	10.0	0.1	7.3	13.8	10.2	11.6	7.1	8.6	11.2	10.1	10.0	8.1	0.6	3.9	12.7	10.8	4.4	7.5	30.0	28.8	21.0	26.9	24.0	20.5	22.2	17.6	17.2	16.5
PPP4R3B	"FLFL2, FLJ31474, KIAA1387, PSY2, SMEK2"	ENSG00000275052	"Protein phosphatase 4 regulatory subunit 3B"	Q5MIZ7	2	55547292-55618880	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001233, CAB017185"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Centrosome"				"Nucleoplasm, Nuclear speckles"	Centrosome	"CAB017185: , HPA001233: AB_1080033"	"unprognostic (9.60e-2)"	"unprognostic (2.47e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.27e-2)"	"unprognostic (8.27e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.69e-1)"	"prognostic unfavourable (6.03e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.77e-1)"	11.9	10.4	12.1	10.6	13.1	8.1	10.9	17.5	13.1	11.2	11.4	8.6	7.4	11.5	8.8	7.8	12.0	12.5	9.1	5.3	12.8		12.7	18.1	8.3	13.0	13.3	7.9	10.8	13.6	10.7	11.7	11.1	11.4	9.5	10.6	7.8	9.6	9.1	6.0	11.0	14.4	10.3	11.1	10.8	11.0	8.0	12.3	18.7	12.6	6.2	14.3	11.3	10.0	17.6	16.9	23.9	19.6	20.0	25.3	21.6	19.7	15.4	17.0	14.3	18.2	19.2	23.4	15.9	17.4	13.8	11.8	18.1	19.1	26.8	32.4	15.7	17.2	19.3	13.1	20.7	38.5	8.1	26.7	14.5	24.2	29.5	30.4	22.2	14.8	31.7	16.8	29.1	21.6	25.3	27.2	18.2	23.1	19.6	20.0	16.7	12.2	18.3	25.7	20.2	19.0	20.7	21.2	12.9	17.3	24.0	25.8	15.1	24.7	16.9	21.2	27.2	10.4	21.9	28.1	21.1	10.3	19.8	29.0	22.5	21.2	15.6	23.9	20.4	19.6	23.0	17.6	21.5	21.2	16.9	16.9	25.3	22.0	18.1	20.0	19.3	9.2	21.5	21.6										
PXN		ENSG00000089159	Paxillin	P49023	12	120210439-120265771	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 49.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003841, HPA051309"	Supported		Enhanced	"Focal adhesion sites,Centrosome,Cytosol"				"Focal adhesion sites"	"Centrosome, Cytosol"	"CAB003841: AB_562188, HPA051309: "	"unprognostic (4.00e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.55e-3)"	"prognostic unfavourable (1.09e-4)"	"prognostic unfavourable (3.72e-5)"	"prognostic unfavourable (7.12e-5)"	"prognostic unfavourable (1.73e-4)"	"unprognostic (3.12e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.75e-2)"	35.4	26.2	17.9	26.7	16.5	31.6	45.9	15.5	18.6	25.0	29.0	12.4	31.7	25.6	27.6	30.9	16.0	29.8	31.8	26.2	18.0	7.6	27.6	13.1	35.8	42.9	15.7	8.1	14.8	16.3	17.6	13.9	34.0	15.8	24.9	23.5	24.7	22.1	40.1	98.5	19.7	34.7	44.4	20.3	34.0	20.6	19.8	14.4	9.9	26.7	22.8	11.6	30.1	45.7	0.5	7.6	49.5	12.3	14.4	26.3	14.5	32.6	16.2	5.8	5.8	11.7	30.4	39.3	27.6	24.1	22.5	11.9	18.9	20.5	2.2	18.2	28.1	23.3	4.0	50.3	18.0	1.8	3.6	0.4	11.9	6.7	16.9	0.5	0.7	14.8	33.0	23.6	26.8	40.0	5.7	3.7	44.0	21.6	2.0	0.7	8.2	56.3	4.8	9.6	2.0	23.1	31.4	9.5	2.8	24.8	7.6	14.9	18.8	2.7	52.7	15.7	17.2	19.5	32.9	4.0	2.2	0.8	45.1	4.9	30.6	9.8	12.3	13.4	26.3	4.4	14.2	0.5	12.1	17.2	7.6	0.4	9.6	12.8	49.5	14.4	0.2	1.2	9.1	14.5	17.9	16.5	15.5	18.6	18.0	7.6	15.7	8.1	15.8	14.4
RAB26		ENSG00000167964	"RAB26, member RAS oncogene family"	Q9ULW5	16	2140803-2154165	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.5;liver: 21.9;pancreas: 24.6;salivary gland: 17.7"	"Cell line enhanced"	"Detected in many"		"A549: 13.6;HeLa: 14.9;MCF7: 8.9;SCLC-21H: 18.9;SK-BR-3: 17.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075624			Uncertain	"Vesicles,Plasma membrane,Centrosome"	"Intracellular and membrane"			"Vesicles, Plasma membrane"	Centrosome	"HPA075624: "	"unprognostic (1.01e-2)"	"prognostic favourable (8.20e-5)"	"unprognostic (7.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.34e-2)"	"unprognostic (9.41e-3)"	"unprognostic (2.81e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.48e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.92e-3)"	0.6	1.0	13.6	0.4	19.9	0.5	0.9	30.5	13.5	2.0	4.1	0.5	1.5	5.7	0.4	2.3	1.2	0.9	1.1	1.2	18.0	6.2	0.7	21.9	0.6	0.6	5.6	9.1	0.6	24.6	3.1	9.2	0.3	2.5	2.2	5.4	0.7	17.7	1.6	1.1	1.2	6.0	0.4	1.9	0.6	5.3	0.6	3.2	0.0	1.2	0.0	1.1	0.9	0.0	0.8	0.2	0.0	0.1	0.0	1.1	0.7	1.1	13.6	0.0	3.5	0.2	0.1	0.1	0.6	1.1	0.5	0.9	0.4	2.7	0.2	0.9	0.8	2.2	0.7	0.2	0.0	1.5	1.4	0.5	14.9	1.2	0.6	0.0	0.4	0.5	0.1	0.1	0.2	0.3	0.3	0.0	1.6	8.9	0.0	0.6	0.8	1.2	1.1	1.1	2.3	5.2	0.9	18.9	3.7	0.3	17.1	0.6	5.6	0.2	0.6	0.0	2.5	0.2	0.2	2.0	0.1	0.2	0.3	0.1	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.1	0.0	0.8	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.7	13.6	19.9	30.5	13.5	18.0	6.2	5.6	9.1	2.5	3.2
RAB3A		ENSG00000105649	"RAB3A, member RAS oncogene family"	P20336	19	18196784-18204074	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 114.7"	"Cell line enhanced"	"Detected in many"		"PC-3: 13.5;SCLC-21H: 24.7;SH-SY5Y: 11.8;U-2197: 17.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003160, CAB009949, CAB078998"	Enhanced	Supported	Approved	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"CAB009949: AB_632292, CAB078998: , HPA003160: AB_1079731"	"unprognostic (1.82e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.80e-3)"	"prognostic unfavourable (3.17e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.13e-1)"	"prognostic favourable (6.14e-7)"	"unprognostic (1.23e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.14e-2)"	2.3	13.0	32.3	2.6	50.5	2.0	2.0	39.1	114.7	2.8	3.1	6.3	0.0	3.6	2.7	2.6	2.4	3.2	2.8	17.0	40.8	32.7	4.1	2.2	2.5	2.4	31.5	35.6	8.0	2.3	5.0	7.5	2.4	38.2	3.8	2.8	5.8	4.2	4.4	7.5	2.5	3.0	2.9	7.0	2.5	2.5	2.2	4.8	0.0	2.9	0.1	2.1	2.9	0.7	4.6	6.0	5.1	3.0	0.7	4.2	2.6	0.9	1.0	2.3	3.2	3.8	1.0	1.4	2.0	1.2	1.4	1.9	0.9	0.5	3.3	2.2	1.6	2.7	10.7	1.3	0.7	0.7	3.4	1.3	3.9	3.7	0.9	2.2	4.1	3.1	1.3	0.8	0.4	0.4	0.7	1.1	1.3	3.2	5.0	0.6	1.9	13.5	3.5	0.2	2.8	1.5	0.5	24.7	11.8	1.0	4.3	2.3	0.9	0.4	0.4	1.2	0.9	17.1	1.1	2.1	4.5	0.8	3.2	1.7	1.1	0.0	3.0	3.8	3.0	2.2	4.0	4.6	3.2	3.0	6.0	2.2	4.1	4.2	5.1	0.7	2.7	5.5	1.8	2.6	32.3	50.5	39.1	95.0	40.8	32.7	31.5	35.6	38.2	4.8
RAPGEF2	"DKFZP586O1422, KIAA0313, PDZ-GEF1, PDZGEF1, RA-GEF"	ENSG00000109756	"Rap guanine nucleotide exchange factor 2"	Q9Y4G8	4	159103013-159360174	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, GTPase activation, Guanine-nucleotide releasing factor"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 9.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 9.4;NK-cells: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057169			Supported	Nucleoplasm,Vesicles,Centrosome				"Nucleoplasm, Vesicles, Centrosome"		"HPA057169: "	"unprognostic (4.88e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.67e-2)"	"unprognostic (7.79e-3)"	"unprognostic (8.16e-2)"	"unprognostic (4.71e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.07e-1)"	"prognostic favourable (1.76e-7)"	"unprognostic (2.29e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.78e-1)"	16.7	8.0	28.4	8.8	23.8	51.0	16.3	21.5	34.1	12.6	14.5	11.3	10.4	10.9	12.7	7.3	9.9	10.2	14.1	14.9	23.4	15.3	16.4	20.9	18.1	8.5	14.1	29.6	10.2	13.4	20.7	13.8	26.1	16.9	9.3	14.8	10.0	18.7	9.4	15.7	12.7	11.9	14.0	13.9	19.2	13.7	6.7	14.3	9.3	27.5	8.9	7.8	11.9	13.8	0.4	1.4	9.4	1.4	5.2	1.5	0.3	3.2	4.4	21.1	6.5	8.3	9.4	32.4	6.3	8.0	5.8	4.2	13.6	7.3	18.6	2.3	6.3	3.0	7.1	8.1	6.9	3.1	5.0	28.9	9.3	7.8	6.0	3.5	40.0	5.4	4.6	13.9	4.9	16.5	6.3	17.4	7.1	5.7	8.7	0.5	9.0	4.4	7.1	5.3	0.7	5.2	7.5	6.0	8.0	9.3	4.5	7.7	2.2	2.3	17.5	9.2	9.7	11.7	5.2	19.4	11.5	0.3	10.9	1.5	5.5	2.7	1.4	1.0	0.8	0.8	1.0	0.4	0.7	0.5	0.8	0.3	0.9	0.4	9.4	5.2	0.9	1.4	1.5	0.3	28.4	23.8	21.5	34.1	23.4	15.3	14.1	29.6	16.9	14.3
RAPSN	"CMS1D, CMS1E, RNF205"	ENSG00000165917	"Receptor associated protein of the synapse"	Q13702	11	47437757-47449178	"Disease related genes, Predicted intracellular proteins"			"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"skeletal muscle: 45.3;tongue: 14.8"	"Cell line enriched"	"Detected in some"	4	"RH-30: 71.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"							HPA039475	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Centrosome, Cytosol"		"HPA039475: AB_10794196"	"unprognostic (5.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.34e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.35e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.64e-4)"	"unprognostic (3.83e-1)"	"unprognostic (4.73e-3)"	"unprognostic (4.48e-2)"	1.7	0.8	0.2	0.1	0.2	0.2	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	2.7	0.7	0.1	0.1	1.4	0.4	0.0	0.1	0.2	0.2	0.1	0.7	0.0	0.0	0.1	0.0	0.0	1.2	0.3	0.4	0.0	0.3	0.8	0.0	45.3	0.2	0.2	0.1	0.2	0.3	0.1	0.2	0.1	0.1	0.4	14.8	0.4	0.0	0.0	0.2	0.1	2.6	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.4	0.1	0.0	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	71.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.6	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.7	0.0	2.6	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.2	0.4	0.0	0.7	0.0	0.3	0.1
RLBP1	CRALBP	ENSG00000140522	"Retinaldehyde binding protein 1"	P12271	15	89209869-89221751	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Transport, Vision"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"retina: 164.1"	"Cell line enriched"	"Detected in single"	48	"SK-MEL-30: 21.4"	"Group enriched"	"Detected in some"	30	"glioma: 3.7;melanoma: 7.4"	"Group enriched"	"Detected in many"	4	"amygdala: 6.9;basal ganglia: 10.6;cerebral cortex: 7.0;hippocampal formation: 3.7"	"Group enriched"	"Detected in some"	7	"basophil: 3.3;neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042051, HPA044083"	Enhanced	Approved	Supported	Nucleoplasm,Centrosome,Cytosol				Cytosol	"Nucleoplasm, Centrosome"	"HPA042051: , HPA044083: "	"unprognostic (3.19e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.76e-1)"		"unprognostic (8.24e-3)"	"unprognostic (5.21e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.76e-1)"		"unprognostic (2.78e-1)"	"unprognostic (1.13e-1)"		"unprognostic (8.42e-2)"	0.2	0.7	6.9	0.6	10.6	0.6	0.2	0.6	11.5	0.2	0.8	0.3	0.1	0.9	0.2	1.0	0.3	0.2	0.3	0.2	3.7	1.3	0.2	0.2	0.3	0.3	1.6	0.6	0.2	0.2	0.2	1.7	0.3	0.4	0.2	0.8	164.1	0.2	0.2	0.5	0.3	0.6	0.5	0.5	0.3	0.2	1.1	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0.0	0.0	3.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	6.9	10.6	0.6	7.0	3.7	1.3	1.6	0.6	0.4	0.1
RNF39	"HZFw1, LIRF"	ENSG00000204618	"Ring finger protein 39"	Q9H2S5	6	30070266-30075887	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 28.3;skin 1: 26.4"	"Cell line enhanced"	"Detected in some"		"A-431: 2.9;HEK 293: 2.6;U-266/84: 8.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.3"	"Group enriched"	"Detected in some"	4	"cerebral cortex: 8.0;hippocampal formation: 4.2"	"Group enriched"	"Detected in some"	6	"cerebellum: 17.9;cerebral cortex: 9.3;hippocampal formation: 5.7"	"CAB019278, HPA047115"	Uncertain		Approved	"Vesicles,Plasma membrane,Centrosome"				"Vesicles, Plasma membrane, Centrosome"		"CAB019278: , HPA047115: "	"unprognostic (1.05e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.72e-3)"	"unprognostic (3.08e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.45e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.06e-4)"	"unprognostic (5.61e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.57e-2)"	0.3	0.2	0.1	0.3	0.3	0.4	5.1	0.3	0.9	7.3	0.7	0.0	1.1	0.9	0.8	0.3	28.3	0.8	1.1	0.2	0.2	0.1	0.3	0.3	3.6	0.3	0.2	0.0	0.6	2.3	0.4	0.4	9.7	0.3	8.1	0.4	0.6	10.2	0.6	0.4	26.4	0.4	1.0	0.2	0.2	4.3	0.8	0.0	0.3	0.4	10.1	11.7	7.8	12.4	0.0	0.0	1.3	0.0	0.2	0.0	0.0	2.9	0.0	0.7	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	1.6	0.0	1.4	0.0	0.5	2.6	1.1	0.3	0.0	0.0	0.1	0.3	0.0	1.9	0.0	0.2	0.0	0.7	0.6	0.0	1.0	0.0	1.3	0.0	0.0	0.3	0.4	0.0	1.9	0.3	0.2	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.5	0.6	0.0	0.3	1.9	8.0	0.7	0.6	0.1	1.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.4	0.2	0.1	0.2	0.0	0.3	0.0
RUVBL2	"ECP51, INO80J, Reptin52, RVB2, TIH2, TIP48, TIP49b"	ENSG00000183207	"RuvB like AAA ATPase 2"	Q9Y230	19	48993448-49015995	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 59.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012432, HPA042880, HPA067966"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Cytosol"	Centrosome	"CAB012432: , HPA042880: AB_2678210, HPA067966: AB_2685933"	"unprognostic (1.71e-1)"	"unprognostic (9.06e-3)"	"unprognostic (3.51e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavourable (9.28e-4)"	"unprognostic (7.06e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.28e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.58e-1)"	6.9	5.3	6.7	7.5	7.1	13.4	4.8	8.2	10.4	4.8	9.9	7.6	6.3	11.2	8.3	5.5	16.1	5.5	7.2	9.1	6.9	6.0	7.6	10.3	5.5	8.2	7.7	8.1	6.5	8.7	1.6	6.4	5.5	6.7	6.0	3.2	6.5	10.0	6.6	27.8	7.7	10.0	3.7	7.1	6.9	10.7	59.0	5.8	14.6	8.8	9.4	8.1	6.4	12.9	12.6	16.4	5.6	14.3	11.0	12.5	15.2	28.8	29.7	3.5	20.0	1.5	2.7	9.4	15.6	6.8	17.9	11.8	15.4	12.5	27.1	12.1	3.1	15.3	2.1	10.2	2.1	16.4	12.2	17.7	8.9	7.8	5.0	34.7	12.4	3.1	2.0	4.0	2.1	6.6	30.6	11.5	1.6	5.9	30.6	4.1	10.7	4.4	25.4	16.0	17.4	3.2	11.1	14.2	20.5	15.7	13.1	5.6	11.6	13.3	9.7	11.4	16.7	7.5	38.6	23.4	26.7	28.0	8.4	17.0	16.3	5.6	14.3	4.2	11.1	11.1	11.2	10.9	11.1	9.1	16.4	12.6	12.2	8.0	1.0	11.0	10.8	12.5	12.5	15.2	6.7	7.1	8.2	10.4	6.9	6.0	7.7	8.1	6.7	5.8
SEMA4F	"SEMAM, SEMAW"	ENSG00000135622	"Ssemaphorin 4F"	O95754	2	74654228-74683853	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064095, HPA065969"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome"				Nucleoplasm	"Plasma membrane, Centrosome"	"HPA064095: , HPA065969: "	"unprognostic (9.69e-2)"	"unprognostic (8.88e-3)"	"unprognostic (1.58e-2)"	"prognostic unfavourable (5.94e-5)"	"prognostic unfavourable (6.96e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.61e-3)"	"unprognostic (6.95e-2)"	"unprognostic (9.01e-3)"	"unprognostic (6.53e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (9.74e-6)"	"unprognostic (2.60e-2)"	"unprognostic (8.08e-2)"	"prognostic favourable (6.94e-4)"	"unprognostic (4.69e-2)"	8.1	5.1	15.5	3.5	15.5	1.3	5.7	12.9	21.3	5.2	3.8	3.3	2.3	1.9	6.6	6.7	2.7	5.6	3.5	4.9	17.2	12.2	4.8	2.1	8.1	5.1	5.3	16.5	9.1	4.6	13.7	10.2	3.5	7.8	5.2	4.2	3.6	5.0	5.7	3.0	4.9	3.0	7.0	5.7	4.7	4.3	7.2	3.8	2.9	4.7	1.3	4.9	3.5	4.7	2.8	0.2	1.4	0.4	2.5	5.6	2.1	7.1	4.9	5.3	7.5	8.7	4.8	3.3	5.0	10.4	9.1	8.4	2.0	4.1	2.4	5.4	7.9	2.1	7.7	8.5	10.1	6.3	6.6	4.2	2.0	4.0	3.1	0.9	6.7	4.4	7.4	6.1	3.2	3.9	0.3	0.1	5.3	2.1	3.8	0.7	2.9	4.7	0.0	6.9	0.0	7.1	3.4	3.3	8.0	7.2	3.0	9.0	3.5	0.5	4.2	15.5	7.5	3.7	9.1	5.8	5.8	0.3	18.9	0.3	8.3	0.5	0.2	1.4	5.6	0.1	3.2	2.8	3.0	4.9	0.2	2.1	3.3	3.9	0.8	2.5	0.4	0.1	2.2	2.1	15.5	15.5	12.9	21.3	17.2	12.2	5.3	16.5	7.8	3.8
SH3RF3	"FLJ00204, POSH2, SH3MD4"	ENSG00000172985	"SH3 domain containing ring finger 3"	Q8TEJ3	2	109129348-109504632	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 13.8;RPMI-8226: 13.2;TIME: 15.3;U-266/84: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"							"HPA044822, HPA048444"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA044822: , HPA048444: "	"unprognostic (1.97e-1)"	"unprognostic (8.84e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavourable (2.33e-4)"	"unprognostic (4.57e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.39e-2)"	17.4	5.6	2.7	3.4	4.4	0.6	18.3	1.7	5.4	5.3	3.6	3.3	2.5	1.0	5.5	2.2	3.4	4.8	5.6	6.4	3.0	2.1	2.5	0.8	6.0	2.9	4.3	1.5	3.0	1.8	0.6	2.6	6.5	3.8	3.4	1.6	4.6	2.4	5.9	6.4	2.9	2.3	4.6	2.8	2.0	2.7	4.3	2.9	1.5	3.4	3.6	4.0	4.6	3.4	0.4	0.4	1.8	0.2	0.0	0.6	0.3	0.0	0.0	0.1	1.4	6.3	4.8	0.0	2.8	8.2	2.1	0.8	0.7	0.0	0.0	2.1	2.0	0.0	0.1	1.2	0.9	0.0	2.8	0.0	0.1	0.0	13.8	0.0	0.0	8.3	1.9	9.6	4.3	7.6	0.0	7.9	4.8	0.0	0.0	4.2	0.7	7.9	1.7	0.0	13.2	0.0	0.0	0.4	1.7	0.0	0.0	0.3	0.1	0.0	15.3	2.7	8.2	7.8	3.6	2.7	17.8	0.0	0.0	4.1	3.7	0.0	0.2	0.7	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.4	0.6	0.6	1.8	0.0	0.0	0.4	0.0	0.3	2.7	4.4	1.7	3.3	3.0	2.1	4.3	1.5	3.8	2.9
SMAD4	"DPC4, MADH4"	ENSG00000141646	"SMAD family member 4"	Q13485	18	51028394-51085045	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019154	Approved		Supported	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Cytosol"	Centrosome	"HPA019154: AB_1853480"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.05e-1)"	"unprognostic (7.29e-3)"	"unprognostic (9.00e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.03e-3)"	"unprognostic (4.40e-2)"	"prognostic favourable (1.92e-5)"	"unprognostic (2.62e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	25.6	17.5	16.0	14.0	16.7	11.4	24.9	29.7	16.0	27.9	22.6	17.9	21.3	15.1	28.2	18.8	21.7	20.5	17.5	19.6	15.3	11.5	21.0	22.0	20.1	16.0	17.2	13.3	30.5	25.0	30.0	28.9	30.6	14.2	27.8	17.4	18.4	23.1	22.8	39.7	18.2	23.4	27.6	13.9	21.7	19.3	17.6	18.4	38.8	35.0	13.9	18.1	29.0	24.1	3.6	3.6	3.4	1.8	2.9	4.7	1.3	8.5	11.3	30.7	8.8	12.7	19.6	17.3	15.0	16.5	20.2	25.4	6.9	2.0	14.2	4.5	13.0	14.1	17.2	6.7	21.5	12.3	9.7	9.8	11.3	7.9	12.6	17.1	7.7	8.9	11.4	9.9	14.6	14.6	11.0	13.1	11.9	4.5	10.1	4.9	16.0	7.1	13.2	15.6	13.9	9.7	3.7	19.0	11.3	14.0	2.6	9.3	7.0	10.0	11.0	17.1	7.9	4.3	9.9	19.7	13.7	12.3	11.1	6.7	11.3	0.8	1.8	1.8	3.2	1.1	3.7	2.2	3.3	2.6	3.6	3.6	4.0	4.7	3.4	2.9	1.3	2.9	4.3	1.3	16.0	16.7	29.7	16.0	15.3	11.5	17.2	13.3	14.2	18.4
SP6	"Epfn, KLF14"	ENSG00000189120	"Sp6 transcription factor"	Q3SY56	17	47844908-47855874	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 33.7;placenta: 24.7;seminal vesicle: 26.2"	"Cell line enriched"	"Detected in some"	5	"BEWO: 44.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebellum: 1.3;pons and medulla: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA024516, HPA044469"			Supported	"Nucleoplasm,Mitotic spindle,Centrosome"				Nucleoplasm	"Mitotic spindle, Centrosome"	"HPA024516: AB_10960551, HPA044469: AB_10966430"	"unprognostic (3.06e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.55e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (2.11e-6)"	"unprognostic (1.22e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.59e-3)"	"prognostic favourable (6.39e-4)"	"unprognostic (3.33e-1)"	"unprognostic (9.93e-2)"	"prognostic favourable (5.72e-4)"	0.9	1.0	0.1	0.5	0.0	0.0	3.8	1.3	0.2	1.7	1.8	0.1	33.7	1.5	0.4	4.1	5.8	1.1	0.4	0.4	0.1	0.1	0.9	0.1	3.6	0.5	0.1	0.0	3.6	0.4	2.0	0.2	24.7	1.1	6.9	0.7	0.2	1.0	26.2	0.1	14.9	5.3	0.3	0.3	0.9	0.3	0.4	0.0	0.8	1.3	5.6	3.6	5.3	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.1	0.4	0.0	0.0	0.0	0.0	44.6	0.2	0.2	0.9	0.2	9.4	0.9	0.0	0.3	0.0	1.3	0.0	1.6	0.2	0.1	0.3	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.9	0.1	2.1	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	5.6	1.4	0.0	0.0	5.7	0.0	2.3	0.0	3.0	0.2	1.3	0.0	0.2	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.3	0.2	0.1	0.1	0.1	0.0	1.1	0.0
SPPL2B	"IMP4, KIAA1532, PSL1"	ENSG00000005206	"Signal peptide peptidase like 2B"	Q8TCT7	19	2328615-2354806	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005592, HPA039292"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome"				"Nucleoplasm, Plasma membrane"	Centrosome	"CAB005592: AB_325074, HPA039292: "	"unprognostic (4.16e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.48e-2)"	"prognostic favourable (5.00e-5)"	"unprognostic (2.34e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.93e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.72e-1)"	"prognostic favourable (1.33e-4)"	"unprognostic (3.29e-3)"	"prognostic unfavourable (6.45e-4)"	"unprognostic (2.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.40e-2)"	5.4	4.6	5.0	11.7	5.4	11.7	4.0	6.9	6.9	3.4	9.0	7.9	9.6	19.3	4.7	10.0	3.2	5.2	9.8	3.3	5.6		4.2	3.9	3.5	10.3	7.1	4.7	3.4	13.8	6.3	11.0	6.8	7.1	4.7	3.9	6.0	10.5	8.7	7.5	8.7	16.2	5.0	7.0	8.1	13.8	20.1	6.4	9.3	3.0	3.7	5.7	2.3	2.0	14.4	17.4	9.3	7.7	6.2	8.2	5.9	8.3	13.3	5.7	10.2	4.7	4.8	14.7	10.9	3.2	4.0	4.3	9.3	9.5	8.0	10.3	5.1	11.2	1.9	3.7	1.2	9.3	8.3	5.3	20.9	12.5	8.9	9.3	6.9	7.0	4.3	3.8	2.7	5.6	8.5	20.4	2.4	9.2	10.0	11.8	10.7	5.5	16.8	3.0	21.9	4.3	21.0	10.2	9.7	10.9	6.7	8.4	11.1	15.6	12.4	7.3	5.3	18.5	8.5	26.9	9.6	8.3	9.2	10.9	12.7	9.3	7.7	7.0	6.6	7.5	4.8	9.0	6.0	6.5	9.4	14.4	7.8	8.2	3.4	6.2	5.1	17.4	5.9	5.9										
SYNJ1	"INPP5G, PARK20"	ENSG00000159082	"Synaptojanin 1"	O43426	21	32628759-32728048	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Endocytosis	"Hydrolase, RNA-binding"	"Disease mutation, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011916	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Cytosol"	Centrosome	"HPA011916: AB_1857692"	"unprognostic (6.84e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.27e-1)"	"prognostic favourable (4.43e-4)"	"unprognostic (1.45e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.63e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.84e-2)"	"prognostic unfavourable (2.58e-4)"	"unprognostic (1.28e-1)"	"unprognostic (6.36e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.92e-1)"	5.5	6.8	13.6	5.0	25.9	20.6	4.2	19.5	39.0	4.8	4.8	6.5	0.8	3.9	4.6	5.3	3.9	4.0	5.2	5.2	18.3	18.2	7.4	5.5	6.5	5.7	16.6	18.4	4.6	4.5	10.6	10.9	9.3	33.5	3.6	5.5	7.0	3.8	4.0	4.4	5.0	4.6	5.0	7.3	6.0	4.2	9.0	5.7	3.2	6.8	1.5	4.8	4.7	3.3	0.4	3.1	11.5	6.0	0.5	3.0	1.1	5.5	2.8	5.1	5.6	8.9	7.2	10.3	11.5	6.6	7.0	5.9	6.3	2.6	2.0	3.9	6.9	5.2	9.1	6.7	8.4	6.5	8.7	13.8	9.0	3.5	4.8	5.7	12.3	4.0	5.0	12.2	6.2	10.9	10.3	11.9	9.0	5.6	5.3	4.7	3.6	6.3	5.8	11.1	7.2	7.4	4.0	5.8	4.5	14.1	9.0	5.5	7.8	7.4	12.1	10.9	5.4	8.7	6.3	6.2	7.2	4.3	8.2	10.8	8.6	3.7	3.4	7.9	1.6	6.0	2.7	0.2	2.4	2.6	3.1	0.4	2.9	2.8	11.5	0.5	5.3	1.6	3.0	1.1	13.6	25.9	19.5	28.7	18.3	18.2	16.6	18.4	33.5	5.7
TCHP	"MGC10854, TpMs"	ENSG00000139437	"Trichoplein keratin filament binding"	Q9BT92	12	109900264-109983841	"Predicted intracellular proteins"	"Apoptosis, Cilium biogenesis/degradation"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038638, HPA061543"	Supported		Supported	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Centrosome, Cytosol"		"HPA038638: AB_10670785, HPA061543: "	"unprognostic (2.21e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.15e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.22e-1)"	"prognostic favourable (5.52e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.92e-2)"	8.6	10.4	16.0	11.3	29.3	8.3	9.3	22.9	25.0	10.2	11.2	19.0	7.5	9.9	13.0	10.9	18.3	8.7	8.3	10.3	15.9	11.0	8.5	7.0	10.0	14.5	23.8	13.9	11.3	12.7	12.1	12.1	10.4	18.6	10.7	9.6	11.0	13.4	11.6	10.8	36.1	10.2	15.0	15.9	15.0	10.2	12.5	24.2	10.9	12.0	7.7	15.1	11.4	15.4	3.2	3.3	4.5	5.2	9.2	7.4	4.4	16.3	14.6	7.9	9.5	7.0	7.6	10.7	15.5	8.3	13.6	7.6	9.2	5.8	23.0	4.6	9.1	13.8	8.6	9.8	12.3	12.3	8.5	16.6	9.1	8.9	8.5	22.5	12.8	6.2	12.0	14.3	10.8	12.1	17.9	4.7	11.2	11.2	20.5	22.9	9.5	14.9	18.9	15.6	19.4	6.2	14.7	11.8	12.4	11.4	12.3	11.0	11.1	16.4	13.4	14.0	9.7	8.9	19.8	13.4	17.0	16.5	14.9	18.7	14.5	0.0	4.2	3.4	6.2	2.7	4.3	3.2	5.4	7.4	3.3	2.3	5.4	4.2	4.5	9.2	5.2	2.4	7.2	4.4	16.0	29.3	22.9	25.0	15.9	11.0	23.8	13.9	18.6	24.2
TMEM169	FLJ34263	ENSG00000163449	"Transmembrane protein 169"	Q96HH4	2	216081866-216102783	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.8"	"Cell line enhanced"	"Detected in some"		"AF22: 8.3;LHCN-M2: 6.7;RPTEC TERT1: 12.2;SCLC-21H: 10.5;SH-SY5Y: 15.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062462, HPA062797, HPA070657, HPA074877"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Cytosol"	Centrosome	"HPA062462: , HPA062797: , HPA070657: , HPA074877: "	"unprognostic (5.15e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.87e-3)"	"unprognostic (4.69e-7)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.43e-1)"	"unprognostic (7.16e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.51e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.02e-1)"	1.7	2.9	5.9	2.5	6.2	1.3	0.9	9.7	16.8	2.1	1.3	3.9	1.6	1.9	1.1	1.9	0.9	2.9	2.5	1.1	5.5	6.3	4.9	4.2	2.1	2.4	5.5	4.8	1.1	1.0	0.8	2.4	0.7	9.1	1.4	1.2	4.9	0.9	1.1	1.5	1.6	1.7	1.2	6.6	2.6	1.0	1.3	2.5	0.7	6.7	0.0	2.0	1.1	0.7	3.0	0.2	4.3	5.7	0.7	6.3	1.3	0.1	0.4	8.3	0.2	0.9	0.1	0.0	0.3	0.2	0.2	0.8	0.4	2.4	0.1	6.1	0.3	0.2	1.1	0.0	0.2	1.2	0.4	2.7	0.1	1.5	1.8	0.2	0.6	0.6	0.6	0.6	0.8	0.0	0.0	0.4	6.7	0.7	0.2	0.3	4.3	0.1	1.5	2.4	0.2	12.2	0.0	10.5	15.1	0.2	0.2	6.0	0.4	1.1	0.1	0.2	0.4	0.2	0.4	1.9	2.0	0.4	1.9	0.2	1.5	1.3	1.8	0.3	2.3	1.5	1.7	2.4	4.0	2.7	0.0	3.0	4.2	1.9	4.3	0.7	5.7	0.2	6.3	1.3	5.9	6.2	9.7	11.5	5.5	6.3	5.5	4.8	9.1	2.5
TRDMT1	"DNMT2, RNMT1"	ENSG00000107614	"TRNA aspartic acid methyltransferase 1"	O14717	10	17142254-17202054	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009468, HPA036945, HPA036946"	Approved		Approved	Nucleoplasm,Nucleoli,Centrosome				Nucleoli	"Nucleoplasm, Centrosome"	"CAB009468: AB_2208432, HPA036945: , HPA036946: "	"unprognostic (4.55e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.49e-6)"	"unprognostic (7.07e-2)"	"unprognostic (3.87e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.27e-4)"	"unprognostic (3.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.64e-2)"	6.1	4.4	4.4	8.5	7.7	4.0	6.3	14.0	6.2	5.3	3.8	4.2	4.7	4.1	7.5	14.4	3.9	6.8	5.1	5.0	4.9	4.5	6.7	2.7	5.3	5.3	4.3	2.9	9.6	5.0	12.8	12.6	5.1	6.2	5.0	3.6	8.0	5.6	3.8	4.3	4.4	5.0	5.4	5.1	5.9	4.2	4.2	6.1	19.9	11.5	3.3	5.7	4.0	5.2	6.1	10.5	5.2	4.4	3.5	8.0	3.6	5.1	2.5	10.0	2.6	3.8	2.2	0.0	4.4	3.2	4.7	5.5	4.2	4.3	3.5	0.6	5.0	2.6	6.7	4.2	5.4	7.4	4.3	5.2	3.8	2.5	3.4	3.4	3.9	3.0	2.6	3.2	2.3	6.1	6.5	3.9	7.7	1.6	17.0	0.8	6.3	2.9	3.7	7.8	2.2	2.5	2.8	2.7	3.4	0.0	1.9	3.4	4.8	3.1	3.6	3.4	7.2	6.3	5.1	5.0	4.7	8.9	4.3	4.8	3.4	5.2	4.4	2.4	3.9	2.5	7.2	5.4	6.6	4.9	5.5	6.1	8.0	5.8	2.8	3.5	1.4	10.5	2.2	3.6	4.4	7.7	14.0	6.2	4.9	4.5	4.3	2.9	6.2	6.1
TRIM38	"RNF15, RORET"	ENSG00000112343	"Tripartite motif containing 38"	O00635	6	25962802-25991226	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA031685	Approved		Approved	"Plasma membrane,Cell Junctions,Centrosome"				Centrosome	"Plasma membrane, Cell Junctions"	"HPA031685: AB_10603218"	"unprognostic (6.62e-2)"	"unprognostic (1.65e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.51e-2)"	"unprognostic (7.79e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.78e-2)"	"prognostic favourable (8.95e-5)"	"unprognostic (2.81e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.36e-1)"	"unprognostic (4.49e-2)"	"prognostic favourable (8.20e-5)"	"prognostic favourable (4.94e-9)"	13.3	8.4	2.5	15.7	2.3	12.0	7.9	1.1	3.4	17.2	12.1	3.1	20.5	6.7	26.2	22.3	15.7	8.9	9.2	5.8	2.8	2.3	26.1	8.8	14.0	14.4	3.7	1.8	11.5	4.3	1.0	4.3	10.3	3.5	15.5	7.8	9.2	9.8	16.5	9.0	5.3	14.6	13.1	4.5	17.6	6.6	5.3	2.9	16.6	13.7	9.5	20.1	18.0	15.4	16.5	10.1	12.1	12.9	6.7	7.9	6.3	3.5	2.0	0.3	4.3	10.3	13.9	3.6	4.5	8.9	8.7	14.5	1.5	3.8	7.9	7.4	5.5	5.6	2.7	4.4	5.2	7.9	1.8	3.5	3.3	1.4	13.7	4.2	7.4	13.8	3.2	5.4	1.9	7.5	2.3	4.4	10.3	1.7	4.0	4.8	1.4	2.7	6.2	4.3	8.2	10.4	7.0	0.1	0.1	3.4	7.1	12.0	1.0	5.5	7.7	1.6	2.7	2.7	3.0	5.1	3.7	8.9	4.2	5.2	9.6	10.1	10.6	4.7	7.6	12.9	7.4	14.3	6.5	6.8	10.1	16.5	6.2	6.7	12.1	6.7	11.4	9.5	7.9	6.3	2.5	2.3	1.1	3.4	2.8	2.3	3.7	1.8	3.5	2.9
TRPV3	VRL3	ENSG00000167723	"Transient receptor potential cation channel subfamily V member 3"	Q8NET8	17	3510502-3557995	"Disease related genes, FDA approved drug targets, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease mutation, FDA approved drug targets, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 15.4;skeletal muscle: 29.1"	"Cell line enhanced"	"Detected in some"		"A-431: 3.5;BEWO: 5.3;CACO-2: 4.2;RH-30: 13.0;T-47d: 5.5;U-266/70: 3.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"basal ganglia: 2.4"	"Cell type enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in many"	6	"cerebellum: 14.0"	HPA069550			Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane"	"Centrosome, Cytosol"	"HPA069550: "	"unprognostic (1.84e-4)"	"unprognostic (2.25e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.92e-4)"	"unprognostic (4.87e-3)"	"unprognostic (2.96e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.88e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.64e-2)"	"unprognostic (2.93e-2)"	0.4	0.2	0.4	3.2	2.4	0.9	4.1	0.3	1.2	0.6	10.6	0.1	0.3	3.2	0.2	0.2	2.3	0.3	0.8	0.3	0.4	0.3	0.2	1.1	0.3	0.5	0.4	0.2	0.3	0.9	0.0	0.7	0.4	0.0	0.2	2.9	0.3	0.5	0.4	29.1	8.4	15.4	0.5	0.5	0.4	1.6	0.8	0.0	0.0	0.2	9.7	3.0	0.7	2.1	0.7	0.6	2.9	0.6	0.6	0.7	0.1	3.5	0.0	0.5	0.1	0.2	0.6	5.3	0.2	0.0	0.0	0.0	4.2	0.9	0.2	1.0	0.1	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.6	0.1	0.2	0.8	0.3	0.0	0.7	1.8	0.0	0.1	0.1	0.0	0.7	0.1	0.2	0.1	0.5	0.1	13.0	0.2	0.0	0.2	0.1	0.0	0.2	0.6	0.0	5.5	0.2	0.1	0.1	0.2	0.1	0.1	3.5	2.7	0.0	0.1	0.1	0.0	2.9	0.4	0.4	0.7	0.2	0.5	0.7	0.4	0.7	0.1	0.5	0.4	0.6	1.0	0.6	0.6	0.6	0.2	0.1	0.4	2.4	0.3	1.2	0.4	0.3	0.4	0.2	0.0	0.0
TSEN2	"MGC2776, SEN2, SEN2L"	ENSG00000154743	"TRNA splicing endonuclease subunit 2"	Q8NCE0	3	12484432-12539623	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	Lyase	"Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027120, HPA027125, HPA027268"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA027120: AB_10600197, HPA027125: AB_10601896, HPA027268: AB_10601347"	"unprognostic (5.58e-2)"	"unprognostic (4.49e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.71e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (1.13e-5)"	"unprognostic (1.42e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.90e-2)"	"unprognostic (6.06e-2)"	"prognostic favourable (3.49e-4)"	8.8	10.6	9.7	8.8	19.1	6.7	10.9	16.5	14.0	10.4	9.8	12.7	8.4	5.8	14.0	9.9	7.9	12.8	10.3	14.3	10.5	12.3	9.8	7.3	7.3	10.9	11.5	7.6	18.0	11.9	14.3	15.3	4.9	10.2	10.5	10.9	13.5	7.2	13.1	16.7	15.3	6.1	12.3	12.3	6.1	8.5	11.3	9.1	9.9	12.5	9.6	8.1	8.6	8.3	8.5	7.1	2.6	4.2	5.0	13.7	5.6	8.0	14.0	7.5	9.9	12.8	13.6	17.4	7.6	6.7	8.1	5.9	7.9	8.6	9.7	5.3	6.2	7.5	12.5	13.0	9.3	7.6	15.6	10.6	18.8	8.1	9.9	16.6	4.1	11.7	15.1	14.8	18.2	6.5	15.6	5.3	9.4	15.1	12.6	7.6	10.6	16.9	9.6	5.2	19.3	12.2	8.2	4.9	8.6	7.0	6.3	5.9	11.4	11.6	5.8	5.2	5.1	7.1	11.7	5.0	12.7	12.0	7.0	16.7	6.5	2.4	4.2	0.3	6.4	4.2	10.9	8.5	9.8	7.4	5.9	8.3	13.7	11.7	2.6	5.0	3.6	7.1	3.5	5.6	9.7	19.1	16.5	14.0	10.5	12.3	11.5	7.6	10.2	9.1
TXLNA	DKFZp451J0118	ENSG00000084652	"Taxilin alpha"	P40222	1	32179686-32198285	"Cancer-related genes, Predicted intracellular proteins"	Exocytosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045383, HPA072477"	Supported		Approved	Nucleoplasm,Centrosome,Cytosol				Cytosol	"Nucleoplasm, Centrosome"	"HPA045383: AB_10967649, HPA072477: "	"prognostic favourable (6.24e-4)"	"unprognostic (1.19e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.04e-2)"	"prognostic favourable (5.53e-4)"	"prognostic unfavourable (1.57e-6)"	"unprognostic (3.67e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.25e-3)"	"prognostic favourable (8.69e-5)"	"unprognostic (5.06e-2)"	"prognostic unfavourable (7.21e-7)"	"unprognostic (3.94e-3)"	"unprognostic (3.28e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.03e-1)"	22.5	29.4	20.2	19.4	27.5	14.0	17.9	23.2	26.4	20.3	23.7	17.0	23.4	16.6	30.4	24.7	24.2	25.0	24.6	16.4	18.5	13.9	20.9	44.8	19.0	19.9	25.6	13.4	26.5	23.6	31.5	35.9	19.3	21.8	24.6	18.5	20.8	23.9	23.3	16.5	31.0	18.9	28.3	19.9	23.5	21.2	38.4	22.9	17.0	22.8	18.8	26.0	19.3	23.5	8.0	14.3	8.4	12.2	14.2	13.9	9.0	19.7	16.9	17.7	19.8	22.9	30.3	14.3	28.3	22.5	27.4	26.3	18.8	21.5	22.6	11.5	27.4	22.4	24.0	18.6	25.0	25.8	18.6	35.7	24.6	24.6	24.4	25.9	28.4	30.3	25.0	28.9	13.7	21.6	14.5	23.4	22.3	10.9	18.9	16.7	25.7	15.6	22.3	26.8	19.9	18.7	25.2	18.5	19.1	29.3	18.6	30.0	17.2	15.8	22.4	29.0	25.1	38.2	36.0	35.0	27.0	20.5	30.0	35.4	26.7	8.4	9.0	4.5	13.9	9.7	11.9	7.3	9.6	10.3	6.9	8.0	8.4	9.1	1.3	14.2	12.2	14.3	7.0	9.0	20.2	27.5	23.2	26.4	18.5	13.9	25.6	13.4	21.8	22.9
TYSND1	"MGC34695, NET41"	ENSG00000156521	"Trypsin domain containing 1"	Q2T9J0	10	70137981-70146676	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 40.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 17.7;PC-3: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030304	Approved		Uncertain	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Centrosome"	Cytosol	"HPA030304: AB_10670560"	"unprognostic (4.75e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.26e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-2)"	15.2	8.2	4.7	7.0	6.8	3.0	8.0	6.7	7.3	6.0	6.7	5.9	6.9	10.1	5.3	8.4	13.9	5.4	5.2	3.5	3.7	2.8	7.4	7.4	3.5	7.2	3.7	3.6	5.6	9.0	3.3	4.5	4.7	3.5	6.9	2.7	6.9	8.0	5.7	5.3	12.5	8.5	4.8	4.7	9.0	8.2	40.7	3.4	6.2	8.5	6.6	10.1	6.5	7.6	6.1	1.4	1.2	1.6	2.9	6.3	2.3	9.4	6.7	0.5	4.0	0.7	0.6	2.4	1.2	0.8	1.4	1.3	4.3	6.0	8.4	4.0	0.3	17.7	0.7	2.6	0.3	5.3	6.0	0.5	1.9	2.1	1.6	0.7	0.0	1.2	5.1	1.2	2.1	1.0	0.0	2.6	0.6	4.2	3.2	3.5	2.2	27.2	5.6	1.6	3.7	0.6	1.6	4.9	2.5	4.1	9.3	3.6	6.0	0.7	1.7	1.6	1.1	3.0	5.3	9.6	5.8	4.1	1.9	3.6	1.2	0.0	1.3	1.2	6.3	1.6	4.1	5.1	3.7	4.9	1.4	6.1	5.3	4.4	0.4	2.9	1.1	1.0	4.0	2.3	4.7	6.8	6.7	7.3	3.7	2.8	3.7	3.6	3.5	3.4
UBR4	"KIAA0462, KIAA1307, RBAF600, ZUBR1"	ENSG00000127481	"Ubiquitin protein ligase E3 component n-recognin 4"	Q5T4S7	1	19074506-19210276	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Calmodulin-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013394, HPA021046"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA013394: , HPA021046: AB_1858578"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.78e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.14e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.14e-3)"	"unprognostic (7.48e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.68e-3)"	"unprognostic (4.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.52e-1)"	24.4	25.4	22.4	29.0	25.4	58.3	23.7	28.5	32.5	22.4	28.5	26.3	31.5	18.2	34.0	32.5	22.7	20.3	27.3	20.5	23.3	15.9	25.5	29.7	31.2	20.3	21.0	20.9	35.5	21.0	40.9	31.4	28.4	25.0	30.7	20.5	30.6	24.7	27.1	55.9	69.0	25.5	39.3	20.2	26.5	30.2	41.1	21.6	37.7	26.1	17.3	25.9	43.4	29.0	4.6	9.1	18.3	18.5	2.7	3.4	4.6	22.9	23.2	21.0	15.5	39.3	20.3	18.2	17.9	18.9	19.5	17.8	37.0	19.8	13.9	16.8	23.6	15.7	16.4	17.8	18.3	11.5	14.5	31.7	22.4	24.1	27.7	19.4	21.1	18.1	22.9	39.7	38.3	21.3	21.6	12.9	18.5	16.4	9.1	23.7	17.0	13.1	12.8	16.4	11.6	17.6	13.5	14.9	14.8	21.2	12.2	15.2	8.4	15.3	33.0	22.9	14.3	27.1	20.0	15.3	9.2	16.1	15.7	30.0	19.4	18.3	18.5	2.9	3.4	3.8	2.9	4.6	3.0	1.9	9.1	2.9	2.7	2.5	9.8	2.7	1.3	4.3	2.1	4.6	22.4	25.4	28.5	32.5	23.3	15.9	21.0	20.9	25.0	21.6
UGP2	"UGP1, UGPP1"	ENSG00000169764	"UDP-glucose pyrophosphorylase 2"	Q16851	2	63840940-63891562	"Enzymes, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 185.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 93.6;T-reg: 29.9"	"Group enriched"	"Detected in all"	5	"granulocytes: 93.6;T-cells: 29.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034696, HPA034697, HPA064836"	Enhanced		Approved	Nucleoplasm,Centrosome,Mitochondria			12000000	"Centrosome, Mitochondria"	Nucleoplasm	"HPA034696: AB_10670171, HPA034697: AB_2674287, HPA064836: AB_2685365"	"unprognostic (1.00e-2)"	"unprognostic (6.93e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.91e-1)"	"prognostic favourable (2.50e-5)"	"unprognostic (2.20e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.81e-1)"	"unprognostic (8.44e-2)"	58.2	14.7	23.3	13.6	22.5	7.8	25.2	12.4	30.4	13.3	38.2	6.7	7.4	12.3	15.5	12.5	19.8	12.7	12.2	46.3	18.8	13.2	33.0	185.5	12.7	15.2	17.3	18.3	12.0	13.4	17.1	22.9	31.0	19.3	11.0	33.1	5.7	18.5	12.9	104.1	11.0	17.2	16.8	8.6	9.9	13.0	8.1	10.5	31.0	17.4	75.5	12.7	19.7	19.5	6.4	5.9	93.6	7.8	12.7	29.9	11.0	27.3	14.4	13.8	9.3	47.2	61.2	58.0	35.4	29.0	19.1	22.8	36.9	23.3	28.7	10.7	38.0	12.0	16.7	22.2	31.0	19.2	7.1	18.2	10.2	25.2	22.5	16.0	16.1	40.1	40.7	17.9	18.5	26.5	9.1	11.7	79.6	10.8	21.7	15.1	33.1	10.1	17.8	27.4	16.6	33.8	16.0	7.3	6.0	28.3	36.4	13.4	10.4	11.4	36.1	20.0	31.6	29.7	18.6	20.9	9.4	36.4	24.0	25.1	61.0	93.6	7.0	9.7	9.9	7.8	10.3	6.4	11.4	10.3	5.9	6.2	12.6	11.2	9.0	12.7	7.6	5.5	29.9	11.0	23.3	22.5	12.4	30.4	18.8	13.2	17.3	18.3	19.3	10.5
USF3	KIAA2018	ENSG00000176542	"Upstream transcription factor family member 3"	Q68DE3	3	113648385-113696646	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029243, HPA029245"	Uncertain		Uncertain	Nucleoplasm,Nucleoli,Centrosome				"Nucleoplasm, Nucleoli"	Centrosome	"HPA029243: AB_10611114, HPA029245: AB_10600443"	"unprognostic (2.80e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.21e-2)"	"unprognostic (7.80e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.30e-1)"	"prognostic favourable (1.74e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.55e-2)"	9.0	5.1	8.8	11.0	7.3	13.8	11.4	13.9	7.5	7.2	12.2	5.3	5.4	4.8	5.8	13.3	7.0	6.3	5.3	8.1	7.6	5.5	12.7	24.0	6.1	9.2	6.3	5.6	6.9	10.8	14.4	8.9	4.9	6.5	6.2	6.7	6.4	8.3	5.4	28.7	11.4	14.7	8.3	11.2	12.0	7.3	4.8	6.9	13.3	7.1	11.5	8.9	6.1	6.0	5.9	5.1	6.9	3.7	2.6	3.1	1.4	5.2	3.9	4.9	4.6	12.0	4.6	3.3	2.1	3.4	2.1	2.0	3.7	2.2	9.2	3.8	5.3	3.3	5.3	4.2	3.9	2.8	2.1	6.6	2.5	6.0	3.6	11.9	7.3	6.7	7.6	3.8	4.4	4.9	3.1	4.9	4.4	7.3	6.6	6.7	3.6	4.0	2.8	3.8	3.6	7.4	7.3	2.3	3.5	5.1	2.8	6.0	3.9	8.9	6.7	3.3	7.1	1.8	3.0	5.7	3.2	11.0	3.7	5.0	2.4	4.1	2.4	3.5	3.1	2.8	2.3	2.2	2.2	2.3	1.7	5.9	2.7	2.8	6.9	2.6	3.7	5.1	1.1	1.4	8.8	7.3	13.9	7.5	7.6	5.5	6.3	5.6	6.5	6.9
USP38	"HP43.8KD, KIAA1891"	ENSG00000170185	"Ubiquitin specific peptidase 38"	Q8NB14	4	143184917-143223830	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 45.3"	"Cell line enhanced"	"Detected in all"		"U-266/84: 35.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036990, HPA047948"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA036990: , HPA047948: AB_2680220"	"unprognostic (5.01e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.04e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.03e-2)"	"unprognostic (7.72e-3)"	"prognostic favourable (1.20e-4)"	"unprognostic (3.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-1)"	7.7	7.8	6.6	6.6	6.5	19.1	8.3	7.4	7.8	7.9	12.1	8.6	8.8	8.8	8.3	7.1	8.6	7.1	7.6	12.5	6.6	5.3	9.3	15.2	12.7	11.1	10.3	5.1	6.3	8.8	10.0	6.2	11.4	5.9	6.6	6.6	7.1	7.2	7.0	45.3	8.9	13.2	6.5	10.8	10.6	7.4	7.5	8.2	22.6	8.6	10.2	8.4	7.8	8.8	6.3	8.1	12.5	5.7	12.3	9.9	5.0	4.7	4.5	4.0	6.8	5.2	5.2	2.9	7.6	7.4	7.0	6.0	12.9	7.0	5.9	5.4	6.4	3.8	9.3	7.5	5.8	14.4	6.0	5.4	5.3	2.7	7.2	10.9	5.4	6.3	6.9	7.2	5.8	7.0	11.7	18.5	4.7	7.5	14.2	2.0	3.6	8.7	9.4	5.9	5.6	4.5	5.5	8.1	7.3	5.9	10.3	6.6	6.3	4.1	8.3	6.5	5.3	5.6	7.9	20.7	35.1	10.7	6.6	8.4	5.4	12.5	5.4	11.7	7.5	5.7	9.6	6.3	6.6	6.5	8.1	5.7	6.7	5.7	5.4	12.3	5.7	3.5	9.9	5.0	6.6	6.5	7.4	7.7	6.6	5.3	10.3	5.1	5.9	8.2
VPS37A	"FLJ32642, HCRP1, PQBP2, SPG53"	ENSG00000155975	"VPS37A, ESCRT-I subunit"	Q8NEZ2	8	17246571-17302427	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024705, HPA024781"	Supported		Approved	Vesicles,Centrosome,Cytosol				Vesicles	"Centrosome, Cytosol"	"HPA024705: AB_10601776, HPA024781: AB_10602100"	"unprognostic (8.28e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.39e-3)"	"unprognostic (3.91e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.88e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.18e-1)"	23.5	21.3	15.1	13.5	15.6	12.8	22.1	23.1	18.1	21.3	23.5	15.8	16.4	18.6	19.1	15.1	22.7	13.3	15.5	34.4	15.8	14.9	23.3	25.9	18.4	14.4	16.6	10.4	21.7	15.8	34.2	20.8	31.6	16.1	20.0	16.2	20.7	15.2	22.7	41.8	16.5	27.3	24.4	20.2	16.4	14.9	27.7	14.6	17.3	18.0	16.4	14.8	27.6	22.7	10.1	11.7	25.0	15.2	20.6	15.5	11.4	7.0	11.7	10.2	8.9	22.6	18.0	11.1	25.3	21.5	23.4	20.2	7.8	6.9	6.1	13.8	20.2	7.0	11.4	11.1	27.7	6.2	3.4	11.2	5.9	8.3	26.5	4.3	10.6	17.5	21.6	21.6	22.2	16.6	8.2	15.8	24.6	4.8	13.1	11.1	10.1	6.1	6.4	11.4	7.2	19.6	9.8	12.2	6.5	10.1	10.1	15.6	6.6	9.1	14.1	14.1	7.2	20.2	13.2	5.0	10.2	7.1	16.1	8.3	14.4	25.0	15.2	13.5	12.9	11.3	15.5	9.9	12.4	12.3	11.7	10.1	11.6	13.8	15.9	20.6	10.0	10.8	11.4	11.4	15.1	15.6	23.1	18.1	15.8	14.9	16.6	10.4	16.1	14.6
WDR83	MORG1	ENSG00000123154	"WD repeat domain 83"	Q9BRX9	19	12666800-12675832	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042629, HPA042838"	Uncertain		Approved	Nucleoplasm,Vesicles,Centrosome				Vesicles	"Nucleoplasm, Centrosome"	"HPA042629: AB_10794763, HPA042838: AB_10794173"	"unprognostic (1.12e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.43e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.60e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.56e-2)"	"prognostic favourable (5.44e-4)"	"unprognostic (1.30e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.37e-1)"	"prognostic favourable (3.12e-4)"	6.4	7.8	10.2	6.2	9.1	8.8	6.5	17.2	14.5	7.1	5.2	9.1	2.3	4.9	5.8	6.1	5.9	11.3	5.2	9.2	8.5	8.9	8.1	5.9	6.0	8.3	12.4	11.6	9.2	11.6	9.4	6.7	4.9	9.1	6.9	2.6	7.7	14.6	6.9	4.6	11.3	6.3	3.8	7.0	7.4	7.1	9.2	10.6	11.7	9.2	2.6	5.8	6.0	5.7	8.8	19.4	5.4	11.1	17.6	11.3	8.6	5.0	8.4	4.8	6.6	9.5	3.5	3.9	4.8	4.5	5.8	6.1	9.8	4.4	7.6	7.0	4.3	5.7	5.6	7.4	1.1	7.7	12.3	6.0	5.6	6.1	7.5	8.3	7.1	6.5	6.0	4.7	3.8	5.8	5.3	0.8	2.6	19.1	12.1	6.8	3.8	14.6	8.6	6.2	7.1	5.5	5.9	10.0	6.7	5.2	7.1	4.2	4.0	8.2	3.1	6.5	2.0	5.1	5.0	19.4	13.0	3.4	10.2	6.4	4.2	4.5	11.1	4.6	9.2	9.6	10.7	8.1	8.9	8.6	11.1	8.8	8.7	11.3	5.4	17.6	4.7	19.4	9.8	8.6	10.2	9.1	17.2	14.5	8.5	8.9	12.4	11.6	9.1	10.6
ZBED1	"ALTE, DREF, hDREF, KIAA0785, TRAMP"	ENSG00000214717	"Zinc finger BED-type containing 1"	O96006	X	2486414-2500967	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 63.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA077591			Approved	"Nucleoplasm,Nuclear membrane,Centrosome"				Nucleoplasm	"Nuclear membrane, Centrosome"	"HPA077591: "	"unprognostic (7.66e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.92e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (3.13e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.27e-1)"	8.5	10.5	24.8	6.0	30.7	3.1	63.7	24.8	29.0	36.8	8.1	1.7	1.7	10.6	28.9	2.8	6.1	6.4	7.1	43.4	27.3	7.2	39.6	13.6	5.9	6.0	25.1	19.6	28.7	10.4	6.8	27.8	37.5	32.5	6.8	6.4	1.7	7.7	6.3	29.5	9.5	11.2	5.1	30.4	7.9	6.6	3.4	27.1	1.7	5.4	1.7	4.8	5.8	31.4	12.7	13.7	13.0	12.4	5.4	11.5	10.2	5.1	12.9	9.4	10.3	6.0	6.4	42.5	7.3	8.1	4.3	5.0	16.4	4.6	10.2	8.5	9.7	2.4	8.9	7.6	3.2	12.0	11.9	7.6	11.0	13.9	7.9	4.6	15.9	9.4	6.0	4.5	3.4	10.2	9.6	3.4	8.4	3.6	7.7	3.7	23.1	7.6	6.2	9.3	4.8	7.2	10.1	11.2	11.0	6.2	16.8	11.6	4.6	10.0	13.9	9.3	4.9	5.1	7.9	4.1	0.0	16.9	3.8	6.7	5.2	1.8	11.6	9.7	11.5	12.4	10.3	9.4	6.8	6.5	13.7	12.7	6.6	5.4	13.0	5.4	9.3	10.1	6.6	10.2	24.8	30.7	24.8	29.0	27.3	7.2	25.1	19.6	32.5	27.1
ZBTB24	"BIF1, KIAA0441, PATZ2, ZNF450"	ENSG00000112365	"Zinc finger and BTB domain containing 24"	O43167	6	109462594-109483237	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017872, HPA049003"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Centrosome"				Nucleoplasm	"Cytokinetic bridge, Centrosome"	"HPA017872: , HPA049003: "	"unprognostic (8.15e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.98e-2)"	"prognostic unfavourable (3.15e-4)"	"unprognostic (4.53e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.60e-1)"	"unprognostic (6.77e-2)"	9.6	7.1	6.6	13.8	13.7	16.6	10.1	12.7	11.5	9.5	7.5	11.4	6.8	7.6	9.8	7.5	8.4	8.4	6.4	5.5	7.0	6.8	9.1	6.6	8.5	16.9	11.5	8.8	8.3	8.2	19.1	10.0	12.4	8.8	8.8	8.5	9.6	9.8	9.1	9.7	12.2	11.1	8.5	7.7	13.7	8.6	9.0	12.1	17.4	10.8	5.2	17.1	10.0	10.2	5.7	2.2	1.7	1.5	2.4	5.3	1.0	3.8	4.0	3.7	9.2	6.0	6.1	6.1	4.5	6.2	5.7	6.5	5.6	3.0	16.6	5.9	5.6	5.1	9.3	7.0	8.6	10.3	9.2	13.4	5.4	4.2	4.4	10.9	6.9	6.1	5.8	5.7	10.0	4.6	11.2	9.4	5.8	6.6	15.6	7.4	9.2	4.5	9.8	5.2	6.9	6.9	6.7	6.3	5.5	5.7	6.1	14.2	4.2	11.9	4.6	4.6	4.6	3.8	9.6	4.6	3.5	17.1	6.0	8.7	7.6	0.1	1.2	1.7	1.5	1.1	0.9	5.7	3.0	1.8	1.4	5.6	3.9	2.2	0.8	2.4	1.5	2.2	5.3	1.0	6.6	13.7	12.7	11.5	7.0	6.8	11.5	8.8	8.8	12.1
ZFP90	"KIAA1954, NK10, ZNF756"	ENSG00000184939	"ZFP90 zinc finger protein"	Q8TF47	16	68530090-68576072	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029017	Uncertain		Supported	"Vesicles,Plasma membrane,Centrosome"				"Vesicles, Plasma membrane, Centrosome"		"HPA029017: AB_10669653"	"unprognostic (3.27e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.78e-1)"	"unprognostic (5.19e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.43e-1)"	"prognostic favourable (1.78e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.60e-2)"	9.6	9.0	16.9	11.5	19.3	7.8	16.2	24.0	19.5	14.2	8.9	18.9	10.4	4.4	15.8	18.2	7.6	14.3	9.5	10.3	15.5	19.8	11.6	7.9	9.6	12.4	16.7	20.5	18.1	8.7	29.1	16.5	8.3	20.0	13.1	9.3	11.4	8.7	13.6	10.0	13.2	8.3	13.6	16.1	13.2	11.2	11.6	19.6	15.8	11.0	3.6	15.5	11.3	9.6	5.8	2.6	7.8	1.9	5.2	8.8	3.0	7.1	7.8	14.7	13.9	13.1	14.0	6.6	6.8	7.8	9.3	10.8	5.5	4.8	7.7	8.8	8.6	6.8	9.0	8.6	10.7	6.7	3.7	1.9	1.5	9.2	10.2	0.0	7.3	12.1	14.2	8.6	12.0	7.4	3.8	2.9	11.4	12.8	7.6	7.4	5.5	5.9	14.1	5.1	5.1	6.4	5.1	16.7	12.7	19.4	1.5	7.3	11.7	10.2	5.3	8.8	5.3	7.4	3.9	5.6	10.4	9.4	2.9	2.7	7.0	7.8	1.7	2.8	6.4	1.9	8.8	5.8	6.0	7.4	2.4	4.1	8.7	7.5	0.5	5.2	1.3	2.6	6.8	3.0	16.9	19.3	24.0	19.5	15.5	19.8	16.7	20.5	20.0	19.6
ZNF121	"D19S204, ZHC32, ZNF20"	ENSG00000197961	"Zinc finger protein 121"	P58317	19	9560353-9584533	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA054961	Uncertain		Approved	Nucleoplasm,Nucleoli,Centrosome				"Nucleoplasm, Centrosome"	Nucleoli	"HPA054961: "	"unprognostic (3.06e-1)"	"unprognostic (9.38e-3)"	"unprognostic (9.51e-2)"	"unprognostic (7.49e-2)"	"unprognostic (3.07e-2)"	"unprognostic (3.91e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.80e-3)"	"prognostic favourable (6.59e-5)"	"unprognostic (9.36e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavourable (1.01e-4)"	"unprognostic (8.75e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.06e-1)"	"prognostic favourable (5.75e-5)"	13.8	8.9	10.4	11.0	12.3	21.0	14.0	16.1	11.8	10.6	8.9	6.2	12.5	6.7	9.4	10.0	16.5	12.4	7.6	10.3	10.3	5.0	9.2	13.2	14.6	13.0	13.6	6.3	13.8	12.5	22.3	20.2	8.3	11.0	11.8	10.6	5.3	14.1	13.7	9.4	18.6	12.3	12.3	14.8	12.4	11.1	6.2	13.0	12.2	11.3	10.4	12.1	15.8	12.7	6.0	4.6	2.9	4.5	7.1	6.8	1.8	7.6	4.9	5.9	12.3	2.7	3.3	9.1	2.6	2.4	4.0	5.0	8.5	3.4	8.7	7.6	2.1	7.6	12.1	7.0	5.6	4.2	19.6	27.2	12.2	7.6	3.4	13.4	13.6	4.5	6.2	3.9	10.3	2.9	9.7	14.8	2.9	6.4	9.9	30.9	14.6	8.6	6.4	8.1	6.0	3.8	32.5	10.6	5.4	5.2	5.2	3.0	4.2	4.3	4.2	12.7	7.1	4.3	6.8	15.7	8.6	10.3	3.4	7.9	4.3	2.9	3.6	2.1	5.5	4.4	6.8	4.0	4.9	5.1	4.1	6.0	6.1	6.8	2.8	7.1	4.5	4.6	4.3	1.8	10.4	12.3	16.1	11.8	10.3	5.0	13.6	6.3	11.0	13.0
ZNF322	"bA457M11.2, bA457M11.3, HCG12, ZNF322A, ZNF388, ZNF489"	ENSG00000181315	"Zinc finger protein 322"	Q6U7Q0	6	26634383-26659752	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043161, HPA046692"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA043161: , HPA046692: "	"unprognostic (1.01e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.39e-3)"	"prognostic favourable (1.28e-4)"	"unprognostic (1.21e-1)"	"unprognostic (9.35e-2)"	"prognostic favourable (8.57e-4)"	"unprognostic (5.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.24e-2)"	"unprognostic (5.71e-2)"	8.8	9.7	7.7	5.4	10.9	0.4	10.1	10.6	15.4	13.1	8.6	7.9	9.5	6.9	12.7	10.8	6.8	9.2	11.5	13.3	8.4	6.9	9.5	7.0	7.9	6.7	8.8	7.0	14.8	6.9	15.0	18.0	8.6	11.8	12.3	8.6	8.6	8.2	15.5	7.7	5.0	7.9	9.7	10.7	8.7	7.6	8.2	12.5	4.3	13.6	6.7	7.2	11.8	8.4	11.2	7.9	10.5	11.2	17.6	11.4	4.9	5.7	4.4	17.3	19.8	11.4	15.2	6.2	7.7	10.2	10.8	13.1	8.5	3.6	7.0	18.6	6.7	7.3	12.8	5.0	13.5	10.8	11.6	12.3	5.7	8.3	12.9	0.0	11.2	9.3	17.7	7.1	8.1	9.3	14.1	7.5	11.8	3.3	8.6	10.3	5.0	5.3	9.7	12.2	9.9	6.7	9.2	14.0	14.8	9.2	8.7	16.2	8.1	8.0	9.2	18.0	7.2	7.3	7.8	7.9	15.8	6.7	3.9	2.0	18.1	3.3	8.7	10.5	11.4	7.4	8.3	11.2	5.8	7.4	7.0	10.5	6.8	9.9	8.3	17.6	11.2	7.9	4.4	4.9	7.7	10.9	10.6	15.4	8.4	6.9	8.8	7.0	11.8	12.5